¼š议日程... · 2017-05-02 · palais des congrès plan 133m132m131m 138m 137m 136m 135m 134m...
TRANSCRIPT
Palais des Congrès plan
133M 132M 131M
138M
137M
136M
135M
134M
128M
127M
126M
125M
124M
121M 122M 123M
EXHIBITION HALL
LONDON PUB
CYBER SPACE ABSTRACTPOSTERS
SINGAPOREFOOD COURT
BAG PICK-UP
MAIN ARENA
EX
HI
BI
TI
ON
EX
HI
BI
TI
ON
103102101
104
111112113
EXHIBITOR SUPPORT CENTRE
MEET WITHTHE TRIALISTS
WC
WC WC
WCWC
WC WC
WC
MEZZANINE MEZZANINE
Level 0
Level 1
ENTRANCE
REGISTRATION AREA
TO LEVEL 1 TO LEVEL 1
CONCIERGE,HOTEL
FACULTYDESKS
TO LEVEL 0,5:
COMPANIES DESK, CLOAKROOM
11T0768_PCRpocket_00_Couv 18/04/11 11:29 Page2
1
MEZZANINE MEZZANINEPRESS
342AB
341351
353
THEATREBORDEAUX
THEATREHAVANE
TRAININGVILLAGE
INNOVATION INCUBATORWEDNESDAY
303
304
305
302313 301
329M
328M
327M
326M
325M
227M320M
227M321M
227M322M
324M
323M
339M
338M
337M
336M
335M
CASE CORNER
WC
WC WC
WCWC
WC WC
WC
PCRTV
352AB
343
334M
333M 332M
331M
330M
312
314 311
INTERACTIVECASE CORNER
233M 232M 231M
237M
236M
235M
234M
227M
226M
225M
224M
221M 222M 223M
EXHIBITION HALL
243
241251
253
BISTROT MONTMARTRE
PCR FAMILY STAND
PREVIEW
THEATREBLEU
ROOMMAILLOT
MAIN ARENA
204
211213 203202201212
WC
WC WC
WCWC
WC WC
WC
MEZZANINE MEZZANINE
242A
242B
GUESTLOUNGE
252AB
Level 2
Level 3
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page1
Collaborations
Jean Marco
William Wijns
Patrick W. Serruys
Jean Fajadet
Marie-Claude Morice
Bernard De Bruyne
Alec Vahanian
Marc van Sambeek
Eric Eeckhout
Alberto Cremonesi
Horst Sievert
Dierk Scheinert
Carlos Ruiz
Philipp Bonhoeffer
Tian-Hai Koh
Martyn Thomas
Programme Committee Members
Emanuele Barbato
Andreas Baumbach
Jeroen J. Bax
Siro Buendia
Bernard Chevalier
Thomas Cuisset
Mark de Belder
Peter de Jaegere
Victoria Delgado
Carlo Di Mario
Joel Dunning
Javier Escaned
Gérard Fournial
Martine Gilard
Javier Goicolea
Giulio Guagliumi
A. Pieter Kappetein
Lene Kløvgaard
Ran Kornowski
Marie Leahy
Thierry Lefèvre
Maciej Lesiak
Bela Merkely
Claude Mialhe
Christophe K. Naber
Kari Niemelä
Marko Noc
Giovanni Pedrazzini
Nicolo Piazza
Jan J. Piek
Jose-Luis Pomar
Nicolaus Reifart
Flavio Ribichini
Marco Roffi
Manel Sabate
Antoine Sauguet
Volker Schächinger
David Taggart
Didier Tchétché
Leif Thuesen
Marco Valgimigli
Robbert Vermeulen
Stephan Windecker
Adam Witkowski
Course directors
Alexandre Abizaid
Ibrahim Al-Rashdan
Jorge Belardi
Ted Feldman
Runlin Gao
Morton J. Kern
Spencer B. King III
Steen D. Kristensen
Mitch Krucoff
Alexandra Lansky
Amir Lerman
Yean Leng Lim
Thomas Lüscher
Tom Mabin
Laura Mauri
Ian Meredith
Richard Ng
John Ormiston
Augusto Pichard
Charanjit Rihal
Teguh Santoso
Ron Waksman
John Webb
Alan C.Y. Yeung
Scientific Advisory Committee
2
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page2
Live centres
3
Cardiovascular Center Aalst - Aalst, BelgiumOperators: E. Barbato, B. De Bruyne, L. DiSerafino
Cardiovascular Institute and Fu Wai Hospital - Beijing, ChinaOperators: C. Mu, Y. Wu, W. Yang, Y. Yang
Ferrarotto Hospital - Catania, Italy
The National Hospital, The Heart Center - Copenhagen, Denmark
Villa Maria Cecilia Hospital - Cotignola, Italy
Medizinische Klinik I - Darmstadt, GermanyOperators: R. Reifart, G. WernerInvited operator: D. Tchétché
Catharina Ziekenhuis - Eindhoven, The NetherlandsOperators: G. Brueren, P.W. Cuypers, J.A.W. Teijink
Heart Center Essen - Essen, GermanyOperators: M. Farazandeh, D. Lindemann, C.K. Naber, T. Schmitz, C. Wald, A. Wolf
CardioVasculäres Center - St. Katharinen - Frankfurt, GermanyOperator: H. Sievert
Universität Leipzig Herzzentrum - Leipzig, GermanyOperators: S. Bräunlich, A. Schmidt, M. Ulrich
St Thomas Hospital - London, United KingdomOperators: V. Bapat, D. Hildick-Smith, S. Redwood, U. Tevidi, M. Thomas, C. Young
Instituto Cardiovascular / Hospital Clínico San Carlos - Madrid, SpainOperators: F. Alfonso, J. Escaned, R. Hernández , P. Jimenez-Quevedo Invited operator: K. Koch
Hôpital Bichat Claude Bernard - Paris, Bichat, FranceOperators: G. Ducrocq, A. Vahanian
Hôpital Henri Mondor - Paris, Créteil, FranceOperators: P. Desgranges, I. Kobeiter
Institut Cardiovasculaire Paris Sud – Massy - Paris, Massy, FranceOperators: B. Chevalier, O. Darremont, T. Lefèvre, Y. Louvard, M.C. MoriceInvited operators: J. Fajadet, D. Hildick-Smith, G. Stankovic
Erasmus University Medical Center, ThoraxCenter - Rotterdam, The NetherlandsOperators: P. de Jaegere, E. Regar, C. Schultz, W. van der Giessen, R.J. van Geuns, N. Van Mieghem
Chest Hospital, Kuwait Heart Center - Safat, KuwaitOperators: M. Abdel Aziz, A. Al Habashi, I. Al Rashdan, C. Thomas
Clinique Pasteur - Toulouse, FranceOperators: J. Fajadet, B. Farah, D. TchétchéInvited operators: V. Dangoisse, G. Guagliumi, S. Kedev, F. Mauri, B. Merkely, S. Saito
Toyohashi Heart Center - Toyohashi, Japan
Institute of Cardiology - Warsaw, PolandOperators: Z. Chmielak, M. Dabrowski, M. Demkow, T. Deptuch, C. Kepka, K. Kukula, A. Witkowski
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page3
Collaborations
TranscatheterValve Symposium (TVS)
EuroPCR is the official meeting of the EuropeanAssociation of Percutaneous Cardiovascular Interventions (EAPCI)
European Association for Cardio-Thoracic Surgery (EACTS)
The scientific programme is the result of close collaboration withthe following European and international societies:
EuroPCR collaborates with the following organisations:
EBAC AccreditationEuroPCR 2011 is accredited by the European Board for Accredi-tation in Cardiology (EBAC) for 18 hours of External CME Cred-its. EBAC works in cooperation with the Europan AccreditationCouncil for Continuing Medical Education (EACCME), which isan institution of the Europan Union of Medical Specialists(UEMS).
US CME AccreditationThe American Medical Association (AMA) has an agreementof mutual recognition of continuing medical education (CME)credit with the European Union of Medical Specialties (UEMS).Under the terms of this agreement, the AMA will convert CMEcredit certified by the European Accreditation Council for Con-tinuing Medical Education (EACCME), the accrediting arm ofthe UEMS, to AMA PRA Category 1 Credit™.Physicians may apply to convert EACCME credit into AMA PRACategory 1 Credit™ by submitting a form and attaching an EACCME credit certificate. Download the form onhttp://www.ama-assn.org/
Dutch AccreditationIn 2011 EuroPCR is accredited by the Association of Surgeonsof The Netherlands.
Swedish Society for Vascular SurgeryIn 2011 EuroPCR is officially endorsed by the Swedish Societyfor Vascular Surgery.
Course accreditation
4
Stent for Life
g CCT g CIT
g ICI g SOLACI
Together we achieve more
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page4
Z Arbeitsgruppe Interventionelle Kardiologie – Deutsche Gesellschaft für Kardiologie
Z Association of Interventional Cardiology of Hungary
Z Association of Interventional Cardiology of Romania
Z Austrian Working Group on Interventional Cardiology
Z Belgian Society for Vascular Surgery (BSVS)
Z Belgian Working Group of Interventional Cardiology
Z British Cardiovascular Intervention Society (BCIS)
Z Bulgarian Working Group on Interventional Cardiology
Z Danish Working Group of Interventional Cardiology
Z Dutch Working Group of Interventional Cardiology
Z Egyptian Working Group of Interventional Cardiology (EWGIC)
Z Euro CTO Club
Z European Bifurcation Club
Z French Group of Interventional Cardiology (GACI)
Z German Working Group of Interventional Cardiology
Z Interventional Cardiology Working Group of the Czech Society of Cardiology
Z Iranian Society of Interventional Cardiology
Z Israeli Working Group on Interventional Cardiology
Z Italian Society of Invasive Cardiology (GISE)
Z Lebanese Working Group of Interventional Cardiology
Z Polish Association of Cardiovascular Interventions
Z Portuguese Association of Interventional Cardiology
Z Russian Society of Interventional Cardioangiology
Z Saudi Arabia Cardiology Interventional Group (SACIG)
Z Scottish Cardiac Society
Z Siberian Association of Interventional Cardioangiologists
Z Slovenian Working Group of Invasive and Interventional Cardiology
Z South African Society of Cardiovascular Intervention (SASCI)
Z Taiwan Society of Cardiology
Z Turkish Working Group of Interventional Cardiology
Z Vascular Surgery Society of Southern Africa (VASSA)
Z Working Group for Interventional Cardiology of the Cyprus Society of Cardiology
Z Working Group of Hemodynamics and Intervention of the Hellenic Cardiological Society
Z Working Group of Interventional Cardiology of the Croatian Cardiac Society
Z Working Group on Interventional Cardiology and Acute Coronary Syndrome of the Swiss Society of Cardiology
Z Working Group on Interventional Cardiology of Latvian Society of Cardiology
Z Working Group on Interventional Cardiology of the Cardiology Society of Serbia
Z Working Group on Interventional Cardiology of the Estonian Society of Cardiology
Z Working Group on PCI of the Danish Society of Cardiology
Z Working Group on PCI of the Norwegian Society of Cardiology
Z Working Group on PCI of the Spanish Society of Cardiology
Z Working Group on PCI of the Swedish Society of Cardiology
Scientific Societies and National Working Groups
5
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page5
Sessions types
Main sessions - 100% revampedThese completely revamped sessions concentrate on one major topicfor four hours. The most popular sessions at EuroPCR are now a part ofthese main sessions - including How should I treat?, Complications,Keynote lectures and live demonstrations. They will be open to thelargest audiences, held in the larger rooms such as the Main Arena.
All you need to knowDesigned to provide a comprehensive, structured update on keyclinical topics and an up-to-date reflection on a specific field. Thesesessions will be immediately transferred to PCRonline and will serve asthe core of a key topic section. Cases will be available on pcronline.comas well as links to the curriculum and web related content.
LTT (Learning the techniques)The renowned LTT sessions are always a success. This year, they will beclassified into one of the following categories: How to treat a patient,How to use or perform a technique. During these highly interactivesessions, audience participation is strongly encouraged. LTT includesLive in-a-box® cases.
Glimpse into the futureLearn about which tools, techniques or technologies may make theirway into tomorrow’s mainstream practice. With live demonstrations.
Innovation dayInnovation is one of the pillars of EuroPCR. This year, you’ll have a fullday to dive into the future. Best of ICI@EuroPCR session will highlightthe best of the Innovations in Cardiovascular Interventions meeting(ICI). Cardiovascular Innovation Pipeline@EuroPCR present innovativecompanies and their latest technologies. The Innovation incubator willshow highly innovative concepts and technologies in cardiovascularinterventions. Last but not least, the new session "ABC for inventors"will end the day. Chaired by Philipp Bonhoeffer, who performed thefirst human transcatheter heart valve implantation, in 2000, thisunique session aims to give young inventors a greater understandingof what it takes to bring their innovation forward.
“Call for” based sessionsAbstracts, Complications, Clinical cases. Your daily practice is that ofmany others. You are a major source of education. That's why this year,EuroPCR proposes >80 abstract sessions and >50 forum based onclinical cases and complications.Beside the sessions, cases submitted for EuroPCR will be displayed at theCase corner (Level 3) and open to all for online consultation.In the same area, the Interactive case corner will allow presenters andattendees to discuss the cases throughout the day.
Participants will exchange in a friendly environment, without any timeconstraints.Check the programme in the Daily!
How should I treat?Based on the EuroIntervention concept, these dynamic sessions bringtogether two experts to discuss the different treatment strategies fora case, and compare this with how the case was actually treated. Theyare the result of a fruitful collaboration between Scientific Societiesfrom all over the globe.
Hot linesThese sessions are reserved for first presentations of recentlycompleted clinical trials and new data or analysis of trials presented atprevious meetings. The Meet with the trialists session covers the best of Hot line sessionsand provides the opportunity to interact directly with the presenters.
Supported by the industry
Tech News & Trends (TNT)Tech News & Trends sessions address innovations, problems anddifficulties in daily practice or more challenging situations. 90 minutesare dedicated to live case transmissions which are the core of thesesessions. Designed to encourage audience interactivity (spot lectures,a limited number of slides), these sessions aim at helping the audiencefind an answer on how to simplify their practice. There are noacademic lectures, only cognitive teaching techniques are used.
SymposiaSymposia aim to develop themes through state-of-the-art lecturesand present clear syntheses of studies and trials. These sessionsshould allow attendees to leave with practical solutions topatient/lesion problems.
How should I treat?Based on the EuroIntervention concept, these dynamic sessions bringtogether two experts to discuss the different treatment strategies fora case, and compare this with how the case was actually treated.
Training villageTraining sessions are specific hands-on workshops with the aim ofimproving not only device knowledge, but also the manipulation skillsof the attendees, through a “coaching” style of teaching. Thesesessions offer a select number of attendees the possibility to gainexperience in a coached environment.
6
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page6
Participants will exchange in a friendly environment, without any timeconstraints.Check the programme in the Daily!
How should I treat?Based on the EuroIntervention concept, these dynamic sessions bringtogether two experts to discuss the different treatment strategies fora case, and compare this with how the case was actually treated. Theyare the result of a fruitful collaboration between Scientific Societiesfrom all over the globe.
Hot linesThese sessions are reserved for first presentations of recentlycompleted clinical trials and new data or analysis of trials presented atprevious meetings. The Meet with the trialists session covers the best of Hot line sessionsand provides the opportunity to interact directly with the presenters.
Supported by the industry
Tech News & Trends (TNT)Tech News & Trends sessions address innovations, problems anddifficulties in daily practice or more challenging situations. 90 minutesare dedicated to live case transmissions which are the core of thesesessions. Designed to encourage audience interactivity (spot lectures,a limited number of slides), these sessions aim at helping the audiencefind an answer on how to simplify their practice. There are noacademic lectures, only cognitive teaching techniques are used.
SymposiaSymposia aim to develop themes through state-of-the-art lecturesand present clear syntheses of studies and trials. These sessionsshould allow attendees to leave with practical solutions topatient/lesion problems.
How should I treat?Based on the EuroIntervention concept, these dynamic sessions bringtogether two experts to discuss the different treatment strategies fora case, and compare this with how the case was actually treated.
Training villageTraining sessions are specific hands-on workshops with the aim ofimproving not only device knowledge, but also the manipulation skillsof the attendees, through a “coaching” style of teaching. Thesesessions offer a select number of attendees the possibility to gainexperience in a coached environment.
7
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page7
8
NEW! Case corner
At EuroPCR we value your work and participation.
On Level 3, a new place has been created where all attendees canreview and discuss the cases that were submitted this year.
In between sessions? Taking a break? Stop by the Case corner: it’sopen all day long!
You will find it on level 3, between the Bordeaux and Havanetheatres. You will know you are in the right place when you reachthe purple carpet. The area is divided into 2 rooms: on one side youwill see the Case corner and on the other the Interactive casecorner.
The Case corner: Look over the complication and clinical cases in a welcoming and user-friendly environment
We believe that all cases submitted have an educational value, sothis year over 350 presentations are displayed via an easy-to-useapplication on 6 different computers.
The Interactive case corner:Take part in case-based exchanges!
In this space participants will discuss, share and learn with theircolleagues in a convivial and open atmosphere.
Facilitators will animate each session to encourage communication.The submitter will present his case and you will be free to askquestions and add your opinion. Receive on the spot feedback totake straight back to the cathlab with you.
Don’t forget to look out for the case discussion that interests youon the schedule available in the Daily.
MUST SEE!
Countries meet EuroPCRThese case-based discussion sessions are designed to act asplatforms for the country involved: China, India, Taiwan, SouthKorea and Russia.See Thursday and Friday programmes for more information!
ForumTalk about your experience: the Forum are peer-led sessionscreated to share, exchange and learn from each other. Everybody isencouraged to take the microphone and make a comment.
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page8
MUST SEE!
Endovascular Programme for interventional cardiologists: follow the “How to” sessions trackIn response to last year’s success the endovascular programmehas strengthened. In 2011 you’ll find more! Sessions, additional Livedemonstrations & increased sessions built from submissions. This programme is for interventional cardiologists who would liketo expand their current practice to endovascular/peripheral field.This tailor-made programme is a real “How to” and covers allperipheral vasculature, with live demonstration as the centrallearning tool.
Innovation incubatorWednesday is dedicated to innovation! Just outside theinnovation session rooms, find the innovation incubator. Grab abite to eat at the buffet table and chat with representatives from12 innovative companies to learn about their latest technology.This space is open to everyone, all day long on Level 3.
PostersFor the second year at EuroPCR, posters will be displayed. Over 160abstracts will be posted on Level 1. Don’t miss the interactiveposter sessions Wednesday and Thursday from 12:00 to 13:30.
Training village Head up to Level 3 and take a look at the training villageprogramme, where you can also sign up for sessions. Rememberplaces are limited to ensure participants spend the maximum oftime practicing themselves.See page 22 for the Training programme at a glance.
EAPCI General Assembly The EAPCI General Assembly will be held Tuesday evening in theMain arena. Besides a welcome by the President, Carlo Di Mario,and an update of EAPCI activities, questions submitted bymembers will be answered at the end of the assembly.
Meet with the trialists Put your questions to the principal investigators of trialspresented in the Late breaking trial sessions. This unique sessionallows participants to engage in in-depth exchange on the latestpioneering studies.Thursday 19th May, 14:00-16:00 - Level 1, room 101/102/103.
9
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page9
How to get the most out of EuroPCR
Once the Board of Directors, the Programme Committee
Members and the Scientific Advisory Board have finalised
a great scientific programme, covering all the hot topics,
with great speakers and world experts sharing their skills
and knowledge, there is still one thing missing…
YOU!As an attendee, you have an important role in the successof EuroPCR. To do this, we ask that you do three things:
. Ask questions! Raise your hand, ask that question and add to
the interactivity of the sessions. By doing so you’ll ensure that
EuroPCR is the best learning forum for you and your colleagues.
. Share your experience! Your personal experience as a practitio-
ner is a source of education in itself. Make sure you share it with
other attendees by picking up the microphone and being an ac-
tive attendee.
. Disagree! You don’t agree with what’s being said – then let us
know! You do things differently in your cathlab? Local constraints
have lead you to find another solution? Share it with us and help
grow the collective intelligence of the community.
Thanks for being an active participant!
10
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page10
11
Coronary & structural heart disease
The coronary and structural heart disease programme is colour-coded in blue.
4 coronary gateways4 categories that mirror the life-cycle of a device, moving from
innovation to the techniques that can be applied to the technology,
onto clinical studies, and finally evidence which often leads us to
establishing guidelines.
They are: Innovation, Technique, Clinic, Evidence.
C InnovationAs a springboard for innovation, EuroPCR puts you in contact with the
latest devices and the best innovations in the field.
The Innovation category helps you keep up to date with the latest
inventions and abreast of this fast-paced industry.
C TechniqueLearn it here and take it back to the cathlab!
The Technique category enables you to get your head - and your hands
around new techniques, as well as fine-tuning the ones you use as
part of your daily practice.
C ClinicFocusing largely on case-based learning, the Clinic category connects
technical know-how with in-depth clinical judgement.
It will help you see the trees from the woods, and ensure you make the
right decision for each individual patient.
C EvidenceWhat data matters?
The Evidence category tries to answer this question. EuroPCR unites a
community that covers over 90 countries, with a variation in local
constraints that is mind boggling to say the least.
How to get the most out of EuroPCR
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page11
Endovascular programme
The endovascular sessions are colour-coded in orange
In response to last year’s success the endovascular programme
has strengthened. It is divided in two, targeting both interventional
cardiologists and peripheral practitioners.
“How to” sessionsA programme for interventional cardiologists wishing to expand
their current practice to endovascular/peripheral. This tailor-made
programme of 7 sessions covers all peripheral vasculature, with
live case demonstration as the central learning tool.
Horst Sievert says, “Attendees can learn almost everything they
need to perform these procedures within 4 days. It starts with
basics on Tuesday and on the other days each session is dedicated
to one vessel area.”
Follow the How to… label. See page 188
“Break-out” programmeFor all those interested working in the endovascular field, these 8
sessions will bring you up-to-speed with the latest techniques,
technology and current controversies, with debate and discussion
in an interactive format.
Follow the Break-out label. See page 187
Don’t miss Carotid revascularisation: Live it!A live comparison of the clinical practice of interventional
cardiologists and cardiac surgeons.
Parallel live transmissions will be broadcast on two screens
showing both the cathlab and operating room, the sound will be
connected alternately from one room to another. The session will
be constructed so there is a real simultaneity between the 2
procedures.
12
.Opening session with continuous live demonstrationand Endovascular Late Breaking Trials
.Live demonstrations from: Frankfurt, Leipzig, Cotignola,London & Paris
.8 Abstract sessions
.6 Forum
.Innovation session in collaboration with CardiovascularInnovation Pipeline: Peripheral vascular disease andstructural heart disease
Highlights
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page12
13
Nurse and technician programme
Follow the Nurse & technician programme colour-coded ingreen
Non-sponsored programme. 7 nurse & technician scientific sessions
Constructing the scientific session programme, Siro Buendía, Lene
Kløvgaard, Marie Leahy and Robbert Vermeulen created a
programme that covers the main topics of interest for nurses and
technicians while ensuring the programme is coherent with the
rest of the EuroPCR programme.
. LTT session “Scrubbing-in for bifurcation PCI”
For the first time, one of the most popular session formats has
been adapted to the nurses & technicians point of view. Interactive
and 100% educative. With Live in-a-box® from Paris, Massy.
. A new forum session
Join the Forum on the treatment of STEMI, Thursday 19th May,
14:00. This original session format will allow you to listen to
different European countries’ perspectives and then participate in
1 hour of open discussion. Express yourself!
Sponsored programme.More than 19 training sessions
The Training village proposed by companies offers practical
education, with a number of sessions specifically for nurses and
technicians.
The number of participants for each session is limited in order to
ensure that each attendee spends the session practicing and not
waiting in line. Sign up on Level 3. See page 22 for the Training
programme at a glance.
Network!The nurses & technicians sessions are all programmed in Room 241.
It’s your place @ EuroPCR.
Meet, share, discuss and network in this dedicated nurses & technicians
room. To make networking with colleagues even easier, you will be
provided with coffee and lunch in the room.
“We must keep working together for the future improvement of
our profession and to offer the best possible patient care.”
Siro Buendia, nurse, Programme Committee Member.
Missed the 2011 call for submissions? Nurse & technician abstract
submissions will open for 2012 this August.
11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page13
Main arena
Theatre Bleu
Theatre Bordeaux
Theatre Havane
Room
Maillot
Room
241
Room
242A
Room
242B
Room
243
Room
251
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
Welcome & Live from
Frankfurt
p. 26
Opening: PCR Family
p. 26
The Great Debate
Med
tronic
Left
main in 201
1 - p
. 27
Live from
Toulouse
p. 32
Late breaking trials
p. 34
EAPCI General Assem
bly
p. 47
Abstracts - Carotid
p. 187
Abstracts - TAVI
p. 36
How should I treat?
Iran - Turkey
p. 42
Abstracts - TAVI
p. 27
Abstracts - DES
p. 36
Abstracts - Devices
p. 43
Forum - Multivessel disease
p. 28
Forum - Dissection
p. 37
Forum - Below the knee
p. 189
All you need to know about...
Pharmacology during PCI
p. 28
Forum - Left main (Part I)
p. 37
Forum - Left main (Part II)
p. 44
What's new in endovascular interventions?
p. 187
How to do
endovascu
lar interve
ntion
s: imaging
,vascu
lar access and e
quipm
ent sele
ction
p. 188
How to do
endovascu
lar interve
ntion
s: carotid and supra-aortic
intervention
sp. 189
Percutaneous revascularisation of CTO: a largely
disregarded alternative to surgery
p. 32
Symposium
Ab
bott
Vascular
PCI S
afety - p
. 47
TNT
Terumo
Left
main/
Multiv
essel d
isease - p
. 35
Symposium
As
traZe
neca
Antip
latelet t
herapy
in ACS
- p. 48
LTT - How to select m
aterial and equipment
for PCI
p. 34
Nurse research from
daily cathlab
practice
p. 217
How should I treat?
Iroko
Cardio
PCI for ACS
- p. 41
How should I treat?
Cordis
Radial vs femoral -
p. 48
Tuesday 17
thLEVEL 1: M
ain Aren
a / LEVEL 2:
Thea
tre Bleu, ro
om M
aillo
t, room
s 24
1 to 253
LEVEL 3:
Thea
tre Hav
ane & Bo
rdea
ux, roo
ms 34
1 to 353
, Training villa
geCo
rona
ry and
stru
ctural hea
rt disease
Endo
vascular
Nurses & te
chnician
sWith
Live
L
LL
LL
L
L
L
11T0768_PCRpocket_02_Glance 18/04/11 11:28 Page14
Room
252AB
Room
253
Room
341
Room
342AB
Room
351
Room
352AB
Room
353
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
Tuesday 17
th
Forum - Structural heart
interventions
p. 29
Forum - Complications
(Part I)
p. 38
Forum - Stent throm
bosis
p. 44
Abstracts - STEMI
p. 29
Abstracts - ACS
p. 38
Abstracts - TAVI
p. 45
Abstracts - CIN (Part I)
p. 30
Abstracts - CIN (Part II)
p. 39
Forum - TAVI
p. 46
Abstracts - Imaging
p. 31
Abstracts - PFO
p. 40
Abstracts - TAVI
p. 46
Symposium
Eurocor
DEB - p
. 30
Stent for Life @ EuroPCR 2011
p. 40
How should I treat?
Med
tronic
Critical lim
b isc
hemia -
p. 190
Forum - Devices
p. 33
Forum - AAA
p. 188
Abstracts - STEMI
p. 44
Symposium
Med
tronic
Corona
ry to
rena
l arte
ries - p
. 33
Symposium
St. Jud
e Med
ical
FFR - p
. 49
SOLACI@EuroPCR
p. 42
Training village at a glance, see page 22
11T0768_PCRpocket_02_Glance 18/04/11 11:28 Page15
Wednesday 18th
LEVEL 1: M
ain Aren
a / LEVEL 2:
Thea
tre Bleu, ro
om M
aillo
t, room
s 24
1 to 253
LEVEL 3:
Thea
tre Hav
ane & Bo
rdea
ux, roo
ms 34
1 to 353
, Training villa
geCo
rona
ry and
stru
ctural hea
rt disease
Endo
vascular
Nurses & te
chnician
sWith
Live
L
Main arena
Theatre Bleu
Theatre Bordeaux
Theatre Havane
Room
Maillot
Room
241
Room
242A
Room
242B
Room
243
Room
251
8h
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
Revascularisation in patients with com
plex left main stenosis
p. 50
Forum - TAVI
p. 50
Complication forum
p. 52
Forum - Dissection
p. 52
Abstracts
Endothelial function
p. 53
New generation DES
(ESC-EACTS revascularisation guidelines)
p. 59
LTT - How to treat a patient with high-risk non ST-segment
elevation acute coronary syndrom
ep. 60
TNT
Med
tronic
TAVI -
p. 69
Percutaneous intervention for m
itral regurgitation
p. 79
TNT
Abbo
tt Va
scular
Mitral -
p. 93
Symposium
Cordis
DAPT -
p. 70
Symposium
Boston
Scien
tific
CAD/
SHD - p
. 71
Symposium
Terumo
Prim
ay PCI -
p. 71
How should I treat?
Med
tronic
MVD
in Asia
Pacific - p
. 72
Abstracts - Diabetics
p. 73
How should I treat?
IHT - C
ordy
namic
Prim
ary PC
I - p. 7
4
Symposium
Bios
enso
rs In
ternationa
lDE
S - p
. 94
Symposium
Eli L
illy
ACS/
PCI - p. 9
4
How should I treat?
Med
tronic
Prim
ary PC
I - p. 9
6
Abstracts - Devices
p. 103
Revascularisation in patients with stable angina and com
plex
multivessel disease
p. 78
L
Secondary revascularisation - Part I - Restenosis in drug-eluting stents
p. 51
L
L
L
L
How to do endovascular interventions:
femoro-popliteal interventions
p. 192
Acute stroke interventions
p. 192
All you need to know about...
Carotid artery stenting
p. 194
Forum - Carotid
p. 195
All you need to know about...
Bleeding / access site
p. 78
Forum - Dissection
p. 88
How should I treat?
Belgium - South Africa
p. 193
How should I treat?
Bulgaria - Siberia
p. 63
Abstracts - STEMI
p. 65
Structural heart disease interventions
p. 218
Coronary clinical cases from
a nursing perspective
p. 218
Lunch
Networking
LTT - Scrubbing-in for bifurcation PCI
p. 219
Forum - Neurology
p. 56
Forum - STEMI
p. 56
Abstracts - Bifurcation
p. 60
Percutan
eous treatment of uncom
mon
structural heart disease disorde
rsp. 64
L
L
Secondary revascularisation - Part II - Revascularisation of
saphenous vein graft attrition
p. 80
L
LTT - How to treat a patient with STEMI caused
by a large thrombus
p. 81
How should I treat?
Egypt - Saudi Arabia
p. 81
Abstracts - Imaging
p. 82
Abstracts - Left m
ain
p. 83
Abstracts - CTO
p. 89
Abstracts - STEMI
p. 90
Abstracts - TAVI
p. 97
Abstracts - Imaging
p. 97
All you need to know about...
Bifurcation stenting
p. 98
How should I treat?
Hungary - Rom
ania - Scotland
p. 88
L
How to do endovascular interventions:
aorto-iliac interventions
p. 198
L
L
Symposium
B. Braun
& M
edrad
DEB - p
. 95/
200
Symposium
Hexa
cath
ACS - p
. 72/
197
11T0768_PCRpocket_02_Glance 18/04/11 11:28 Page16
Room
252AB
Room
253
Room
341
Room
342AB
Room
343
Room
351
Room
352AB
Room
353
Near Theatre Bordeaux
and P
CRTV studio
8h
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
Forum - Left main
p. 53
Abstracts
Dissection
p. 53
Abstracts - Devices
p. 54
Abstracts - Devices
p. 54
How should I treat?
Estonia - Latvia - Russia
p. 57
How should I treat?
Denm
ark - Norway - Sweden
p. 58
Glimpse into the future - Future treatment decision-making based
on intracoronary lesion assessment
p. 55
Abstracts - Access site
p. 61
Abstracts - Multivessel disease
p. 62
Abstracts - Mitral valve
p. 62
Forum - Access site
p. 63
Forum - TAVI
p. 69
Abstracts - Left atrial
appendage
p. 66
Abstracts - Critical limb
ischemia
p. 195
Late breaking first-in-Hum
antrials
p. 66
Abstracts - Devices
p. 67
How should I treat?
Czech Republic - Germany
p. 68
How should I treat?
Minva
sys
Bifurcation - p
. 74
Symposium
Baye
r Hea
lthcare
CIN
- p. 7
6
Abstracts - Fem
oro-popliteal
p. 196
How should I treat?
Abbo
tt Va
scular
CTO - p
. 76
Symposium
St. Jud
e Med
ical
OCT - p
. 77
How should I treat?
Cook
Med
ical
SFA - p
. 198
Critical limb ischemia
p. 199
Best of ICI Technoparade
p. 84
Forum - Plug it
p. 84
Abstracts - Bifurcation
p. 85
How should I treat?
Austria - U.K. - Netherlands - Slovenia
p. 85
Glimpse into the future - TAVI: what lays ahead and how to
improve procedural outcomes
p. 86
How should I treat?
France - South Africa
p. 87
Forum - STEMI
p. 92
LTT - How to perform
transseptal catheterisation
p. 61
LTT - How to perform manual
thrombus aspiration in STEMI
p. 65
L
L
L
LTT - How to use rotablator
p. 83
L
LTT - How to perform PCI via
transradial access
p. 90
Abstracts - Devices
p. 90
Cardiovascular Innovation Pipeline
Coronary artery disease
p. 91
Renal denervation therapy
p. 199
Abstracts - TAVI
p. 92
Forum - Multivessel
disease
p. 93
How should I treat?
Terumo
Bifurcation an
d CTO - p
. 99
How should I treat?
Maq
uet C
ardiov
ascu
lar
AMI - p. 1
00
ABC for inventors
p. 101
Symposium
Sano
fi Av
entis
ACS - p
. 102
How should I treat?
Tryton
Med
ical
Bifurcation - p
. 102
Symposium
Volca
noIm
aging - p
. 103
How should I treat?
Hexa
cath
SFA / Re
nal a
rtery -
p. 201
Abstracts - Carotid
p. 200
L
Wednesday 18th
Innovation Incubator Space - Level 3
p. 59 /1
93
Training village at a glance, see page 22
Cardiovascular Innovation Pipeline -
Peripheral vascular disease and SHD
p. 75/
196
11T0768_PCRpocket_02_Glance 18/04/11 11:28 Page17
Thursday 19th
LEVEL 1: M
ain Aren
a, ro
om 101
/102
/103
/ LEVEL 2:Th
eatre
Bleu, ro
om M
aillo
t, room
s 24
1 to 253
LEVEL 3:
Thea
tre Hav
ane & Bo
rdea
ux, roo
ms 34
1 to 353
, Training villa
geCo
rona
ry and
stru
ctural hea
rt disease
Endo
vascular
Nurses & te
chnician
sWith
Live
L
Main arena
Theatre Bleu
Theatre Bordeaux
Theatre Havane
Room
Maillot
Room
101/102/103
Room
241
Room
242A
Room
242B
Room
243
8h
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
Meet w
ith the trialists
p. 140
Current challenges with transcatheter aortic valve im
plantation
for severe aortic stenosis
p. 104
Symposium
Edwards
Life
sciences
TAVI -
p. 124
Symposium
The Med
icines Com
pany
High
-risk
PCI -
p. 125
Symposium
Abbo
tt Va
scular
STEM
I - p. 1
26
Symposium
Orbu
sNeich
DAPT -
p. 126
Forum - India
meets EuroPCR
p. 127
Forum - Taiwan meets EuroPCR
p. 131
EuroIntervention / European
Heart Journal @ EuroPCR
p. 141
How to write a paper?
p. 146
Forum - Thoracic
aorta
p. 209
LPrimary PCI in STEMI - towards optimal results in com
plex lesions
p. 131
L
Glimpse into the future - Bioresorbable scaffolds:
a new era in clinical interventional cardiology
p. 105
TNT
Terumo
Bifurcation/
CTO - p
. 124
L
Complex coronary chronic total occlusion interventions: live from
Toyohashi Heart Center, Japan and CCT meeting@
EuroPCR
p. 106
L
LTT - How to treat a patient
with multivessel coronary disease
p. 112
How to do endovascular interventions:
below the knee interventions
p. 202
New developments in the
modern cathlab
p. 220
The miscellaneous abstract
session
p. 220
Lunch
Networking
The treatment of STEMI from a cathlab
managem
ent perspective
p. 221
Forum - SVG
p. 106 How should I treat?
Denm
ark - Lebanon
p. 111
Forum - SVG
p. 107
Abstracts - Imaging
p. 107
Abstracts - Bifurcation
p. 112
Abstracts - TAVI
p. 120
Abstracts - STEMI
p. 127
Abstracts - Cell regeneration
p. 135
Abstracts - CTO
p. 142
Abstracts - TAVI
p. 150
Computed tomography:
interactive case reading
p. 112
Forum - China meets EuroPCR
p. 119
How should I treat?
Iran - Turkey
p. 203
Forum - Carotid
p. 203
How should I treat?
Portugal - Spain
p. 134
How should I treat?
Italy - Switzerland
p. 142
Forum - CTO
p. 149
L
L
Complication forum
p. 140
Where cardiologists and cardiac surgeons can meet: the
beginning of a great future
p. 132
LTT - How to treat a patient with
coronary bifurcation lesions
p. 133
LTNT
Edwards
Life
sciences
TAVI -
p. 147
Symposium
Daiichi San
kyo & Eli L
illy
ACS/
PCI - p. 1
47
Symposium
CID
DES - p
. 148
L
L
How to do endovascular interventions:
renal and visceral interventions
p. 206
LSymposium
Med
tronic
DEB - p
. 149
/208
11T0768_PCRpocket_02_Glance 18/04/11 11:29 Page18
Room
243
Room
251
Room
252AB
Room
253
Room
341
Room
342AB
Room
343
Room
351
Room
352AB
Room
353
8h
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
Abstracts - Imaging
p. 107
Forum - Aneurysms
p. 108
Forum - Bifurcation
p. 108
Abstracts - Devices
p. 109
Abstracts
Endothelial function
p. 109
Abstracts - Devices
p. 110
Forum - Dissection
p. 110
Abstracts - Devices
p. 110
Multilevel vascular disease
p. 202
All you need to know about…
Gender differences in PCI
p. 113
Forum - STEMI
p. 114
Abstracts - Access site
p. 114
Abstracts - TAVI
p. 115
Abstracts - Devices
p. 117
Late breaking science
p. 120
LTT - How to perform OCT
imaging
p. 121
Abstracts - Adjunctive
pharmacotherapy
p. 121
Abstracts - FFR
p. 121
Abstracts - Multivessel disease
p. 122
How should I treat?
Croatia - Cyprus - Greece - Serbia
p. 118
Forum - Mitral valve
p. 117
Abstracts - Im
aging
p. 118
Forum - STEMI
p. 123
Abstracts - STEMI
p. 123
Invasive strategies for STEMI initially treated with fibrinolysis:
a case-based discussion
p. 116
How should I treat?
Boston
Scien
tific
Infra
ingu
inal cha
lleng
es -
p. 204
How should I treat?
Biotronik
Femoral
and inf
rapo
pliteal
- p. 2
04
Abstracts - Endothelial
function
p. 128
Abstracts - Elderly
p. 128
Symposium
Sten
tys
STEM
I - p. 1
29
Abstracts - Devices
p. 205
How should I treat?
Med
tronic
TAVI -
p. 129
Symposium
Minva
sys
Bifurcation - p
. 130
Abstracts - OCT
p. 131
All you need to know about...
Intracoronary im
aging
p. 135
LTT - How to use
pressure-derived FFR
p. 136
Abstracts - Access site
p. 136
Abstracts - Secondary
revascularisation
p. 137
Cathete
r-based managem
ent of
massive intravascu
lar throm
bosis
p. 206
Abstracts - TAVI
p. 137
Best of AsiaPCR/SingLive 2011
p. 138
Glimpse into the future - Novel approaches to treatment of
mitral valve disease
p. 138 Abstracts - M
ultilevel vascular
disease
p. 207
Abstracts - SVG
p. 139
Forum - Devices
p. 144
Abstracts - Adjunctive
pharmacotherapy
p. 144
Abstracts - Devices
p. 145
Abstracts - TAVI
p. 145
Imaging valvular disease: clinical
and pathologic correlates
p. 146
Hybrid approach for the treatment of
the thoracic aortic disease
p. 207
All you need to know about...
Percutaneous assist-devices
p. 143
How should I treat?
Terumo
STEM
I - p. 1
50
Abstracts - Imaging
p. 151
Abstracts - ACS
p. 152
How should I treat?
Abbo
tt Va
scular
LM/B
ifurcations
- p. 152
Abstracts - Devices
p. 153
Symposium
Med
tronic Ardian
Rena
l den
erva
tion tre
atmen
t - p. 2
08
Abstracts - Stent thrombosis
p. 155
Intera
ctive meeting w
ith the p
rincipal investigato
rsof essential on
going
or future clinical trials
p. 154
Abstracts - Bifurcation
p. 112
Abstracts - TAVI
p. 120
Abstracts - STEMI
p. 127
Abstracts - Cell regeneration
p. 135
Abstracts - CTO
p. 142
Abstracts - TAVI
p. 150
L
L
Thursday 19th
Training village at a glance, see page 22
11T0768_PCRpocket_02_Glance 18/04/11 11:29 Page19
Friday 20th
LEVEL 1: M
ain Aren
a / LEVEL 2:
Thea
tre Bleu, ro
om M
aillo
t, room
s 24
1 to 253
LEVEL 3:
Thea
tre Hav
ane & Bo
rdea
ux, roo
ms 34
1 to 353
, Training villa
geCo
rona
ry and
stru
ctural hea
rt disease
Endo
vascular
Nurses & te
chnician
sWith
Live
L
Main arena
Theatre Bleu
Theatre Havane
Room
Maillot
Room
241
Room
242A
Room
242B
Room
243
Room
251
Room
252AB
8h
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
Cardiovascular interventions: intercontinental crossfire
With LIVE from Asia-Pacific & Ethica award
p. 156
Complication forum
p. 157
LTT - How to treat a patient with coronary chronic total occlusion
p. 157
Carotid revascularisation: Live it! Great news:
carotid stenting is Class I recommendation
p. 210
Abstracts - Thoracic aorta
p. 211
Abstracts - Imaging
p. 160
Abstracts - Fem
oro-popliteal
p. 212
2010 ESC - EACTS guidelines on
myocardial revascularisation
p. 159
Abstracts - M
itral valve
p. 165
LAw
ards and closing
ceremony
p. 169
L L
Forum - India meets
EuroPCR
p. 160
Forum - South Korea
meets EuroPCR
p. 165
Forum - Russia meets
EuroPCR
p. 169
Abstracts - Clinical trials
p. 165
Abstracts - Specific patient
subsets
p. 160
How to do endovascular interventions: abdom
inal aortic
aneurysm treatment in the cathlab
p. 211Forum - Aneurysms
p. 166
Forum - Spasms
p. 169
L
11T0768_PCRpocket_02_Glance 18/04/11 11:29 Page20
Room
253
Room
341
Room
342AB
Room
343
Room
351
Room
352AB
Room
353
8h
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
Friday 20th
Room
252AB
Abstracts - STEMI
p. 161
Abstracts - Stent thrombosis
p. 166
Cardiogenic shock: an update
p. 162
Forum - Left main
p. 163
Forum - CTO
p. 162
Forum - CTO
p. 167
Late breaking registries and trial updates
p. 158
Abstracts - Devices
p. 167
Forum - Imaging
p. 168
Forum - Aorto-iliac
p. 212
Forum - TAVI
p. 168
Forum - Secondary
revascularisation
p. 164
Forum - Devices
p. 164
Training village at a glance, see page 22
11T0768_PCRpocket_02_Glance 18/04/11 11:29 Page21
Training villag
e - Lev
el 3
Corona
ry and
stru
ctural hea
rt disease
Nurses & te
chnician
s
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
8h30
Vascular closure
p. 173
Bifurcation lesions
p. 173
Tuesday 17
th
CORDIS CARDIAC
& VASCULAR INSTITU
TE
CROSSROADS, The Abbott
Vascular Education Network
EDWA
RDS LIFESCIEN
CES
MEDTRONIC A
CADEMIA
ST. JUDE M
EDICA
L
Radial approach
p. 173
AMI for nurses
p. 227
Bifurcation lesions
p. 174
Transcatheter heart valves
p. 174
Transcatheter heart valves
p. 174
MVD
p. 174
Hemostasis
managem
ent
p. 175
Hemostasis
managem
ent for
nurses
p. 227
Hemostasis
managem
ent
for nurses
p. 227
Hemostasis
managem
ent for
nurses
p. 227
Training villag
e - Lev
el 3
11T0768_PCRpocket_02_Glance 18/04/11 11:29 Page22
Corona
ry and
stru
ctural hea
rt disease
Nurses & te
chnician
sTraining villag
e - Lev
el 3
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
8h30
Vascular closure
p. 175
Radial approach
p. 175
Wednesday 18th
CORDIS CARDIAC
& VASCULAR INSTITU
TE
CROSSROADS, The Abbott
Vascular Education Network
EDWA
RDS LIFESCIEN
CES
MEDTRONIC A
CADEMIA
ST. JUDE M
EDICA
L
Bifurcation lesions
p. 176
Intracardiac echocardiography in TAVI
p. 176
Vascular closure
p. 175
AMI for nurses
p. 228
CTO
p. 177
Transcatheter heart valves
p. 177
Transcatheter heart valves
p. 177
MVD
p. 178
FFR for physicians
p. 178
STEMI
p. 176
Transcatheter heart valves
p. 177
Transcatheter heart valves
p. 177
Transcatheter heart valves
p. 177
Bifurcation lesions
p. 177
MVD
p. 178
MVD for nurses
p. 228
AMI for nurses
p. 228
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for physicians
p. 178
FFR for physicians
p. 178
FFR for physicians
p. 178
FFR for physicians
p. 178
11T0768_PCRpocket_02_Glance 18/04/11 11:29 Page23
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
8h30
TAVI
p. 183
Friday 20th
MEDTRONIC A
CADEMIA
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
8h30
Radial approach
p. 179
FFR for nurses
p. 229
AMI
p. 180
CORDIS CARDIAC
& VASCULAR INSTITU
TE
CROSSROADS, The Abbott
Vascular Education Network
EDWA
RDS LIFESCIEN
CES
MEDTRONIC A
CADEMIA
ST. JUDE M
EDICA
L
Vascular closure
p. 179
Intracardiac echocardiography
in TAVI
p. 179
Radial approach
p. 180
CTO
p. 180
Bifurcation lesions
p. 181
AMI
p. 180
Transcatheter heart valves
p. 181
Transcatheter heart valves
p. 181
Transcatheter heart valves
p. 181
Transcatheter heart valves
p. 181
TAVI
p. 182
TAVI
p. 182
TAVI
p. 182
TAVI
p. 182
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
OCT for physicians
p. 182
OCT for physicians
p. 182
OCT for physicians
p. 182
OCT for physicians
p. 182
OCT for physicians
p. 182
Training villag
e - Lev
el 3
Thursday 19th
Corona
ry and
stru
ctural hea
rt disease
Nurses & te
chnician
s
11T0768_PCRpocket_02_Glance 18/04/11 11:29 Page24
scientific programme
Coronary and structural heart
disease programme
PART I
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page25
10:00-11:00 Main arena Innovation
Main session
Welcome and live demonstration from Frankfurt
Chairperson: W. Wijns
Panellists: A. Cremonesi, T. Lüscher, C. Rihal, C. Ruiz, P.W. Serruys,
R. Whitbourn
With continuous live demonstration from CardioVascular Center Frankfurt -
Germany
▸ Introduction - W. Wijns
▸ Renal denervation: a new treatment option in hypertension and beyond?
T. Lüscher
11:00-12:30 Main arena
Main session
PCR Family: Innovation in education at work
Chairperson: W. Wijns
Panellists: E. Eeckhout, J. Ge, T.H. Koh, J. Marco, M.C. Morice, R. Ng,
P.W. Serruys, M. Thomas, A. Vahanian
▸ Introduction - W. Wijns
European Society of Cardiology: a word from the President - M. Komajda
PCR courses
▸ EuroPCR - W. Wijns
▸ AsiaPCR/SingLive - T.H. Koh
▸ PCR London Valves - M. Thomas
PCR communications
▸ PCRonline - A. Vahanian
▸ PCR Publishing: impact factors in the digital era - P.W. Serruys
▸ Percutaneous interventional cardiovascular medicine. The PCR-EAPCI
textbook - E. Eeckhout
PCR educative solutions - J. Marco
PCR trials - P.W. Serruys
EAPCI: vision of the future - J. Fajadet, EAPCI President-Elect 2011-2013
and the EAPCI President-Elect 2013-2015
Tuesday 17th
26
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page26
Tue
sday 1
7th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
12:30-14:00 Main arena
Symposium
The Great Debate - Left main in 2011: CABG or PCI?
With an unrestricted educational grant from MEDTRONIC
Chairperson: G. Wimmer-Greinecker
Panellists: A. Erglis, V. Falk, D. Hildick-Smith, M.C. Morice,
D. Taggart, L. Torracca
Objectives:
▸ To provide the audience with expert commentary on the efficacy and
safety of left main treatment options
▸ To provide physicians with the factual information they need to help
patients make informed decisions about their treatment options
▸ To comment on the data and evidence currently available and outline what
is being done to improve our understanding
13:30-15:00 Room 242B Clinic
Abstract session
Results of TAVI: evaluation by echocardiography
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: H. Eltchaninoff, D. Messika-Zeitoun, O. Bodea
▸ Introduction - H. Eltchaninoff
▸ Early hemodynamic changes and myocardial injury after transfemoral TAVI
R. Dworakowski
▸ Left ventricular mass regression one year after TAVI - A. Tzikas
▸ Hemodynamic performance of transcatheter self-expandable aortic
bioprosthesis: immediate results and long-term echocardiographic
follow-up - C. Fraccaro
▸ Serial echocardiographic follow-up of the CoreValve bioprosthesis: 1-year
results of 400 patients from the Italian registry - M. De Carlo
▸ Intracardiac echocardiography: an ideal guiding tool for TAVI in an
extremely high-risk population - T. Bartel
▸ Intracardiac echocardiography is an accurate and safe technique for
guidance during TAVI - J. Kefer
▸ Take-home message - D. Messika-Zeitoun
27
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page27
13:30-15:00 Room 243 Technique
Forum
PCI in complex multivessel disease
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: P. MacCarthy, P. Ruygrok
▸ Introduction - P. MacCarthy
▸ Complete revascularisation in multivessel coronary artery disease in high
risk patient - W.J. Chung
▸ Transradial PCI for left main and multivessel coronary artery disease
W.J. Chung
▸ Double occlusion PCI: elective chronic occlusion and unexpected subacute
stent thrombosis - F. Hernandez
▸ A challenging case of successful complete revascularisation by antegrade
and retrograde PCI - H. Watanabe
▸ Angiography is not enough for decision making on revascularisation in
patients with borderline coronary lesions - J. Legutko
▸ Take-home message - P. Ruygrok
13:30-15:00 Room 251 Evidence
All you need to know about adjunctive pharmacology
during PCI
Chairpersons: M. Valgimigli, A. Baumbach
Objective:
▸ At the end of this 90-minute ‘All you need to know about...’ session the
audience should have an up to date knowledge of the field, relevant for
their clinical practice. They should be familiar with the current evidence
base, existing guidelines and have an understanding of the open questions
that need addressing in the near future
▸ Introduction and objectives - A. Baumbach
▸ Background - Anti-thrombotics in PCI: pathophysiological considerations
for the interventional cardiologist - D. Ardissino
▸ Clinical data - Conventional and new anti-thrombotics in PCI: practical
implications for optimal use in 2011? - D. Angiolillo
▸ Issues and clinical practice - Anti-thrombotic treatment dosing: how to
best use the available drugs - T. Cuisset
▸ Guidelines - F. Weidinger
▸ Unresolved issues - Risk scores and point-of care testing in 2011 - J. Mehilli
▸ Question & answer - M. Valgimigli
Tuesday 17th
28
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page28
Tue
sday 1
7th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
13:30-15:00 Room 252AB Clinic
Forum
Challenging structural heart interventions
Session comprising selected EuroPCR 2011 clinical case & complication
submissions
Chairperson: P. Bonhoeffer
▸ Introduction - P. Bonhoeffer
▸ Isolated interventricular septal diverticulum presented as unstable angina
A case report - Y.C. Huang
▸ A pressing matter - idiopathic mediastinal fibrosis with severe
compression of the pulmonary arteries - M. Spence
▸ Rupture of the left-coronary sinus of valsalva aneurysm - another
syndrome mimicking acute STEMI - F. Cuculi
▸ Percutanous retrievement of Amplazer migrated in left pulmonary artery
after initial success of post-surgical ventricular septal defect - I. Sheiban
▸ Percutaneous rescue of left ventricular embolised amplatzer septal
occluder device - R. Parma
▸ Take-home message - P. Bonhoeffer
13:30-15:00 Room 341 Clinic
Abstract session
Primary PCI in STEMI patients: where is the challenge?
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: V. Schächinger, M. Degertekin, S. Hardas
▸ Introduction - V. Schächinger
▸ Real picture of reperfusion map with coronary angioplasty in patients with
acute myocardial infarction in Spain - the RACIMO multicentre experience
A. Iniguez
▸ PCI and acute myocardial infarction: temporal changes in presentation,
management and in-hospital mortality - K. Jansen
▸ Analysis of subset of patients who undergo delayed primary PCI
P. Rubartelli
▸ Early hospital discharge at 48 hours following primary PCI for myocardial
infarction is both safe and feasible - E.C. Sammut
▸ Comparative analysis of DES vs. bare metal stents for the treatment of
STEMI - acute and mid-term outcomes - V. Esteves
▸ Take-home message - M. Degertekin
29
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page29
13:30-15:00 Room 351 Clinic
Abstract session
Be careful! Contrast induced nephropathy is a real issue in daily
practice - Part I
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: C. Rihal, A. Bartorelli
▸ Introduction - C. Rihal
▸ Keynote lecture - R. Mehran
▸ Prevalence of renal insufficiency in Chinese patients who undergo
coronary angiography or PCI: an observational study - Y. Chen
▸ Variations in the risk of contrast induced nephropathy in patients
undergoing PCI - R. Jabara
▸ A randomised, double-blinded comparison of Iopromide and Iodixanol in
renally impaired patients undergoing cardia catheterisation (DIRECT
study) - Y. Chen
▸ Sodium bicarbonate plus N-acetylcysteine to prevent contrast induced
nephropathy in the setting of primary PCI (BIcarbonato e N-Acetil-cisteina
nell'infaRto mIocardico acutO, the BINARIO study, NCT01218178)
A.M. Leone
▸ The effect of renal dysfunction on periprocedural outcome in patients
undergoing elective PCI: an open-label multicentre registry - A. Ntalianis
▸ Take-home message - A. Bartorelli
13:30-15:00 Room 352AB
Symposium
Drug-eluting balloons: current practice and future perspectives
With an unrestricted educational grant from EUROCOR
Chairpersons: A. Serra, S. Silber
Objectives:
▸ To understand the drug-eluting balloon family of products: Dior and Freeway
▸ To present the recent data in clinical research obtained with the second
generation coating of drug-eluting balloon
▸ To understand the clinical data and benefits of this drug-eluting balloon in
further indications
Tuesday 17th
30
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page30
Tue
sday 1
7th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Current role and indications for drug-eluting balloons - S. Silber
▸ The VALENTINES trial; highlighting the creation of the biggest database on
treatment of in-stent restenosis so far - P. Stella
▸ Practical input and Spanish registry: global and subgroup results (in-stent
restenosis, small vessels) - A. Serra
▸ Acute myocardial infarction in India - P. Chandra
▸ Diabetic disease, progress in the Argentinean experience - A. Rodriguez
▸ Periphery, a glimpse on first experiences, comment on Columbian results,
announcement of activation and first results of randomised studies
K.L. Schulte
▸ Discussion
▸ Take-home message - H. Tan
13:30-15:00 Room 353 Technique
Abstract session
Novel imaging techniques for assessment of PCI
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: M. Gilard, M. Kimura
▸ Introduction - M. Gilard
▸ Mechanisms of non-fatal stent related myocardial infarction late following
coronary stenting with DES and bare metal stents: insights from optical
coherence tomography - P. Davlouros
▸ Comparison of neointimal coverage between zotarolimus-eluting stent and
everolimus-eluting stent using optical coherence tomography - Y.S. Jang
▸ Early detection of stent tissue coverage and apposition after primary
angioplasty: an optical coherence tomographic study of chromium
cobaltum and first generation DES - F. Prati
▸ Usefulness of a trans-stent fractional flow reserve gradient for assessing
the results of DES implantation - S.J. Tahk
▸ A six-month analysis of quantitative echogenicity of the second generation
everolimus-eluting bioresorbable vascular scaffold in relationship with
baseline greyscale intravascular ultrasound morphology of the scaffolded
plaque - S. Brugaletta
▸ Quantitative multi-modality imaging analysis of a fully bioresorbable
scaffold: a head-to-head comparison between quantitative coronary
angiography, intravascular ultrasound and optical coherence tomography
J.L. Gutiérrez-Chico
▸ Take-home message - M. Kimura
31
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page31
14:00-15:00 Main arena
Main session
Live demonstration from Toulouse
Chairpersons: G. Wimmer-Greinecker, M.J. Kern
Panellists: A. Erglis, V. Falk, D. Hildick-Smith, M.C. Morice, D. Taggart,
L. Torracca
With continuous live demonstration from Clinique Pasteur, Toulouse -
France
14:00-17:00 Theatre Bordeaux Clinic
Plenary session
Percutaneous revascularisation of coronary chronic total
occlusion: a largely disregarded alternative to surgery
Chairpersons: N. Reifart, O. Katoh
Panellists : N. Boudou, G. Cassel, J. Escaned, A. Gershlick,
F. Hellig, T. Lefèvre, Y. Louvard, J. McKibbin, E. Tsuchikane, P.T. Tsui,
G. Werner
Objectives:
▸ To review evidence on the clinical benefit of coronary chronic total
occlusion recanalisation
▸ To identify good candidates for coronary chronic total occlusion recanalisation
▸ To understand the various procedural techniques and their outcomes
▸ Introduction and objectives - N. Reifart
▸ Essentials of ante and retrograde techniques - O. Katoh
14:15-15:00 Live demonstration from Ferrarotto Hospital, Catania - Italy
▸ Keynote lecture - Reflect together on how to balance benefit and risk when
considering opening a coronary chronic total occlusion - G. Werner
▸ How should I treat – Under the auspices of French Group of Interventional
Cardiology and South African Society of Cardiovascular Intervention
- Case presentation - N. Boudou
- How would I treat? - Y. Louvard
- How would I treat? - F. Hellig
- How did I treat? - N. Boudou
- Discussion and consensus
▸ Complication case - A tale of “three ventricles” - S. Fairley
▸ Complication case - Double distal coronary perforation - S. Mansour
16:10-16:50 Live demonstration from Ferrarotto Hospital, Catania - Italy
▸ Final key remarks - O. Katoh
Tuesday 17th
32
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page32
Tue
sday 1
7th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
14:00-15:00 Room 253 Technique
Forum
Stent malapposition
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: G. Guagliumi, T. Johnson
▸ Introduction - G. Guagliumi
▸ The late stent malapposition develops also after paclitaxel-balloon
predilatation before bare metal stent implantation - T. Kovarnik
▸ Vulnerability of late-acquired stent malapposition after Sirorimus-eluting
stent implantation detected by serial coronary angioscopy - N. Takaharu
▸ A case of peri-stent contrast staining after sirolimus-eluting stent
implantation - T. Satoh
▸ Take-home message - T. Johnson
14:00-15:30 Room 342AB
Symposium
The role of the interventional cardiologist from the coronary to the renal
arteries
With an unrestricted educational grant from MEDTRONIC
Chairperson: C. Lotan
Objectives:
▸ To share the body of scientific evidence for Resolute and the role of
Resolute Integrity in daily clinical practice
▸ To present Medtronic's cardiovascular pipeline in particular focusing on
the drug filled stent concept, drug-eluting balloon concept and the
radiofrequency ablation concept in resistant arterial hypertension
▸ Introduction and objectives - C. Lotan
▸ One additional step forward in clinical evidence: Resolute - S. Windecker
▸ Discussion
▸ DES in complex patients: Resolute Integrity - Two case presentations
- Case 1 - F. Burzotta
- Case 2 - C. Von Birgelen
▸ Discussion
▸ Drug-eluting balloons: value in interventional cardiology - G.M. Sangiorgi
▸ Drug-filled stent: a glimpse into the future - J. Wilcox
▸ Radiofrequency ablation in resistant arterial hypertension: the role of the
interventional cardiologist - R. Whitbourn
▸ Discussion
▸ Take-home message - C. Lotan
33
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page33
14:30-17:00 Theatre Havane Technique
LTT - How to select material and equipment for PCI
Facilitators: E. Barbato, F. Mauri, J. Marco
Panellists: M. Awata, F. D'Ascenzi, P. Davlouros, L.W. Tam
Media driver: L.A. Malek
Live in-a-box®
15:00-17:00 Main arena Evidence
Hot Line session
Late breaking trials
Chairpersons: P.W. Serruys, T. Lüscher
Panellists: P. Agostoni, R. Byrne, M.J. Kern, L. Mauri, G. Montalescot
▸ Randomised comparison of manual compression and use of Femoseal
vascular closure device for closure after femoral artery access coronary
angiography. The closure devices used in everyday practice (CLOSE-UP
study) - N.R. Holm
▸ Discussion - P. Agostoni
▸ Panel discussion
▸ High residual platelet reactivity after clopidogrel loading and long-term
thrombotic events in patients with acute coronary syndrome undergoing
invasive treatment: the RECLOSE 2-ACS trial - D. Antoniucci
▸ Discussion - G. Montalescot
▸ Panel discussion
▸ A prospective, randomised and multicentre trial comparing Titan-2 BAS
and Xience-V stent: the BASE-ACS trial - P. Karjalainen
▸ XAMI: randomised multicentre trial comparing first generation Sirolimus
with second generation Everolimus DES in acute myocardial infarction
S.H. Hofma
▸ Discussion - L. Mauri
▸ Panel discussion
▸ The first randomised trial comparing the reservoir-based polymer-free
CRE8 DES to Taxus Liberté: the NEXT study - D. Carrié
▸ NOYA I: a prospective randomised trial of NOYA Sirolimus-eluting stent
with biodegradable coating compared to Firebird 2 Sirolimus-eluting stent
with durable coating in patients with coronary artery disease - 9-month
angiographic and 12-month clinical results - R. Gao
▸ Discussion - P.W. Serruys
▸ Panel discussion
Tuesday 17th
34
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page34
Tue
sday 1
7th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ The ECO-PLEASANT trial: comparison of efficacy between two different
paclitaxel-eluting stents: Coroflex Please and Taxus Liberté stent in Korea
H.S. Kim
▸ Discussion - R. Byrne
▸ Panel discussion
▸ A randomised, double-blinded comparison of Iopromide and Iodixanol in
renal impaired patients undergoing cardiac catheterisation (DIRECT
study) - Y. Chen
▸ Discussion - M.J. Kern
▸ Panel discussion
15:00-18:00 Theatre Bleu
Tech News & Trends (TNT) session
Left main and multivessel disease
With an unrestricted educational grant from TERUMO
Chairpersons: A. Baumbach, J. Fajadet
Panellists: I.C. Hsieh, M.A. Rosli
Objectives:
▸ To understand how to build the decision making process in order to
propose the best treatment option for one individual patient
▸ To provide a better understanding on the best strategy and technique in
patients with left main and/or complex multivessel disease undergoing PCI
▸ To share knowledge on the Nobori DES results in patients with left main
and/or multivessel disease
▸ Introduction and objectives - A. Baumbach
15:05-15:50 Live demonstration from Clinique Pasteur, Toulouse - France
▸ Proper patient selection: surgeon's view - A.P. Kappetein
▸ Proper patient selection: interventionalist's view - A. Protopopov
16:10-16:55 Live demonstration from Clinique Pasteur, Toulouse - France
▸ Clinical outcomes of Nobori DES in left main and multivessel disease
J. Mehilli
▸ Myocardial revascularisation in Bangladesh - F. Malik
17:15-17:55 Live demonstration from Clinique Pasteur, Toulouse - France
▸ Take-home message - A. Baumbach
35
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page35
15:00-16:30 Room 242A Technique
Abstract session
Valve in valve: TAVI for treatment of degenerative bioprosthesis
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: J. Webb, L. Torracca, R. Moreno
▸ Introduction - J. Webb
▸ Transcatheter valve-in-valve implantation using CoreValve Revalving
System in high risk patients with failed aortic bioprosthesis: a multi-
centre experience - M.L. Laudisa
▸ Valve-in-valve procedure with the Edwards transcatheter heart valve to treat
bioprosthetic valve degeneration in high-risk surgical patients - A. Ielasi
▸ Transaortic transcatheter aortic valve implantation within a previous
bioprostic aortic valve replacement - J. Cockburn
▸ Impact of 20mm transcatheter aortic valves on valve-in-valve
hemodynamics for small degenerated bioprostheses - E. Tseng
▸ Impact of patient prosthesis mismatch after transcatheter aortic valve-in-
valve implantation in degenerated bioprostheses - M. Seiffert
▸ Impact of transcatheter aortic valve orientation on valve-in-valve
hemodynamics - E. Tseng
▸ Take-home message - L. Torracca
15:00-16:30 Room 242B Technique
Abstract session
DES in special lesions and patient subsets
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: H.M. Mardikar, M. Lesiak, N. Melikian
▸ Introduction - H.M. Mardikar
▸ Effect of PCI with Paclitaxel-eluting stent in hemodialysis patients:
comparison with Sirolimus-eluting stent - H. Takimura
▸ Clinical outcomes after PCI with DES in patients with chronic kidney
disease - H. Takimura
▸ Small coronary vessels stenting in the DES era: very long-term (>3 years)
clinical outcomes - I. Sheiban
▸ DES improve long-term outcomes compared to bare metal stents (BMS)
for the treatment of isolated proximal left anterior descending (LAD)
coronary artery - O. Guttmann
▸ Clinical benefit from drug-eluting vs. bare metal stents after rotational
atherectomy for the treatment of calcified coronary lesions: results from a
single-centre registry - F. Mangiacapra
▸ Comparison of Everolimus- vs. first generation DES in left main coronary
artery lesions: the HSR-EMO experience - A. Ielasi
▸ Take-home message - M. Lesiak
Tuesday 17th
36
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page36
Tue
sday 1
7th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
15:00-16:30 Room 243 Technique
Forum
Coronary and aortic dissection during PCI
Session comprising selected EuroPCR 2011 complication submissions
Chairpersons: F. Eberli, F. Tomai
▸ Introduction - F. Eberli
▸ Iatrogenic aorto-coronary dissection: oops! - S. Bagga
▸ Left main dissection during coronary angiography for unstable angina in a
38 year-old female - D. Alexopoulos
▸ Aortic and coronary dissection during elective PCI - G.B. Danzi
▸ Aortic dissection during coronary chronic total occlusion case
A. Ghofraniha
▸ Successful recovery from large iatrogenic aortic dissection by stenting to
left main trunk entry site - H. Matsuo
▸ Take-home message - F. Tomai
15:00-16:30 Room 251 Technique
Forum
Complications encountered during left main interventions - Part I
Session comprising selected EuroPCR 2011 complication submissions
Chairpersons: T. Mabin, M. Sousa Uva
▸ Introduction - T. Mabin
▸ Treatment of left main coronary artery dissection with culotte technique as
a complication of percutaneous intervention - O. Celik
▸ A not so noble complication - P. Scott
▸ Migration: not just for the birds! - S. Mansour
▸ Left main stem PCI: now you see it, now you don't - M. Williams
▸ Stent lost: an interventional cardiologist nightmare - R.A. Parisi
▸ Take-home message - M. Sousa Uva
37
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page37
15:00-16:30 Room 252AB Clinic
Forum
Unusual PCI complications - Part I
Session comprising selected EuroPCR 2011 complication submissions
Chairpersons: E. Eeckhout, G. Heyndrickx
▸ Introduction - E. Eeckhout
▸ An accumulation of complications - K. Onsea
▸ A case of PCI procedure successfully bailed out from multiple
complications - Y. Kawamura
▸ Challenging complication of routine PCI - A. Qasim
▸ Retrieving the trapped buddy - E. Wong
▸ Inadvertent removal of fully deployed stent during retrieval of another
dislodged stent in the right coronary artery with goose-neck snare
M. Celik
▸ Take-home message - G. Heyndrickx
15:00-16:30 Room 341 Clinic
Abstract session
Biomarkers in stable and unstable coronary syndromes
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: I. Meredith, P. Cervinka
▸ Introduction - I. Meredith
▸ The role of micro RNAs involved in the psychological stress-induced
cardiac disorders in rats - Y. Wang
▸ ADAMTS13 antigen levels are associated with increasing atherosclerotic
burden in patients with stable coronary artery disease - A.J. Peace
▸ Early and long-term changes in serum concentration of high-sensitive
C-reactive protein and fibrinogen after implantation of sirolimus-eluting
coronary stents - S. Provatorov
▸ Preprocedural elevated white cell count and eosinophilia predict outcome
in primary PCI - K.S. Rathod
▸ Soluble Fms-like Tyrosine Kinase-1 (sFLT1) and its role in post-PCI
myocardial infarction (Type 4a MI) - M. Möckel
▸ Low hdl cholesterol levels are an independent predictor of coronary artery
disease in patients with aortic aneurysms - S. Aso
▸ Take-home message - P. Cervinka
Tuesday 17th
38
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page38
Tue
sday 1
7th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
15:00-16:30 Room 351 Clinic
Abstract session
Be careful! Contrast induced nephropathy is a real issue in daily
practice - Part II
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: E. Esplugas, Y. Chen
▸ Introduction - E. Esplugas
▸ Invasive renal hemodynamics after left ventricular and coronary
angiography with randomised use of different contrast media - M. Möckel
▸ Hypersensitive c-reactive protein and the risk of contrast induced acute
kidney injury in patients undergoing PCI - F. Gao
▸ Serum NGAL identifies contrast nephropathy early in patients with
diabetes mellitus and chronic kidney disease undergoing coronary
angiography and angioplasty - A. Qureshi
▸ Possible association between admission hyperglycemia and contrast
medium induced nephropathy in patients undergoing primary PCI
S. Fukuzawa
▸ Preliminary results from a randomised trial on the role of Glucose-Insulin-
Potassium and N-Acetyl-Cysteine for prevention of contrast induced
nephropathy in high-risk patients undergoing PCI - A. Nusca
▸ A comparison between serum creatinine and cystatin-C for the early
diagnosis of contrast induced nephropathy after coronary angiography
and interventions - F. Ribichini
▸ Take-home message - R. Mehran
39
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page39
15:00-17:00 Room 352AB Clinic
Plenary session
Stent for Life @ EuroPCR 2011 - How do we optimise
the delivery and quality of primary PCI?
Chairpersons: S.D. Kristensen, P. Widimsky
Panellists: D. Deleanu, O. Goktekin, J. Jorgova, C. Vrints
Objectives:
▸ To understand the causes of treatment delay and how to reduce it
▸ To review options for optimal medical therapy during patient transportation
▸ To identify the conditions for a successful STEMI network
▸ Introduction and objectives - S.D. Kristensen
▸ Reduction in patient and system delay is the key to improvement - M. Sabate
▸ Discussion
▸ Can we optimise diagnosis and therapy during transport to primary PCI?
A. Van't Hof
▸ Discussion
▸ Major challenges in setting up STEMI centres - G. Guagliumi
▸ Discussion
▸ A remarquable case story - M. Ostojic
▸ Discussion
▸ Stent for Life: what have we achieved and what is the future? - S.D. Kristensen
▸ Take-home message - P. Widimsky
15:00-16:30 Room 353 Clinic
Abstract session
PFO: clinical experience and new devices
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: P. Bonhoeffer, G. Manoharan
▸ Introduction - P. Bonhoeffer
▸ Percutaneous closure of patent foramen ovale: experience from Sydney,
Australia - K. Liou
▸ Percutaneous transcatheter closure of interatrial septal defect in adults:
procedural outcome and long-term results - J. Kefer
▸ Amplatzer patent foramen ovale occluder vs. bioabsorbable device biostar
for patent foramen ovale closure. safety and efficacy at 12-month follow
up - A. Giardina
▸ Application of Cardio-O - fix occluders for transcatheter percutaneous
closure of undesirables shunts - preliminary experience - M. Knop
▸ Take-home message - G. Manoharan
STENT
FOR LIFE
Tuesday 17th
40
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page40
Tue
sday 1
7th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
15:30-17:00 Room 241
How should I treat?
PCI for acute coronary syndrome: from trial data on triple
antiplatelet therapy into clinical practice
With an unrestricted educational grant from IROKO CARDIO
Chairperson: C. Hamm
Objectives:
▸ To understand the importance of accurate risk stratification and
assessment of bleeding risk
▸ To learn how to tailor antiplatelet therapy to improve patient outcomes,
balancing major adverse cardiac events reduction and safety
▸ To understand options for combining antiplatelet therapies with
complementary modes of action to optimise platelet inhibition
▸ Introduction and objectives - C. Hamm
▸ A NSTEMI diabetic patient: the challenge continues
- Case presentation - L. Holmvang
- How would I treat? - M. Valgimigli
- How would I treat? - M. Noc
- How did I treat? - L. Holmvang
- Discussion
- Consensus - C. Hamm
▸ A young STEMI patient: high-risk requires higher protection
- Case presentation - J.P. Collet
- How would I treat? - M. Valgimigli
- How would I treat? - M. Noc
- How did I treat? - J.P. Collet
- Discussion
- Consensus - C. Hamm
▸ Take-home message - C. Hamm
STENT
FOR LIFE
41
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page41
15:30-17:00 Room 342AB Clinic
Plenary session
SOLACI@EuroPCR - How to deal with complex interventions:
the Latin American vision
Chairpersons: D. Echeverri, C. Ruiz
Objectives:
▸ To provide practical recommendations for selection of patients candidate
for complex PCI
▸ To review tips & tricks for complex interventions and prevention of
complications
▸ Introduction - D. Echeverri
▸ PCI in multivessel disease - Strategies to identify risk - A. Abizaid
▸ My worst complication - PCI in multivessel disease case presentation
J. Gaspar
▸ TAVI - Latino American experience - J. Belardi
▸ My worst complication - TAVI case presentation - O. Mendiz
▸ Complex congenital interventions - Technical concepts that should be kept
in mind - C. Zabal
▸ Discussion - C. Ruiz
16:30-18:02 Room 242A
How should I treat?
Challenging coronary artery intervention
Under the auspices of the Iranian Society of Interventional Cardiology
and the Turkish Working Group of Interventional Cardiology
Chairpersons: M. Hashemian, M. Degertekin
Objective:
▸ To learn how to prevent and treat one of the undesired complications of
the rapid-growing TAVI technique
▸ Welcome - W. Wijns
▸ Introduction and objectives - M. Hashemian
▸ Total occlusion of left main coronary artery during TAVI
- Case presentation - S. Abdi
- How would I treat? - M. Maadani
- How would I treat? - E. Atalar
- How did I treat? - S. Abdi
- Discussion
- Consensus - M. Hashemian
Tuesday 17th
42
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page42
Tue
sday 1
7th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Treatment of left main coronary artery disease in patients with acute
coronary syndrome
- Case presentation - E. Ilkay
- How would I treat? - E. Atalar
- How would I treat? - M. Maadani
- How did I treat? - E. Ilkay
- Discussion
- Consensus - M. Degertekin
▸ Take-home message - M. Degertekin
16:30-18:00 Room 242B Innovation
Abstract session
Innovations in catheter and stent design
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: R. Kornowski, F. Schiele, G. Van Langenhove
▸ Introduction - R. Kornowski
▸ Comparison of novel slender 6.5 french ('Virtual 4 French') sheathless
guiding catheter vs. 5 french guiding catheter for transradial coronary
intervention
▸ Stent boost performed only with a guide wire with double distal marker as
surrogate of conventional stent boost for procedural cost saving
C. G. Landaluce
▸ Plaque sealing and passivation with a mechanical self-expanding low
outward force nitinol VShield device for the treatment of intravascular
ultrasound and optical coherence tomography-derived thin cap
fibroatheromas (TCFAS) in native coronary arteries - J. Wykrzykowska
▸ Preliminary experience with Acrobat Svelte stent-on-a-wire system in
complex coronary interventions - A. Rezq
▸ Treatment of coronary artery aneurysm with a novel covered stent
S. Tondi
▸ Efficacy of 4F inner catheter as a distal stent delivery device - T. Ashikaga
▸ Take-home message - F. Schiele
43
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page43
16:30-18:00 Room 251 Technique
Forum
Complications encountered during left main interventions - Part II
Session comprising selected EuroPCR 2011 complication submissions
Chairpersons: J.L. Pomar, T. Santoso
▸ Introduction - J.L. Pomar
▸ Emergency stenting of unprotected left main coronary artery after acute
catheter induced occlusive dissection - D. Melehi
▸ Left main dissection - W. Kadro
▸ Catheter-induced left main dissection requiring complex trifurcation PCI
F. De Vroey
▸ A left main nightmare - R. Leung
▸ Left main trunk perforation sealed with 90-second perfusion balloon
inflation - A. Endo
▸ Take-home message - T. Santoso
16:30-18:00 Room 252AB Technique
Forum
Stent thrombosis
Session comprising selected EuroPCR 2011 clinical case & complication
submissions
Chairpersons: T. Cuisset, A.M. Kayani
▸ Introduction - T. Cuisset
▸ Stent thrombosis due to a combination of reasons: modern issues added
to old knowledge - G. Tsigkas
▸ BK stent thrombosis - R. Chawla
▸ Rheolytic thrombectomy of the left main and left anterior descending
coronary arteries - V. Zeienin
▸ Delayed stent thrombosis of covered stent - S. Munwar
▸ A case of very late stent thrombosis caused by stent malapposition and
stent fracture following Sirolimus-eluting stent implantation - A. Miyoshi
▸ Take-home message - A.M. Kayani
16:30-18:00 Room 253 Clinic
Abstract session
Biomarkers should be routinely measured after PCI
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: P. Vranckx, M. Sousa Uva
Tuesday 17th
44
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page44
Tue
sday 1
7th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction - M. Sousa Uva
▸ Periprocedural myocardial infarction following stent implantation:
comparison between first and second generation DES - K. Tandjung
▸ Insights on the mechanisms of periprocedural myocardial infarction after
PCI - X. Muschaert
▸ Six-month follow-up of the prevention of cardiac and vascular
periprocedural complications in patients undergoing coronary
angiography or angioplasty: intracoronary Adenosine administration to
prevent periprocedural myonecrosis in elective coronary angioplasty - A
prospective double-blind randomised trial (PREVENT-ICARUS trial)
G.G. Secco
▸ Routine vs. ad hoc measurement of serum creatine Kinase after PCI:
a long-term prognostic comparison - R. Lim
▸ Closing lecture and take-home message - P. Vranckx
16:30-18:00 Room 341 Clinic
Abstract session
Predictors of clinical outcome after TAVI
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: M. Thomas, P. Kala
▸ Introduction - M. Thomas
▸ Gender differences in patients undergoing TAVI with the Medtronic
CoreValve system - Y. Elhmidi
▸ Incidence, predictors and prognostic value of major hemorrhagic
complications following TAVI procedure - N. Amabile
▸ The impact of peripheral arterial disease on outcome after TAVI: results
from the German TAVI registry - J.M. Sinning
▸ The impact of preprocedural renal function on outcome after TAVI
J.M. Sinning
▸ Stroke within 30 days predicts all-cause mortality after percutaneous
aortic valve implantation: long-term results from the corevalve 18F safety
and efficacy study - C.K. Naber
▸ The influence of a systemic inflammatory response syndrome on
prognosis after TAVI - J.M. Sinning
▸ Take-home message - P. Kala
45
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page45
16:30-18:00 Room 351 Clinic
Forum
TAVI cases - Part I
Session comprising selected EuroPCR 2011 clinical case & complication
submissions
Chairpersons: R. Lange, N. Piazza
▸ Introduction - R. Lange
▸ TAVI via femoral and transapical routes in one single patient - J. Brito
▸ Corevalve dislodgment while retrieving the delivery catheter - N. Van Mieghem
▸ An unusual scenario - M. Abdel-Wahab
▸ Severe valvular aortic regurgitation late after Edwards Sapien TAVI
J. Newton
▸ Combined transcatheter aortic and mitral valve-in-valve implantation in a
patient with degenerated bioprostheses and high surgical risk - M. Seiffert
▸ Take-home message - N. Piazza
16:30-18:00 Room 353 Clinic
Abstract session
Quality of life and neurocognitive function after TAVI
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: M. Gilard, G. Manoharan, H. Rickli
▸ Introduction - M. Gilard
▸ Neurocognitive function after transfemoral aortic valve implantation - a
diffusion-weighted magnetic resonance imaging study - A. Ghanem
▸ Quality of life in patients undergoing percutaneous aortic valve
implantation - S. Stortecky
▸ Health-related quality of life shows sustained improvement with
transcatheter aortic valve - R. Bonan
▸ Durability of quality of life improvement in elderly patients after TAVI
M. Barbanti
▸ Percutaneous aortic valve implantation improves quality of life in a
geriatric patient population - R. Bekeredjian
▸ TAVI improves quality of life in high surgical risk patients with severe
symptomatic aortic stenosis - S. Salizzoni
▸ Take-home message - G. Manoharan
Tuesday 17th
46
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page46
Tue
sday 1
7th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
17:00-18:30 Main arena
Main session
EAPCI General AssemblyChairperson: C. Di Mario - EAPCI President 2009-2011
▸ Welcome - C. Di Mario
▸ EAPCI: the second biggest association within the ESC - V. Schaechinger
▸ EAPCI Board election results - W. Wijns
▸ Stent for Life: promoting primary angioplasty in Europe - S.D. Kristensen
▸ Practical examples of online certification platform - L. Gonçalves
▸ Cardiovascular Interventions in Europe 2009/2010 - S. Cook
▸ Interventional sessions during ESC Congress 2011 - D. Dudek
▸ EAPCI 2010-2011 Budget Update - K. Niemela
▸ ESC Transcatheter Valve Registry - C. Di Mario
▸ Questions & answers
17:00-18:30 Theatre Bordeaux
Symposium
PCI safety: a resolved issue or a never-ending target for theinterventional cardiologist?With an unrestricted educational grant from ABBOTT VASCULAR andCROSSROADS, the Abbott Vascular Education NetworkChairperson: A. Bartorelli
Objectives:▸ To understand the importance of DES safety and the impact of it for other
medical specialities
▸ To understand the different parameters which have an impact on DESsafety
▸ To discuss how patient's safety could be increased
▸ Introduction and objectives - A. Bartorelli
▸ Are DES a nightmare for the non-cardiac surgeons? - A. D'Hoore, F. Rocco
▸ From bare metal stent to DES: safety remains important - M. Valgimigli
▸ Bioresorbable vascular scaffold: the impact of resorption on safetyA. Abizaid
▸ Improving safety in the cathlab and beyond - C. Dubois
▸ Discussion
▸ Take-home message - A. Bartorelli
47
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page47
17:00-18:30 Theatre Havane
Symposium
Antiplatelet therapy in acute coronary syndromes: managing patientsacross the spectrum of riskWith an unrestricted educational grant from ASTRAZENECAChairpersons: C. Hamm, P.G. Steg
Objectives:▸ To recognise the growing evidence base for newer treatment options for
patients with acute coronary syndromes
▸ To understand the range of patient risk profiles presenting with acutecoronary syndromes and contemporary best practice for treatment
▸ To consider the importance of improving long-term outcomes for patientswith acute coronary syndromes
▸ Introduction and objectives - C. Hamm
▸ Long-term outcomes following acute coronary syndromes - M. Claeys
▸ Antiplatelet therapy for PCI: balancing the risks and benefits - S. Rao
▸ Antiplatelet strategies in acute coronary syndromes: 'ready to wear' or'bespoke therapy' - P.G. Steg
▸ Moderated cases: considering the options in the variety of patients withacute coronary syndromes - S. James
▸ Take-home message - P.G. Steg
17:00-18:30 Room 241
How should I treat?
Radial versus femoral in complex proceduresWith an unrestricted educational grant from CORDIS CARDIAC & VASCULAR INSTITUTEChairperson: M. Sabate
Objectives:▸ To understand the impact of bleeding complications due to dual
antiplatelet therapy or antithrombotic drugs and how to reduce these bychoosing the right vessel access
▸ To be able to discuss the available evidence associated with the percutaneoustreatment of complex coronary artery disease
▸ To recognise which patient should be referred to femoral or radial approach
▸ Introduction and objectives - M. Sabate
▸ Radial or femoral approach in a STEMI case
- Case presentation - D. Fraser
- How would I treat? - F.J. Neumann
- How would I treat? - O. Varenne
- How did I treat? - D. Fraser
- Discussion
- Consensus - M. Sabate
Tuesday 17th
48
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page48
Tue
sday 1
7th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Femoral or radial approach in a patient with aortic aneurysm
- Case presentation - E. Stabile
- How would I treat? - F.J. Neumann
- How would I treat? - O. Varenne
- How did I treat? - E. Stabile
- Discussion
- Consensus - M. Sabate
▸ Take-home message - M. Sabate
17:00-18:30 Room 342AB
Symposium
Fractional flow reserve to simplify: improving outcomes in multiple
patient subsets
With an unrestricted educational grant from ST. JUDE MEDICAL
Chairpersons: J. Escaned, S.J. Park
Objectives:
▸ To highlight the complementary value of intracoronary imaging and
physiology in the cathlab
▸ To review current evidence for improved clinical outcomes in fractional
flow reserve-guided interventions
▸ To discuss the use and value of fractional flow reserve in patients with
acute coronary syndromes
▸ Introduction and objectives - J. Escaned
▸ Fractional flow reserve and the vulnerable plaque: closer links than
commonly thought - B. De Bruyne
▸ Morphology and/or function: trials and tribulations of an IVUS-man
A. Pichard
▸ Clinical outcome after fractional flow reserve-guided decisions - N.H. Pijls
▸ What is the place of fractional flow reserve in acute coronary syndromes?
K.G. Oldroyd
▸ Discussion
▸ Take-home message - S.J. Park
49
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page49
08:00-12:00 Main arena Clinic
Main session
Revascularisation in patients with complex left main stenosisChairpersons: M.C. Morice, P. SergeantPanellists : A. Chieffo, M. de Belder, M. Lesiak, T. Majwal, D. Pagano, J.L. Pomar, K. Prathap, T. Santoso, V. Schächinger, M. Sobhy, P. Widimsky
Objectives:▸ To understand which patients with bifurcation left main disease with
or without other coronary lesions could be candidate for PCI
▸ To understand the best PCI techniques in order to achieve the best long-term outcomes
▸ Introduction and objectives - M.C. Morice
08:05-08:55 Live demonstration from Chest Hospital, Kuwait Heart Center,Safat - Kuwait
▸ Keynote lecture - Reflect together on the strategy for the best treatment ofa patient with complex left main stenosis - J.L. Pomar
09:10-10:00 Live demonstration from Institute of Cardiology, Warsaw - Poland
▸ How should I treat - Under the auspices of the InterventionalCardiology Working Group of the Czech Society of Cardiology and theGerman Working Group of Interventional Cardiology
- Introduction and objectives - V. Schächinger
- Case presentation - P. Widimsky
- How would I treat? - P. Kala
- How would I treat? - H. Mudra
- How did I treat? - P. Widimsky
- Discussion & consensus - V. Schächinger
10:50-11:45 Live demonstration from Chest Hospital, Kuwait HeartCenter, Safat - Kuwait
▸ Final key remarks - P. Sergeant
08:00-09:00 Theatre Bleu Clinic
Forum
TAVI complications - Part I
Chairpersons: S. Redwood, P. Nataf
▸ Introduction - S. Redwood
▸ Catastropic obstruction of a patent left internal mammary artery duringsubclavian CoreValve TAVI - C. Eftychiou
▸ Post-implantation repositioning of the CoreValve percutaneous aortic valvecomplicated by ischemic stroke - R. Parma
▸ Multiple TAVI for severe aortic regurgitation in true porcelain aorta - B. Reimers
▸ Take-home message - P. Nataf
Wednesday 18th
50
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page50
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
08:00-12:00 Theatre Bordeaux Clinic
Plenary session
Secondary revascularisation - Part IRestenosis in DES: an unfrequent but complex diagnostic and therapeutic problemChairpersons: J. Escaned, L. ThuesenPanellists: F. Alfonso, R. Byrne, H.M. Garcia-Garcia, A. Kastrati, V. Legrand,R. Mehran, S.J. Park, B. Scheller, A. Seth, M. Sousa Uva, P. Stella, G. Van Langenhove, R. Virmani, D.O. Williams, A. Witkowski
Objectives:▸ To review updated evidence on the epidemiology, causes and prognosis of
restenosis in DES
▸ To highlight the importance of invasive and non-invasive diagnostic techniquesin assessing the mechanisms of DES restenosis and its functional impact
▸ To understand the modalities and technical aspects of DES restenosistreatment and how to optimise its results
▸ Introduction and objectives - Scope of the problem: epidemiology of in-stent restenosis in DES - J. Escaned
08:05-08:55 Live demonstration from Instituto Cardiovascular / HospitalClínico San Carlos, Madrid - Spain
▸ Keynote lecture - Reflect together on how to optimise outcomes inpatients with restenosis in DES - A. Kastrati
09:10-10:00 Live in-a-box® from Instituto Cardiovascular / HospitalClínico San Carlos, Madrid - Spain
▸ How should I treat - Under the auspices of the Belgian Working Group onInterventional Cardiology
- Introduction and objectives - G. Van Langenhove
- Case presentation - T. Adriaenssens
- How would I treat? - C. Van Mieghem
- How would I treat? - A. Guedes
- How did I treat? - T. Adriaenssens
- Discussion & consensus - V. Legrand
10:50-11:45 Live demonstration from Instituto Cardiovascular / HospitalClínico San Carlos, Madrid - Spain
- Final key remarks - L. Thuesen
51
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page51
08:00-09:00 Theatre Havane
Forum
Complication forum
Chairpersons: E. Esplugas, M.J. Kern
Panellists: E. Barbato, N. Piazza, Y. Chen, J. Shivkumar
Objectives:▸ To learn how to anticipate and treat common complications during PCI
▸ To demonstrate exceptional complication cases
▸ To show novel techniques to treat these complications
▸ Introduction - E. Esplugas
▸ Case 1 - M. Postu
▸ Case 2 - J. Shannon
▸ Case 3 - E. Barbato
▸ Conclusion - M.J. Kern
08:00-09:00 Room 242A Clinic
Forum
Very young patients presenting with myocardial infarction
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: P. Cervinka, N. Melikian
▸ Introduction - P. Cervinka
▸ PCI for Stanford type A aortic dissection leading to subtotal occlusion ofleft main - L. Major
▸ Acute coronary syndrome in a teenager, left main total occlusion, shockA. Magdy
▸ Spontaneous coronary artery dissection in a 32 year-old woman eightweeks after delivery - G. Plehn
▸ Take-home message - N. Melikian
Wednesday 18th
52
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page52
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
08:00-09:00 Room 243 Innovation
Abstract session
Microvascular function after PCISession comprising selected EuroPCR 2011 abstract submissionsChairpersons: P. Wenaweser, S. Cook
▸ Introduction - P. Wenaweser
▸ Cholesterol levels predict the presence of coronary microvasculardysfunction - F. Mangiacapra
▸ Angiographic patterns of myocardial reperfusion after primary angioplastyand ventricular remodelling - G. Niccoli
▸ Microcirculatory function early after primary PCI is predictive of the extentof non-viable myocardium and late left ventricular function - A. Ntalianis
▸ Head-to-head comparison of Sirolimus-eluting stent vs. bare metal stentevaluating the endothelial dysfunction in the same patient with multiplecoronary artery lesions - A.N. Mischie
▸ Take-home message - S. Cook
08:00-09:00 Room 252AB Clinic
Forum
Unusual forms of left main diseaseSession comprising selected EuroPCR 2011 clinical case submissionsChairpersons: J. McKibbin, D. Capodanno
▸ Introduction - J. Mckibbin
▸ Left main coronary stenosis after Bentall intervention: percutaneoustreatment - C. Bernelli
▸ An unusual case of left main stenosis - D. Mylotte
▸ PCI for left main coronary chronic total occlusion - T. Bochenek
▸ Take-home message - D. Capodanno
08:00-09:00 Room 253 Clinic
Abstract session
Coronary perforation and spontaneous dissection: clinical outcomeSession comprising selected EuroPCR 2011 abstract submissionsChairpersons: J. Goicolea, C.H.P. Ang, A. Garachemani
▸ Introduction - J. Goicolea
▸ Spontaneous coronary artery dissection: characteristics of a large patientcohort and long-term clinical follow-up - M. Paulo Guzman
▸ Contemporary prevalence and scenarios of coronary perforation duringPCI - J.G. Del Angel Soto
▸ Replacement of heparin with bivalirudin does not change outcomes aftercoronary perforation related to PCI - R. Romaguera
▸ The different healing process of edge dissections fater Sirolimus- andZotarolimus-eluting stent implantation observed by optical coherencetomography - Y. Takeda
▸ Take-home message - C.H.P. Ang 53
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page53
08:00-09:00 Room 341 Innovation
Abstract session
New stents: bench testing
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: J. Ormiston, G. Harris
▸ Introduction - J. Ormiston
▸ Stent fracture in various DES - How does it occur? - Y. Kinoshita
▸ Conformability of the Nevo; Sirolimus-eluting coronary stent system incomparison with the Xience; Everolimus-eluting coronary stent system:results from a bench top study and an angiographic assessment from theNevo II clinical trial - J. Gomez-Lara
▸ Scanning electron microscopic observation of coating irregularities andtheir precursors in unexpanded durable polymer-based DESM.W.Z. Basalus
▸ A novel approach to investigate incomplete stent apposition using virtualbench testing - P. Mortier
▸ Take-home message - G. Harris
08:00-09:00 Room 343 Technique
Abstract session
Arterial access: use of closure devices
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: S. Garg, I. Horvath
▸ Introduction - S. Garg
▸ Vascular complications in patients undergoing transfemoral coronaryangiography with and without use of vascular closure devices - J. Auer
▸ Randomised comparison of manual compression and use of Femosealvascular closure device for closure after femoral artery access coronaryangiography. The CLOSure dEvices Used in everyday Practice (CLOSE-UP) study - N.R. Holm
▸ Large single operator experience with Perclose closure device with noinfection and excellent outcomes - G. Kang
▸ The effects of time, repeat access and vascular closure device use on thecommon femoral artery: initial results of the REPEAT study - Z. Turi
▸ Take-home message - I. Horvath
Wednesday 18th
54
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page54
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
08:00-12:00 Room 352AB Innovation
Glimpse into the future
Glimpse into the future - Future treatment decision-making based on
intracoronary lesion assessment
Chairpersons: P.W. Serruys, B. Meier
Panellists: B. De Bruyne, J. Goldstein, G. Guagliumi, A.F.W. Van Der Steen
Objectives:
▸ To understand the role of angiography and pressure-derived fractional
flow reserve in lesion assessment and decision-making
▸ To understand the potential and limitations of novel intravascular
diagnostic techniques
▸ To learn how innovative diagnostic strategies may influence treatment
decisions in the future
▸ Introduction and objectives - P.W. Serruys
▸ Intravascular imaging is not necessary - An angiographer's view - B. Meier
▸ My treatment decision-making is based on fractional flow reserve
normalisation - B. De Bruyne
08:25-09:05 Live demonstration from Erasmus University Medical Center,
ThoraxCenter, Rotterdam - The Netherlands
▸ My decision-making is based on IVUS assessment - A. Colombo
▸ IVUS - New approaches that should be used in every cathlab - E. Regar
▸ My decision-making is based on optical coherence tomography
C. Di Mario
▸ My decision in stent failure is based on optical coherence tomography
G. Guagliumi
09:45-10:25 Live demonstration from Erasmus University Medical Center,
ThoraxCenter, Rotterdam - The Netherlands
▸ Stent treatment length should rely on virtual histology assessment
D. Dudek
▸ Stent treatment length should rely on near infra-red spectroscopic
assessment - J. Goldstein
▸ Invasive imaging and tissue characterisation: it's physics, not magic
A.F.W. Van Der Steen
10:55-11:35 Live demonstration from Erasmus University Medical Center,
ThoraxCenter, Rotterdam - The Netherlands
▸ Multislice computed tomography will provide quantitative luminography,
plaque characterisation and non-invasive fractional flow reserve: the
ultimate dream - P.W. Serruys
▸ Discussion
▸ Take-home message - P.W. Serruys
55
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page55
08:30-09:30 Room 241 Clinic
Forum
Neurological complications during PCI: it can happen any day
Session comprising selected EuroPCR 2011 clinical case & complication
submissions
Chairpersons: C. Nienaber, C. Macaya
▸ Introduction - C. Nienaber
▸ Bubble trouble - A.A. Fassa
▸ Contrast agent neurotoxicity mimicking subarachnoid hemorrhage
M. Klemenc
▸ Aborted stroke during thrombectomy in right coronary artery - L. Henareh
▸ Neuro-salvage for acute basilar artery embolism during coronary
intervention - M.S. Lin
▸ Take-home message - C. Macaya
08:30-10:00 Room 242B Technique
Forum
PCI in thrombotic coronary artery lesions
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: F. Weidinger, W. Wang
▸ Introduction - F. Weidinger
▸ Optical coherence tomography guided PCI in very late DES thrombosis
T. Adriaenssens
▸ Multimodality intracoronary imaging optimises primary PCI strategy in
stent thrombosis - P.S.C. Rees
▸ Acute myocardial infarction as first presentation of acute myeloblastic
leukaemia in a young woman - R. Goncalves
▸ What is the best strategy in coronary ectasia and acute myocardial
infarction with massive intracoronary thrombus? - Y. Noji
▸ How should I treat totally occluded ectatic right coronary artery containing
huge thrombus? - A. Rahman
▸ Take-home message - W. Wang
Wednesday 18th
56
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page56
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
08:30-10:30 Room 342AB
How should I treat?
Real life bifurcation: challenges and complications
Under the auspices of the Working Group on Interventional Cardiology of
the Estonian Society of Cardiology and the Working Group on
Interventional Cardiology of Latvian Society of Cardiology and the
Russian Society of Interventional Cardioangiology
Chairpersons: A. Erglis, J. Eha, D. Iosseliani
Objectives:
▸ To learn how to treat real life bifurcation lesions to avoid complications
▸ To teach how to manage complications in bifurcation PCI
▸ To understand the application of evidence from clinical randomised trial to
real life practice
▸ Introduction and objectives - D. Iosseliani
▸ Complications in real life bifurcation PCI - Perfect is the enemy of good
- Case presentation - I. Narbute
- How would I treat? - I. Kumsars
- How would I treat? - O. Sukhorukov
- How did I treat? - I. Narbute
- Discussion
- Consensus - A. Erglis
▸ Challenges in real life bifurcation PCI
- Case presentation - O. Sukhorukov
- How would I treat? - D. Asadov
- How would I treat? - I. Kumsars
- How did I treat? - O. Sukhorukov
- Discussion
- Consensus - D. Iosseliani
▸ Keep it simple in left main disease
- Case presentation - M. Elmet
- How would I treat? - T. Hermlin
- How would I treat? - I. Narbute
- How did I treat? - M. Elmet
- Discussion
- Consensus - J. Eha
▸ Take-home message - A. Erglis
57
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page57
08:30-10:30 Room 351
How should I treat?
Primary PCI for acute myocardial infarction in patients
with multivessel coronary disease
Under the auspices of the Working Group on PCI of the
Danish Society of Cardiology, the Working Group on PCI of
the Norwegian Society of Cardiology and the Working
Group on PCI of the Swedish Society of Cardiology
Chairpersons: S. Rotevatn, J. Carlsson, E. Joergensen
Objectives:▸ To learn the spectrum of patients with multivessel coronary disease
presenting with acute myocardial infarction
▸ To review the guidelines and confront with clinical challenges
▸ To understand how to treat patients with acute myocardial infarction andmultivessel coronary disease
▸ Introduction and objectives - S. Rotevatn
▸ PCI in a patient with acute myocardial infarction and severe multivesseldisease
- Case presentation - T. Ramunddal
- How would I treat? - U. Jensen
- How would I treat? - V. Tuseth
- How did I treat? - T. Ramunddal
- Discussion
- Consensus - J. Carlsson
▸ Acute myocardial infarction in a patient with multivessel coronary disease
- Case presentation - E.J.S. Packer
- How would I treat? - V. Tuseth
- How would I treat? - J.S. Jensen
- How did I treat? - E.J.S. Packer
- Discussion
- Consensus - S. Rotevatn
▸ Severe three-vessel disease in an 85-year-old man with inferior STEMI
- Case presentation - M. Maeng
- How would I treat? - J.S. Jensen
- How would I treat? - U. Jensen
- How did I treat? - M. Maeng
- Discussion
- Consensus - E. Joergensen
▸ Take-home message - J. Carlsson
STENT
FOR LIFE
Wednesday 18th
58
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page58
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
09:00-17:00 Near Theatre Bordeaux and TV studio
Innovation
Innovation Incubator Space
On your way to or from a session, visit the Innovation Incubator Space and
learn about the latest technology from innovative companies. Grab a bite
from the buffet and talk with the representatives at each table. This space is
open to everyone, all day long.
▸ Cardiatis - Multilayer flow modulator for global aneurysm repair
▸ Avinger - Optical coherence tomography for peripheral intervention
▸ Avidal Vascular - Wombat drug reservoir technology
▸ Envision Scientific - Focusnp: sirolimus based nano carrier eluting-
coronary stent system
▸ Svelte Medical Systems - Novel DES: an amino acid based drug carrier
▸ Abbott Vascular - ABSORB bioresorbable vascular scaffold for peripheral
use
▸ ReCor Medical - Therapeutic ultrasound for the treatment of mitral
regurgitation
▸ Meril Life Sciences - Novel nanotechnology based Mitsu: merilimus
eluting coronary stent system
▸ Concept Medical - Magictouch: a sirolimus based nano carrier eluting
balloon catheter for treatment of coronary artery disease
▸ Valtech - Cardioband: transfemoral, surgical like, adjustable mitral
annuloplasty
09:00-11:30 Theatre Bleu Evidence
Plenary session
New generation DES (ESC-EACTS revascularisation guidelines) - Head-to-
head comparisons focusing on patient-oriented outcomes
Chairpersons: W. Wijns, A.P. Kappetein
Panellists: S. Garg, J. Marco, L. Mauri, S. Silber, P. Vranckx
Objectives:
▸ To provide attendees with a comprehensive synthesis on head-to-head
comparisons between the DES with respect to clinical efficacy and safety
▸ To provide attendees with key scientific messages for selecting DES in
daily practice
59
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page59
▸ Introduction and objectives - A.P. Kappetein
▸ Patients at risk: all-comers versus selected - S. Garg
▸ Data adjudication and end-point definition - P. Vranckx
▸ Key statistical metrics for data interpretation - A.P. Kappetein
▸ Biomatrix - S. Windecker
▸ Endeavor
▸ Nobori - B. Chevalier
▸ Resolute
▸ Xience - G.W. Stone
▸ Yukon - J. Mehilli
▸ Panel discussion and audience interaction
▸ Take-home message - W. Wijns
09:00-12:00 Theatre Havane Clinic
LTT - How to treat a patient with high-risk non ST-segment
elevation acute coronary syndrome
Facilitators: C.K. Naber, T. Cuisset
Panellists: B. He, S. Mishra, M. Noc
Media driver: F. Mangiacapra
Live in-a-box® from Heart Centre, Essen - Germany
09:00-10:30 Room 243 Technique
Abstract session
Dedicated stents for bifurcation lesion PCI
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: A. Mehta, G. Pavlides, G. Stankovic
▸ Introduction - A. Mehta
▸ Complex coronary bifurcation lesions treated with the novel polymer-free
dedicated bifurcation paclitaxel-eluting stent (Nile pax): clinical and
angiographic clinical results of the prospective, multicentre bipax clinical
trial - R. Costa
▸ The dedicated drug-eluting Bifurcation Optimisation Stent System (BiOSS)
Registry first-in-human results - R.J. Gil
▸ Treatment of bifurcations with the dedicated Sideguard nitinol stent
compared with conventional 2-stents strategies - N. Foin
▸ Facilitated culottes in coronary artery bifurcation stenting using a
dedicated side branch stent: two-year clinical outcome
D. Solomon Asgedom
Wednesday 18th
60
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page60
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Advanced bifurcation systems mother-daughter platform, a novel system
in treatment of coronary bifurcation lesions: preliminary results of the
prospective, multicentre first-in-man experience - M. Khorsandi
▸ Final Results from the AnGIoSculpt® MuLti-Center Coronary BIfurcation
STudY - AGILITY Trial - J.W. Moses
▸ Take-home message - G. Stankovic
09:00-10:30 Room 252AB Technique
LTT - How to perform transseptal catheterisation
Facilitators: A. Vahanian, G. Ducrocq
Panellists: B. Cauchemez, A. El Etriby, H. Gamra,
C. Ruiz, T.R.D. Shaw, K. Srinivasa
Media driver: L. Delorme
Live in-a-box® from Hôpital Bichat Claude Bernard, Paris - France
09:00-10:30 Room 253 Technique
Abstract session
Transradial access: technical and procedural aspects
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: R. Hoffmann, S. Saito
▸ Introduction - R. Hoffmann
▸ Effect of adding Nitroglycerine to Lignocaine on radial artery diameter
during local anesthesia for transradial coronary angiogram - S. Satheesh
▸ Efficacy of Nicorandil in preventing radial artery spasm during transradial
interventions - K. Manickam
▸ Usefulness of bivalirudin as compared to unfractionated heparin in PCI
using the radial approach - S. Mansour
▸ Single transradial catheter for right and left coronary diagnosis and
intervention - A. Youssef
▸ Feasibility and safety of a novel sheath less system during routine
percutaneous transradial coronary angiography - N. Gadkar
▸ Radial approach for coronary chronic total occlusion lesions: acute,
long-term results and impact of learning curve - F. Burzotta
▸ Take-home message - S. Saito
61
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page61
09:00-10:30 Room 341 Clinic
Abstract session
PCI in multivessel disease patients: determinants of long-term clinical
outcome
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: A.T.L. Ong, P. Kohl, W.J. van der Giessen
▸ Introduction - A.T.L. Ong
▸ Complete revascularisation and clinical outcomes of patients with
multivessel disease - E. Barbato
▸ Clinical risk stratification is a better determinant of long-term survival
following multivessel PCI compared to anatomic risk stratification using
the Syntax score - R. Lehmann
▸ 'Residual' Syntax score after PCI for triple vessel coronary artery disease:
quantifying the adverse effect of incomplete revascularisation - C.J. Malkin
▸ Percutaneous revascularisation of coronary lesions with established
surgery class I indications without surgical back-up: one-year outcomes
R. Del Castillo
▸ Does high Syntax score really predict worse outcome in PCI-treated
patients with complete revascularisation strategy? - I. Hamanaka
▸ One-year retrospective study to evaluate the outcome in patients with first
time diagnosis of three-vessel coronary artery disease: implementation of
the Syntax score - A. Cuneo
▸ Take-home message - P. Kolh
09:00-10:30 Room 343 Clinic
Abstract session
Edge-to-edge mitral valve repair: clinical, hemodynamic and
echocardiographic evaluation
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: T. Feldman, V. Delgado, S. Kar
▸ Introduction - T. Feldman
▸ Percutaneous mitral valve repair in high-risk patients - The Swiss
experience after the first 100 patients - D. Suerder
▸ Changes in systolic function after interventional mitral valve
reconstruction: a 2D speckle tracking analysis - T. Wengenmayer
▸ Role of intracardiac echocardiography during percutaneous edge-to-edge
mitral valve repair with the MitraClip system: a single centre experience
M. Barbierato
Wednesday 18th
62
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page62
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Quality of life of high-risk patients following percutaneous mitral valve
repair with the MitraClip system - V. Cammalleri
▸ MitraClip therapy demonstrates favorable mid-term outcomes in ACCESS-
EUROPE heart failure patients with left ventricular ejection fraction ≤ 30%:
preliminary report from the 6-month ACCESS-EU analysis cohort
F. Maisano
▸ Endovascular MitraClip-repair of severe mitral valve regurgitation in
patients with end-stage heart failure - R. Bekeredjian
▸ Take-home message - V. Delgado
09:00-10:30 Room 353 Technique
Forum
Problems on the road to coronary intervention
Session comprising selected EuroPCR 2011 complication submissions
Chairpersons: S. Kedev, C. Mialhe
▸ Introduction - S. Kedev
▸ Vascular closure device: complications with closure - A. George
▸ Femoral access complication: percutaneous treatment - I. Dato
▸ Double jeopardy! Percutaneous treatment of bilateral groin hemorrhage
after high-risk PCI - S. Arain
▸ A case of iatrogenic brachial artery dissection, rupture and artero-venous
fistula formation - A.R. De Caterina
▸ Falling in a trap - P.T. Tsui
▸ Take-home message - C. Mialhe
10:30-12:00 Room 242A
How should I treat?
Bifurcations in coronary chronic total occlusion PCI - Incidence,
treatment, strategies, results
Under the auspices of the Bulgarian Working Group on Interventional
Cardiology and the Siberian Association of Interventional
Cardioangiologists
Chairpersons: V. Gelev, A. Osiev
Objectives:
▸ To learn that bifurcation lesions after coronary chronic total occlusion is a
separate vital issue which demands an independent approach to the
decision
▸ To teach how to use different techniques of stenting after coronary chronic
total occlusion recanalisation
▸ To understand the necessity of carrying out further researches and
approaches to the decision
▸ To state that there are special features of bifurcation lesions in patients
who underwent coronary chronic total occlusion recanalisation and in
coronary non-chronic total occlusion patients
63
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page63
▸ Introduction and objectives - V. Gelev
▸ Stenting of bifurcation lesions after retrograde recanalisation of rightcoronary chronic total occlusion
- Case presentation - A. Biryukov
- How would I treat? - V. Ganyukov
- How would I treat? - I. Zheleva
- How did I treat? - A. Biryukov
- Discussion
- Consensus - A. Osiev
▸ Combined approach - Antegrade and retrograde for recanalisation ofbifurcation right coronary chronic total occlusion
- Case presentation - O. Radev
- How would I treat? - I. Zheleva
- How would I treat? - V. Ganyukov
- How did I treat? - O. Radev
- Discussion
- Consensus - V. Gelev
▸ Take-home message - A. Osiev
10:30-12:00 Room 242B Clinic
Plenary session
Percutaneous treatment of uncommon structural heart disease disorders -Ventricular septum defect, paravalvular leak and coronary fistulaChairpersons: P. Ruygrok, E. EeckhoutPanellists: F. Bourlon, J. Dugal
Objectives:▸ To understand the clinical presentation and evolution of uncommon
congenital or acquired structural heart disease disorders in order toprevent adverse outcomes
▸ To learn about the diagnostic work-up in order to choose the besttherapeutic strategy
▸ To review the possibilities and limitations of the available percutaneoustreatment modalities
▸ Introduction and objectives - P. Ruygrok
▸ Closure of ventricular septum defects after myocardial infarction - P. Ruygrok
▸ Case presentation - C. Ruiz
▸ Closure of paravalvular leaks - C. Rihal
▸ Case presentation - E. Eeckhout
▸ Interventions on coronary fistulae and malformations - H. Sievert
▸ Case presentation - N.Q. Nguyen
▸ Take-home message - E. Eeckhout
Wednesday 18th
64
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page64
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
10:30-12:00 Room 243 Clinic
Abstract session
Primary PCI in STEMI patients with left main or multivessel occlusion
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: A. Rahman, F. Eberli, F. Weidinger
▸ Introduction - A. Rahman
▸ In-hospital and long-term outcomes of patients with STEMI with
unprotected left main coronary artery stenosis undergoing primary PCI in
a hospital without on-site cardiac surgery - F. Tomassini
▸ One-stage PCI of left main stenosis and infarct-related left anterior
descending or circumflex arteries in STEMI patients - E. Merkulov
▸ Treatment of multivessel coronary artery disease in primary PCI for
STEMI: culprit only revascularisation is associated with higher major
adverse cardiovascular event rates - D.A. Jones
▸ Acute simultaneous total occlusion of two major coronary arteries in
STEMI - J. Guo
▸ Is the Syntax score a predictor of early outcome in patients with
cardiogenic shock complicating acute myocardial infarction?
M. Abdel-Wahab
▸ Primary PCI in the presence of left bundle branch block - K. Lee
▸ Take-home message - F. Eberli
10:30-12:00 Room 252AB Technique
LTT - How to perform manual thrombus aspiration in STEMI
Facilitators: P. MacCarthy, P. Musialek, M. Oberhoff
Panellists: G. Brueren, F. Malik, H. Mardikar
Media driver: A.A. Fassa
Live in-a-box®
STENT
FOR LIFE
65
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page65
▸ CTO-1 collagenase total occlusion first-in-man clinical trial -
▸ Discussion
▸ First-in-man use of lineage-specified stem cells for the treatment of heart
failure: the C-CURE trial -
▸ Discussion
10:30-12:00
Drug-eluting balloons
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: S.T. Lim, S. Silber, R. Starc
▸ Introduction -
▸ Paclitaxel-coated balloon in combination with bare metal stent for
treatment of de novo coronary lesions: an optical coherence tomography
first-in-man randomised trial balloon first vs. stent first
J.L. Gutiérrez-Chico
▸ Comparison of bare metal and DES restenosis after treatment with a novel
drug-eluting balloon - a subgroup analysis of the PEPPER first-in-man
trial -
▸ Trend towards lower target lesion revascularisation and measure adverse
cardiovascular event rates in patients treated with drug-eluting balloon
compared with DES -
▸ Treatment of the coronary in-stent restenoses with Paclitaxel coated
balloon catheters -
▸ 3-year clinical outcome after PCI with drug-eluting balloon in small
coronary vessels -
▸ Predictors of recurrent restenosis after Paclitaxel-eluting balloon for the
treatment of DES restenosis -
▸ Take-home message -
10:30-12:00 Room 253 Technique
Abstract session
Left atrial appendage closure from single centre experience to large
randomised trials
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: I. Horvath
▸ Introduction - I. Horvath
▸ Last chance access closure of the left atrial appendage - A.K. Roy
▸ Transcatheter left atrial appendage occlusion in atrial fibrillation:
comparison of non-dedicated vs. dedicated Amplatzer devices - S. Gloekler
▸ Technique and 30-day results with the Amplatzer cardiac plug for left atrial
appendage occlusion in anticoagulant ineligible patients - D. Meerkin
▸ The safety of percutaneous left atrial appendage closure for stroke
prevention in atrial fibrillation patients: is there evidence for a learning
curve? - S. Kar
▸ Left atrial appendage closure and the Protect AF trial: results at 1500
patient-years of follow-up - S. Kar
▸ Anticoagulation after left atrial appendage closure using the Watchman
device in patients not taking Warfarin - M.W. Bergmann
▸ Take-home message - I. Horvath
10:30-12:00 Room 342AB Evidence
Hot Line session
Late breaking first-in-human trials
Chairpersons: A. Cribier, R. Erbel, J. Simpson
▸ BIOSOLVE-I safety and clinical performance of the first drug-eluting
absorbable metal scaffold - M. Haude
▸ Discussion
▸ First-in-man experience with the DES Orsiro in the treatment of patients
with single de novo coronary artery lesions (BIOFLOW-I) - M. Hamon
▸ Discussion
▸ TA-AVI: 3-month first-in-man results with the Symetis Acurate transapical
aortic valve - J. Kempfert
▸ Discussion
▸ Diagnosis of ischemia-causing stenoses obtained via non-invasive
fractional flow reserve (DISCOVER-FLOW): a prospective multicentre first-
in-man study - B.K. Koo
▸ Discussion
Wednesday 18th
66
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page66
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ CTO-1 collagenase total occlusion first-in-man clinical trial - B. Strauss
▸ Discussion
▸ First-in-man use of lineage-specified stem cells for the treatment of heart
failure: the C-CURE trial - D. Dolatabadi
▸ Discussion
10:30-12:00 Room 343 Technique
Abstract session
Drug-eluting balloons
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: S.T. Lim, S. Silber, R. Starc
▸ Introduction - S.T. Lim
▸ Paclitaxel-coated balloon in combination with bare metal stent for
treatment of de novo coronary lesions: an optical coherence tomography
first-in-man randomised trial balloon first vs. stent first
J.L. Gutiérrez-Chico
▸ Comparison of bare metal and DES restenosis after treatment with a novel
drug-eluting balloon - a subgroup analysis of the PEPPER first-in-man
trial - R. Toelg
▸ Trend towards lower target lesion revascularisation and measure adverse
cardiovascular event rates in patients treated with drug-eluting balloon
compared with DES - M. Unverdorben
▸ Treatment of the coronary in-stent restenoses with Paclitaxel coated
balloon catheters - G. Goranov
▸ 3-year clinical outcome after PCI with drug-eluting balloon in small
coronary vessels - M. Unverdorben
▸ Predictors of recurrent restenosis after Paclitaxel-eluting balloon for the
treatment of DES restenosis - S. Habara
▸ Take-home message - R. Starc
67
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page67
10:30-12:00 Room 351
How should I treat?
PCI of the left main in acute myocardial infarction
Under the auspices of the Interventional Cardiology
Working Group of the Czech Society of Cardiology and the
German Working Group of Interventional Cardiology
Chairpersons: M. Zelizko, A. Elsaesser
Objectives:
▸ To learn indications of left main PCI in myocardial infarction
▸ To teach technical skills of left main PCI and pharmacological management
▸ To understand limitations and importance of global clinical assessment
▸ Introduction and objectives - M. Zelizko
▸ STEMI - primary PCI of the left main
- Case presentation - I. Bernat
- How would I treat? - M. Mates
- How would I treat? - V. Klauss
- How did I treat? - I. Bernat
- Discussion
- Consensus - M. Zelizko
▸ Left main - PCI in acute coronary syndrome
- Case presentation - H. Moellmann
- How would I treat? - V. Klauss
- How would I treat? - M. Mates
- How did I treat? - H. Moellmann
- Discussion
- Consensus - A. Elsaesser
▸ Take-home message - A. Elsaesser
STENT
FOR LIFE
Wednesday 18th
68
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page68
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
10:30-12:00 Room 353 Clinic
Forum
TAVI cases - Part II
Session comprising selected EuroPCR 2011 clinical case & complication
submissions
Chairpersons: J. Webb, G. Fournial
▸ Introduction - J. Webb
▸ Transcatheter implantation of the CoreValve self-expanding aortic
prosthesis for failed bioprosthetic aortic valve - M. Lelek
▸ TAVI for AR and mild calcification - A. Mostafa
▸ TAVI complicated by common femoral artery rupture and occlusion;
endovascular repair with viabahn endoprosthesis - A. Silvestro
▸ Left internal mammary artery graft occlusion during TAVI - O. Sousa
▸ Distal left anterior descending coronary artery obstruction: a rare
complication of transapical aortic valve implantation - D. Dvir
▸ Take-home message - G. Fournial
11:30-13:30 Theatre Bleu
Tech News & Trends (TNT) session
Medtronic CoreValve: the next generation
With an unrestricted educational grant from MEDTRONIC
Chairperson: A. Linke
Panellists: J. Bosmans, E. Grube, B. Reimers
Objectives:
▸ To provide latest experience and usage/implementation of the Accutrack
delivery system
▸ To provide all the insights of the new indication of subclavian access
▸ To provide the latest information on product durability and the experience
with ReDo cases
▸ Introduction and objectives - A. Linke
11:35-12:20 Live in-a-box® from Clinique Pasteur, Toulouse - France
▸ Accutrack - D. Tchétché
▸ Subclavian access - F. Maisano
▸ Durability - N. Piazza
12:35-13:20 Live demonstration from Institute of Cardiology, Warsaw -
Poland
▸ Take-home message - A. Linke
69
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page69
12:00-13:30 Main arena
Symposium
Breaking the link between stenting and dual antiplatelet therapy
With an unrestricted educational grant from CORDIS CARDIAC
& VASCULAR INSTITUTE
Chairpersons: C. Spaulding, M. Thomas
Objectives:
▸ To use clinical cases to discuss the current problems related to prolonged
dual antiplatelet therapy in clinical practice
▸ To review the current rate of stent thrombosis, the guidelines and ongoing
trials on dual antiplatelet therapy
▸ To understand the potential of future stent technologies to further reduce
the rate of stent thrombosis
▸ Introduction and objectives - M. Thomas
▸ Case presentation: late stent thrombosis with currently available DES
I. Nadra
▸ Discussion - Stent thrombosis in 2011: have things really changed?
L. Mauri
▸ Case presentation: planned PCI followed by a mandatory surgery: how
should we treat? - J. Silvain
▸ Discussion - Dual antiplatelet therapy: current guidelines and future
directions - G. Montalescot
▸ Case presentation: unplanned surgery 4 months after PCI: what should we
do? - S. Cook
▸ Discussion - Will changes in DES design modify dual antiplatelet therapy
paradigms? - C. Spaulding
▸ Discussion
▸ Take-home message - M. Thomas
Wednesday 18th
70
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page70
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
12:00-13:30 Theatre Bordeaux
Symposium
Reducing clinical risk for coronary artery disease and structural heart
disease intervention: the role of medical device innovation
With an unrestricted educational grant from BOSTON SCIENTIFIC
Chairpersons: K. Dawkins, J. Ormiston
Objectives:
▸ To evaluate innovation and advances in technology and engineering
▸ To discuss how these advances impact clinical outcomes for patients
▸ Introduction and objectives - J. Ormiston
▸ Do different DES polymers offer a clinical advantage? - M. Valgimigli
▸ How does stent design impact clinical outcomes: lessons from pre-clinical
work - R. Virmani
▸ Can stent performance on the bench predict stent performance in vivo?
J. Escaned
▸ Do real-world outcomes replicate randomised clinical trial data? Stent
performance differences within SCAAR - S. James
▸ Take-home message: safety and clinical outcomes can be improved by
continuing to innovate - J. Ormiston
▸ Performance goals for percutaneous structural heart solutions: the next
steps in left atrial appendage closure and percutaneous valve technologies
K. Dawkins
12:00-13:30 Theatre Havane
Symposium
Primary PCI: step-by-step decision process
With an unrestricted educational grant from TERUMO
Chairpersons: J. Marco, P. W. Serruys
Objectives:
▸ To understand the added value of a step-by-step decision-making process
for treatment of complex patients with STEMI
▸ To define risk-benefits for different approaches for each step in
management of patients with STEMI
▸ To demonstrate interaction of patient condition and treatment options
▸ Introduction and objectives - P. W. Serruys
▸ Case presentation - G. Olivecrona
▸ Vascular access site - M. Roffi
▸ Pharmacological management - R. Kornowski
▸ Thrombus management - G. Sardella
▸ New optical imaging techniques to guide treatment - P.W. Serruys
▸ Proper selection of the stents - H. Ince
▸ Discussion
▸ Take-home message - J. Marco
STENT
FOR LIFE
71
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page71
12:00-13:30 Room Maillot
Symposium
Titanium-nitride-oxide bioactive stent technology in acute coronary
syndrome patients: present and future
With an unrestricted educational grant from HEXACATH
Chairpersons: J. Fajadet, M. Sabate
Objectives:
▸ To review why acute coronary syndrome patients are a challenging
indication for PCI
▸ To understand the titanium-nitride-oxide coated stents potential interest
for acute coronary syndrome patients
▸ To describe the latest Titan2 bioactive stent clinical data and share the next
applications of this technology
▸ Introduction and objectives - M. Sabate
▸ How the thrombogenic and inflammation context of acute coronary
syndrome patients must lead to a rationale stent choice - M. Sabate
▸ Perspective of optical coherence tomography findings after Titan2 stent
implantation in acute coronary syndrome patients - P. Karjalainen
▸ Optimal revascularisation in patients with acute myocardial infarction: the
CATS-AMI large scale registry - M. Angioi
▸ Randomised comparison between the bioactive stent Titan2 and the
Everolimus-eluting stent Xience V: the BASE-ACS trial - P. Karjalainen
▸ Introducing the future of bioactive stents - J. Fajadet
▸ Discussion
▸ Take-home message - J. Fajadet
12:00-13:30 Room 242A
How should I treat?
How to treat complex coronary disease in Asia Pacific
With an unrestricted educational grant from MEDTRONIC
Chairpersons: S. Lu, I. Meredith
Objectives:
▸ To discuss the alternative approaches to treating multivessel disease
▸ To explain the benefits behind a staged approach to PCI treatment of
multivessel disease
▸ To determine the challenges behind treating a left main/bifurcation as part
of multivessel disease
Wednesday 18th
72
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page72
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction and objectives - I. Meredith
▸ Complex multivessel disease PCI in a diabetic patient
- Case presentation - S. Worthley
- How would I treat? - P. Chandra
- How would I treat? - Y.S. Jang
- How did I treat? - S. Worthley
- Discussion
- Consensus - I. Meredith
▸ A complex triple vessel PCI
- Case presentation - G. Wen-Yi
- How would I treat? - H.S. Kim
- How would I treat? - M. Lee
- How did I treat? - G. Wen-Yi
- Discussion
- Consensus - I. Meredith
▸ Take-home message - I. Meredith
12:00-13:30 Room 242B Clinic
Abstract session
Which DES for diabetics?
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: J. Belardi, U. Kaul, B. Merkely
▸ Introduction - J. Belardi
▸ Clinical evaluation of the Everolimus-drug eluting coronary stent Xience V
for the treatment of de novo coronary lesions in the daily practice in
diabetic patients - A. Iniguez
▸ Treatment with the Resolute Zotarolimus-eluting stent in subjects with
diabetes mellitus: pooled analysis from the Resolute clinical programme
S. Silber
▸ Clinical outcomes in diabetic and non diabetic patients treated with
Endeavor Resolute Zotarolimus eluting-stent: a multicentre Italian
observational study - A. Ielasi
▸ Major cardiovascular events after coronary Everolimus-eluting stent(s) in
diabetic patients. The Middle East diabetic Xience registry - T. Majwal
▸ Initial clinical and angiographic results of the Titanic XV prospective
randomised trial: the Titan vs. Everolimus (Xience V) stent in diabetic
patients - J.R. Lopez-Minguez
▸ Two-year clinical outcomes of diabetic patients treated with a new
generation DES - M. Wiemer
▸ Take-home message - U. Kaul
73
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page73
12:00-13:30 Room 243
How should I treat?
Treatment of primary PCI: the combination of a perfusion
and an aspiration technique
With an unrestricted educational grant from IHT - CORDYNAMIC
Chairperson: S.D. Kristensen
Objectives:
▸ To establish the key points for a successful primary PCI
▸ To present a new strategy to approach primary PCI
▸ To become familiar with new devices to obtain optimised results with the
new strategy presented
▸ Introduction and objectives - S.D. Kristensen
▸ Thrombus aspiration technique. Is it always the best choice?
- Case presentation - I. Malik
- How would I treat? - P. Widimsky
- How would I treat? - E. Garcia
- How did I treat? - I. Malik
- Discussion
- Consensus - S.D. Kristensen
▸ How can we improve lesion assessment in primary PCI?
- Case presentation - G. Marti
- How would I treat? - P. Widimsky
- How would I treat? - E. Garcia
- How did I treat? - G. Marti
- Discussion
- Consensus - S.D. Kristensen
▸ Take-home message - S.D. Kristensen
12:00-13:30 Room 253
How should I treat?
Can we all treat Medina 1.1.1 bifurcation lesions?
With an unrestricted educational grant from MINVASYS
Chairpersons: A. Abizaid, R. Mehran
Objectives:
▸ To understand the technique and the concept
▸ To assess procedural and final results
▸ To discuss the achievements with and without the use of additional
assessment devices
STENT
FOR LIFE
Wednesday 18th
74
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page74
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction and objectives - A. Abizaid
▸ Bifurcation lesion 1.1.1 with the Nile concept, without additionalassessment devices
- Case presentation - T. Carreres
- How would I treat? - B. Garcia Del Blanco
- How would I treat? - P. Motreff
- How did I treat? - T. Carreres
- Discussion
- Consensus - R. Mehran
▸ Bifurcation lesion 1.1.1 with the Nile concept, with additional assessmentdevices
- Case presentation - J. Wykrzykowska
- How would I treat? - B. Garcia Del Blanco
- How would I treat? - P. Motreff
- How did I treat? - J. Wykrzykowska
- Discussion
- Consensus - A. Abizaid
▸ Take-home message - R. Mehran
12:00-13:30 Room 341 Innovation
Plenary session
Cardiovascular Innovation Pipeline - Peripheral vascular disease and structural heart diseaseChairpersons: M.C. Morice, H. Sievert, P. Bonhoeffer
▸ Overview of companies - E. Lehto
▸ ReCor Medical - Therapeutic ultrasound for the treatment of mitralregurgitation - W. Schillinger
▸ Questions & answers
▸ Pi-R-Squared - Impacting valve repair - M. Jonas
▸ Questions & answers
▸ Cardatis - Multilayer flow modulator for global aneurysm repair - P. Gruffaz
▸ Questions & answers
▸ Avinger - Optical coherence tomography for peripheral intervention
▸ Questions & answers
▸ Odierna - Software for automatic IV-optical coherence tomography stentanalysis, image registration and 3D reconstruction - G. Ughi
▸ Questions & answers
▸ Avidal Vascular - the Wombat drug reservoir technology
▸ Questions & answers
75
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page75
12:00-13:30 Room 342AB
Symposium
Contrast agents and renal safety/contrast induced nephropathy -
Pathomechanisms, new clinical evidence, and practical guidance for PCI
in risk patients
With an unrestricted educational grant from BAYER HEALTHCARE
Chairpersons: M. Gilard, T. Lüscher
Objectives:
▸ To understand the pathomechanisms of contrast induced nephropathy and
the differences between contrast media classes
▸ To improve safety of interventions in patients at high risk of contrast
induced nephropathy
▸ To be informed about the newest and largest contrast induced
nephropathy trial
▸ To be informed about the current guidelines for the prevention of contrast
induced nephropathy
▸ Introduction and objectives - T. Lüscher
▸ Pathomechanisms of contrast induced nephropathy: why low-osmolar
contrast agents should be preferred, and why hydratation is the key
P. Persson
▸ Safe interventions in patients with impaired renal function - M. Möckel
▸ Findings from the direct STUDY - The largest, double-blinded prospective,
comparative, contrast induced nephropathy study to date - Y. Chen
▸ Practical recommendations and guidelines on interventions in patients
with impaired renal function - C. Rihal
▸ Discussion
▸ Take-home message - M. Gilard
12:00-13:30 Room 351
How should I treat?
How to treat a coronary chronic total occlusion, an European perspective
With an unrestricted educational grant from ABBOTT VASCULAR and
CROSSROADS, the Abbott Vascular Education Network
Chairperson: A. Serra
Objectives:
▸ To receive practical recommendations on coronary chronic total occlusion
treatment from a European perspective
▸ To learn how to prevent and to treat complications
▸ To receive recommendations on when to use antegrade or retrograde
approach
Wednesday 18th
76
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page76
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction and objectives - A. Serra
▸ How to cross the lesion if the balloon doesn't cross
- Case presentation - E. Barbato
- How would I treat? - G. Werner
- How would I treat? - G. Sianos
- How did I treat? - E. Barbato
- Discussion
- Consensus - A. Serra
▸ How to optimise antegrade approach
- Case presentation - J. Spratt
- How would I treat? - G. Werner
- How would I treat? - G. Sianos
- How did I treat? - J. Spratt
- Discussion
- Consensus - A. Serra
▸ Take-home message - A. Serra
12:00-13:30 Room 352AB
Symposium
Optical coherence tomography lesion assessment to impact decision-making in PCIWith an unrestricted educational grant from ST. JUDE MEDICALChairpersons: F. Prati, E. Regar
Objectives:▸ To show how lesion assessment with optical coherence tomography can
influence decision-making in PCI
▸ To discuss what might be the place of optical coherence tomography inclinical practice
▸ To discuss how to start an optical coherence tomography programme
▸ Introduction and objectives - E. Regar
▸ The role of optical coherence tomography in assessing stent placementC. Di Mario
▸ The role of optical coherence tomography in acute coronary syndromes:new insights in the pathophysiology or a new tool to guide treatment?E. Regar
▸ The role of optical coherence tomography in assessing stent strutcoverage: lessons for dual anti-platelet therapy - A.V. Finn
▸ Why and how can optical coherence tomography become part of yourclinical practice - T. Adriaenssens
▸ Discussion
▸ Take-home message - F. Prati
77
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page77
13:00-14:30 Room 251 Evidence
All you need to know about prevention of bleeding
complications and access site selection
Chairpersons: T. Cuisset, F.J. Neumann
Objective:
▸ At the end of this 90-minute ‘All you need to know about...’ session the
audience should have an up-to-date knowledge of the field, relevant for
their clinical practice. They should be familiar with the current evidence
base, existing guidelines and have an understanding of the open questions
that need addressing in the near future
▸ Introduction - F.J. Neumann
▸ Background - Bleeding complications have become a major concern in
patients undergoing coronary interventions - J-P. Bassand
▸ Clinical data - How to optimise the safety of antithrombotic agents
K. Huber
▸ Technical aspects - How access site selection and technical aspects can
decrease the rate of bleeding complications - P. Vranckx
▸ Guidelines - Any help from the Guidelines for bleeding prevention and
access site selection? - S. Silber
▸ Unsolved issues with transradial access - Impact of transradial approach
on patient outcome - J. Nolan
▸ Questions & answers - T. Cuisset
13:30-17:30 Main arena Clinic
Main session
Revascularisation in patients with stable angina and complex multivessel
disease
Chairpersons: B. De Bruyne, L. Torracca
Panellists : P. Avraamides, F. Casselman, S.B. King III, D. Hasdai,
S.M. Kalarickal, T. Mabin, T. Majwal, P. Musialek, M. Ostojic, S. Windecker,
R. Zambahari
Objectives:
▸ To provide a better definition of multivessel coronary disease by
anatomical vs. functional viewpoint
▸ To reconsider the practical diagnostic work-up in patients with risk
factors, angina or ischemia and complex multivessel disease
▸ To understand the relative role and impact of medical treatment, PCI and
CABG
Wednesday 18th
78
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page78
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction and objectives - B. De Bruyne
13:35-14:25 Live demonstration from Institute of Cardiology, Warsaw -
Poland
▸ Keynote lecture - Reflect together on two essential issues: the changing
definitions of complete revascularisation and what determines the choice
between PCI and surgery - S. Windecker
14:40-15:30 Live demonstration from Chest Hospital, Kuwait Heart Center,
Safat - Kuwait
▸ How should I treat - Under the auspices of the Working Group for
Interventional Cardiology of the Cyprus Society of Cardiology and the
Working Group on Interventional Cardiology of the Cardiology Society of
Serbia
- Introduction and objectives - M. Ostojic
- Case presentation - M. Tesic
- How would I treat? - D. Orlic
- How would I treat? - G. Georgiou
- How did I treat? - M. Tesic
- Discussion & consensus - P. Avraamides
16:20-17:10 Live demonstration from Institute of Cardiology, Warsaw -
Poland
▸ Final key remarks - L. Torracca
13:30-16:30 Theatre Bleu Clinic
Plenary session
Percutaneous intervention for mitral regurgitation
Chairpersons: A. Vahanian, F. Maisano
Panellists: J. Hausleiter, S. Kar, K.H. Kuck, J. van der Heijden, N. Wunderlich
With continuous live demonstration from The National Hospital, The Heart
Center, Copenhagen - Denmark
Objectives:
▸ To understand which patients with mitral regurgitation could qualify for
transcatheter mitral repair
▸ To understand the key role of non-invasive imaging modalitites for the
selection of patients and guidance of transcatheter mitral regurgitation
▸ To provide an overview of the state of the experience of the MitraClip
therapy
79
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page79
▸ Introduction and objectives - F. Maisano
▸ Who might be candidates for percutaneous treatment of mitral
regurgitation from a surgeon's point of view - N. Moat
▸ Discussion
▸ How to grade mitral regurgitation severity before and after percutaneous
treatment - M. Sarano
▸ Discussion
▸ Impact of functional mitral regurgitation in heart failure patients. Do we
need mitral regurgitation grade <1 after treatment? - V. Delgado
▸ Overview of experience :
- Peer-reviewed published data on annuloplasty device - G. Pedrazzini
- The EVEREST trial: 2-year follow-up - T. Feldman
- European experience with the MitraClip therapy and the Access registry
F. Maisano
▸ Discussion
▸ Final key remarks - A. Vahanian
13:30-16:30 Theatre Bordeaux Clinic
Plenary session
Secondary revascularisation - Part II
Revascularisation of saphenous vein graft attrition:
complex decisions in high-risk patients
Chairpersons: C. Macaya, P. Kolh
Panellists: A. Abizaid, I.A. Alhaddad, M. Borger, J. Escaned, P. Vermeersch,
D.O. Williams
Objectives:
▸ To understand the role of a multidisciplinary approach in the selection of
revascularisation modalities in patients with saphenous vein graft attrition
▸ To learn about the added value of computed tomography angiography
prior to invasive coronary angiography
▸ To learn how to improve the safety and efficacy of PCI on saphenous vein
graft
Wednesday 18th
80
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page80
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction and objectives - C. Macaya
13:35-14:25 Live demonstration from Instituto Cardiovascular / Hospital
Clínico San Carlos, Madrid - Spain
▸ DES vs. bare-metal stent in saphenous vein graft: do we need a large
randomised trial? - D.O. Williams
▸ Implementing distal and proximal embolic protection devices in
saphenous vein graft PCI - L. Mauri
▸ Emerging percutaneous options in patients with degenerated saphenous
vein grafts - A. Colombo
▸ Emerging surgical options in patients with degenerated saphenous vein
grafts - M. Borger
▸ Revascularisation of occluded saphenous vein graft: a bridge too far or a
reasonable option? - R. Hoffmann
▸ Best of both worlds: combining multislice computed tomography and invasive
angiography in patients with saphenous vein grafts - C. Van Mieghem
▸ Panel discussion
15:30-16:20 Live demonstration from Instituto Cardiovascular / Hospital
Clínico San Carlos, Madrid - Spain
▸ Final key remarks - J. Escaned
13:30-16:30 Theatre Havane Clinic
LTT - How to treat a patient with STEMI caused by a
large thrombus
Facilitators: J. Goicolea, P. MacCarthy, M. Noc
Panellists: G. Brueren, M. Gilard
Media driver: L. Delorme
Live in-a-box® from Catharina Ziekenhuis, Eindhoven
The Netherlands
13:30-15:00 Room 242A
How should I treat?
Complications during early invasive strategy in NSTEMI
Under the auspices of the Egyptian Working Group of
Interventional Cardiology (EWGIC) and the Saudi Arabia
Cardiology Interventional Group (SACIG)Chairpersons: M. Sobhy, M.A. Youssef
Objectives:▸ To redefine the timing of invasive strategy in NSTEMI patients
▸ To understand, in multivessel disease patients, which vessel should betreated first
▸ To understand the role of thrombus aspiration in NSTEMI patients
▸ To underline the place and the timing of emergency CABG in NSTEMI patients
STENT
FOR LIFE
STENT
FOR LIFE
81
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page81
▸ Introduction and objectives - M. Sobhy
▸ Expected complications during early invasive strategy in NSTEMI
- Case presentation - M. Sadaka
- How would I treat? - A. El Etriby
- How would I treat? - W. Ahmad
- How did I treat? - M. Sadaka
- Discussion
- Consensus - M. Sobhy
▸ Managing NSTEMI in patient with multivessel disease and ischemic mitralregurgitation; is PCI an option for such a patient rather than CABG andmitral repair?
- Case presentation - H. Mhish
- How would I treat? - M. Balghith
- How would I treat? - S. El Tobgy
- How did I treat? - H. Mhish
- Discussion
- Consensus - M.A. Youssef
▸ Take-home message
13:30-15:00 Room 242B Technique
Abstract session
IVUS in acute coronary syndrome: how lesion morphology may impact on
outcome
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: A. Pichard, J.B. Ge
▸ Introduction - A. Pichard
▸ Coronary atherosclerotic disease in Saudi patients: a pilot IVUS analytical
study of patients presenting with acute coronary syndrome - S. Lawand
▸ Is angiography enough for optimal stenting of the culprit lesion in patients
with acute myocardial infarction (STEMI and NSTEMI)? An intravascular
ultrasound and virtual histology (IVUS-VH) study - J. Jakala
▸ Reproducibility of volumetric virtual histology IVUS analyses in
coronary lesions prior to stenting: an European multicentre study on
between-centre reproducibility - J. Huisman
▸ Role of IVUS in acute myocardial infarction patients undergoing PCI - K. Ahmed
▸ VH-IVUS findings predict major adverse cardiovascular events, post-PCI
myocardial infarction and troponin rise: the VIVA (VH-intravascular
ultrasound in vulnerable atherosclerosis) study - P.A. Calvert
▸ Continuous neointimal hyperplasia formation after five years of different
generations of DES: is there enough evidence of late 'catch-up'? - C. Collet
▸ Take-home message - J.B. Ge
Wednesday 18th
82
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page82
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
13:30-15:00 Room 243 Technique
Abstract session
PCI for unprotected left main stenosis
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: A.P. Kappetein, S.J. Park, F.W. Mohr
▸ Introduction - A.P. Kappetein
▸ Risk assessment for PCI of the unprotected left main coronary artery in an
all-comer population - C. Dubois
▸ Everolimus-eluting stent implantation for unprotected left main disease: a
single-centre experience - T.C. Aranzulla
▸ Importance of medical therapy among patients with unprotected left main
trunk disease who underwent PCI - M. Shiba
▸ The value of a combination of the Syntax Score and the Euroscore for the
prediction of clinical outcomes in patients after left main coronary artery
stenting - J.M. Sinning
▸ How safe and efficacious is PCI for unprotected left main stem disease in
a high volume non-surgical centre? - J.P. Fernandez
▸ Results and predictors of long-term outcomes after unprotected left main
coronary artery angioplasty in octogenarians - S. Rekik
▸ Take-home message - S.J. Park
13:30-15:00 Room 252AB Technique
LTT - How to use rotablator
Facilitators: F. Mauri, B. Merkely
Panellists: S. Kedev, F. Ribichini
Media driver: E. Sorbets
Live in-a-box® from Clinique Pasteur, Toulouse - France
83
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page83
13:30-15:00 Room 341 Innovation
Plenary session
Best of Innovations in Cardiovascular Interventions (ICI) Technoparade
Chairpersons: R. Kornowski, C. Lotan
Objective:
▸ To explain the pathways for development of biotechnical innovation
▸ Introduction - The Innovations in Cardiovascular Interventions (ICI)
meeting and its philosophy - C. Lotan
▸ Israel and biotechnology: the 'start-up' nation - R. Kornowski
▸ Globalisation of innovation - M.W. Krucoff
▸ Real View - Holographic 3D/4D imaging display - E. Bruckheimer
▸ Valtech - Technology for mitral valve regurgitation - D. Brown
▸ Neovasc Reducer - Coronary sinus implant for refractory myocardial
ischemia - S. Banai
▸ Corindus - Robotics in the catheterisation laboratory - G. Weisz
▸ CorAssist - ImCardia implanted extra-ventricular energy transfer device for
diastolic dysfunction - A. Elami
▸ Panel discussion
▸ Take-home message - Innovation: how to succeed in the early stage and
the late stage of a new technology? - C. Lotan
13:30-15:00 Room 342AB Clinic
Forum
Plug it
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: B. Meier, F. Bourlon
▸ Introduction - B. Meier
▸ Acquired gerbode defect closure using an Amplatzer device: long-term
follow-up - J.G. Allin
▸ Short- and mid-term follow up after percutaneous closure of a
pseudoaneurysm of the mitral aortic intervalvular fibrosa - M. Denk
▸ Percutaneous closure of ruptured sinus of valsalva aneurysm - J.G. Allin
▸ Simultaneous double-plug closure of mitral paravalvular leak - G. Smolka
▸ Transcatheter treatment of a fissuration of an ascending aortic aneurysm
with an Amplatzer septal occluder device - M. Galli
▸ Take-home message - F. Bourlon
Wednesday 18th
84
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page84
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
13:30-15:00 Room 343 Technique
Abstract session
PCI techniques for bifurcation lesions
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: B. Chevalier, I. Iakovou, M. Lee
▸ Introduction - B. Chevalier
▸ Angiographic and IVUS predictors of side branch failure during PCI with
provisional side branch stenting approach in complex coronary
bifurcation lesions - R. Costa
▸ Final proximal post-dilatation to optimise results in bifurcation stenting
N. Foin
▸ 2 steps post-dilatation instead of kissing balloon after provisional stenting
of bifurcations: insight from bench model and first in-vivo experience
N. Foin
▸ Non-compliant balloons for final kissing inflation in coronary bifurcation
lesions treated with provisional T-stenting: a pilot study - D. Mylotte
▸ Simultaneous kissing stents to treat left main stem bifurcation disease:
real world results in 140 consecutive patients - J. Gunn
▸ Early and long-term outlook of PCI for bifurcation lesions in young
patients - G.M. Sangiorgi
▸ Take-home message - M. Lee
13:30-15:30 Room 351
How should I treat?
Severe aortic stenosis with concomitant coronary artery disease or with
low ejection fraction in elderly patients
Under the auspices of the Austrian Working Group on Interventional
Cardiology, the British Cardiovascular Intervention Society (BCIS),
the Dutch Working Group of International Cardiology and the Slovenian
Working Group of Invasive and Interventional Cardiology
Chairpersons: W. Wisser, M. de Belder, J. Piek, M. Bunc
Objectives:
▸ To understand the issues behind the management of concomitant
significant coronary disease
▸ To suggest optimal treatment options in patients with severe aortic
stenosis with concomitant coronary disease
▸ To understand how to manage expected or unexpected ventricular
dysfunction during TAVI
85
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page85
▸ Introduction and objectives - M. de Belder
▸ A patient with "suicide ventricle" during TAVI
- Case presentation - S. Redwood
- How would I treat? - B. Prendergast
- How would I treat? - P. Den Heijer
- How did I treat? - S. Redwood
- Discussion
- Consensus - M. de Belder
▸ A high-risk patient with severe aortic stenosis and significant coronary
disease
- Case presentation - J. Baan
- How would I treat? - P. Den Heijer
- How would I treat? - B. Prendergast
- How did I treat? - J. Baan
- Discussion
- Consensus - J. Piek
▸ Elderly patient with severe aortic stenosis, multivessel coronary disease
and low ejection fraction
- Case presentation - I. Kranjec
- How would I treat? - D. Zorman
- How would I treat? - M. Heigert
- How did I treat? - I. Kranjec
- Discussion
- Consensus - M. Bunc
▸ Take-home message - W. Wisser
13:30-16:30 Room 352AB Innovation
Glimpse into the future
Glimpse into the future - TAVI: what lays ahead and how to improve
procedural outcomes
Chairpersons: J. Webb, N. Piazza
Panellists: L. Büllesfeld, E. Grube, R. Lange, M.B. Leon
Objectives:
▸ To understand and explore the role of imaging modalities to facilitate
patient selection and device implantation
▸ To know ancillary techniques to facilitate TAVI in the future
▸ To be familiar with emerging implants and indications for TAVI
Wednesday 18th
86
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page86
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction and objectives - J. Webb
▸ Glimpse into future imaging modalities - Novel imaging modalities in the
evaluation of patients undergoing TAVI prior, during and after the
procedure - L. Buellesfeld
13:45-14:00 Recorded case and commentary by L. Buellesfeld
▸ Glimpse into ancillary TAVI devices
– Novel percutaneous access and closure devices - M.B. Leon
– Percutaneous closure of transapical access: hype or progress? - C. Ruiz
– Innovations in embolic protection during TAVI - E. Grube
14:50-15:05 Recorded case on TAVI facilitated by embolic protection device
and commentary by E. Grube
▸ Glimpse into future TAVI devices and indications
– Tissue engineered heart valves: ready for clinical use? - S. Hoerstrup
– TAVI for treatment of degenerated surgical bioprostheses - N. Piazza
– Overview of new transfemoral TAVI systems in the coming year - J. Webb
– Overview of new transapical TAVI systems in the coming year - T. Walther
– TAVI: will it become the default strategy? - R. Lange
▸ Take-home message - N. Piazza
13:30-15:00 Room 353
How should I treat?
Coronary chronic total occlusion: who should intervene and when
Under the auspices of the French Group of Interventional Cardiology (GACI)
and the South African Society of Cardiovascular Intervention (SASCI)
Chairpersons: T. Lefèvre, G. Cassel
Objectives:
▸ To understand how to select the optimal indications for coronary chronic
total occlusion treatment
▸ To understand how to select the optimal approach and avoid
complications
▸ To be able to set-up a coronary chronic total occlusion programme in a
dedicated cath lab
▸ Introduction and objectives - T. Lefèvre
▸ Complex challenging coronary chronic total occlusion
- Case presentation - N. Boudou
- How would I treat? - Y. Louvard
- How would I treat? - F. Hellig
- How did I treat? - N. Boudou
- Discussion
- Consensus - T. Lefèvre
87
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page87
▸ Triple vessel disease including coronary chronic total occlusion:
cardiologist or surgeon?
- Case presentation - J.R. Vorster
- How would I treat? - F. Hellig
- How would I treat? - Y. Louvard
- How did I treat? - J.R. Vorster
- Discussion
- Consensus - G. Cassel
▸ Take-home message - G. Cassel
14:30-16:30 Room 251 Clinic
Forum
Management of coronary perforations during PCI - Part I
Session comprising selected EuroPCR 2011 clinical case & complication
submissions
Chairpersons: V. Gelev, G. Fu
▸ Introduction - V. Gelev
▸ A case of coronary rupture - Retrograde approach for right coronary
artery chronic total occlusion - M. Chan
▸ Conservative strategy for localised coronary perforation - S. Wafa
▸ Novel treatment of coronary artery perforation - M.N. Khan
▸ Complication: coronary perforation of left anterior descending
R. Vijayvergiya
▸ Coronary stent fracture leading to coronary vessel perforation - S. Kohli
▸ Take-home message - G. Fu
15:00-17:00 Room 242A
How should I treat?
How to predict and prevent the stent thrombosis
Under the auspices of the Association of Interventional Cardiology of
Hungary and the Association of Interventional Cardiology of Romania and
the Scottish Cardiac Society
Chairpersons: D. Deleanu, H. Eteiba, I. Ungi
Objectives:
▸ To understand the possible mechanisms and principal causes of stent
thrombosis in order to reduce the risk of this complication
▸ To understand the possible mechanisms and principal causes of stent
thrombosis in order to recognise the risk factors with imaging techniques
Wednesday 18th
88
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page88
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction and objectives - D. Deleanu
▸ Stent thrombosis
- Case presentation - A. Konyi
- How would I treat? - G. Szabo
- How would I treat? - L. Zarma
- How did I treat? - A. Konyi
- Discussion
- Consensus - I. Ungi
▸ Stent thrombosis due to coagulopathy
- Case presentation - C. Udroiu
- How would I treat? - L. Zarma
- How would I treat? - G. Szabo
- How did I treat? - C. Udroiu
- Discussion
- Consensus - D. Deleanu
▸ Stent thrombosis after primary PCI
- Case presentation - K.G. Oldroyd
- How would I treat? - M. Lindsay
- How would I treat? - L. Zarma
- How did I treat? - K.G. Oldroyd
- Discussion
- Consensus - H. Eteiba
▸ Take-home message - H. Eteiba
15:00-16:30 Room 242B Technique
Abstract session
Coronary chronic total occlusion recanalisation: technical aspectsSession comprising selected EuroPCR 2011 abstract submissionsChairpersons: T. Santoso, A. Protopopov, G. Sianos
▸ Introduction - T. Santoso
▸ Impact of calcium distribution for successful revascularisation of coronary
chronic total occlusion: assessment from computed tomography coronaryangiography - M. Araki
▸ Impact of novel 0.010-inch Athlete Wizard guidewire use on successful
recanalisation of coronary chronic total occlusions via antegrade accessin a large single-centre registry - A. Kido
▸ Safety and efficacy of the Rendezvous method in retrograde recanalisation
for coronary chronic total occlusions - H. Tanaka
▸ Safety of retrograde recanalisations to coronary chronic total occlusion viatransseptal pathways with use of a novel metal-catheter - H. Takimura
▸ Well developed collateral circulation is associated with better vascular functiondistal to recanalised coronary chronic total occlusions - S. Brugaletta
▸ Coronary chronic total occlusion treatment guided by fractional flow
reserve - R. Sachdeva
▸ Take-home message - G. Sianos 89
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page89
15:00-16:30 Room 243 Innovation
Abstract session
Primary PCI in STEMI patients: new techniques
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: J.E. Nordrehaug, D. Carrié, F. Schiele
▸ Introduction - J.E. Nordrehaug
▸ A pooled analysis of the effect of endovascular cooling on infarct size in
patients with STEMI - D. Erlinge
▸ Drug-eluting balloon in acute myocardial infarction (DEBAMI) trial
T.H. Koh
▸ ST-segment resolution and clinical outcome with ischemic post-
conditioning - and comparison to magnetic resonance - J. Lonborg
▸ Ischemic postconditioning can reduce the infarct size in patients with
STEMI - T. Watanabe
▸ Single-centre experience using M-Guard stent platform in primary PCI in
STEMI - P. Anthopoulos
▸ Novel use of a pericardium-covered stent (PCS) to treat massive intra-
coronary thrombus - J. Gunn
▸ Take-home message - D. Carrié
15:00-16:30 Room 252AB Technique
LTT - How to perform PCI via transradial access
Facilitators: V. Dangoisse, S. Kedev, F. Mauri
Panellists: S. Mishra, D. Tchétché
Media driver: E. Sorbets
Live in-a-box® from Clinique Pasteur, Toulouse - France
15:00-16:30 Room 253 Innovation
Abstract session
New stents: pre-clinical studies
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: W.J. van der Giessen, S. Verheye, P. Wong
Wednesday 18th
90
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page90
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction - W.J. van der Giessen
▸ Safety of Nevo Sirolimus-eluting stents with RES technology
demonstrated using overlapping exaggerated dose formulation stents in
the porcine coronary artery model - G.S. Price
▸ Stenting with Xience V in comparison to Endeavor Resolute and bare
metal stent in an atherosclerotic rabbit double injury model - C. Van Dyck
▸ Capture of circulatory endothelial progenitor cells and accelerated
re-endothelialisation of a bioengineered stent in human ex vivo shunt and
rabbit denudation model - H.J. Duckers
▸ Anti-CD34 stent surface modification reduce thrombogenicity and increase
endothelialisation - R. Virmani
▸ Endothelialisation of polymer-free drug coated stents - R. Virmani
▸ Lipostent: a liposome based gene-eluting stent resulting in enhanced
re-endothelialisation in a preclinical model - F. Sharif
▸ Take-home message - S. Verheye
15:00-16:30 Room 341 Innovation
Plenary session
Cardiovascular Innovation Pipeline - Coronary
heart disease
Chairpersons: P.W. Serruys, R. Waksman, W. Wijns
▸ Overview of companies - H. Call
▸ Svelte Medical Systems - Novel DES: an amino acid based drug carrier
J.F. Granada
▸ Questions & answers
▸ Arterial Remodeling Technology - Novel PLA-dedicated proprietary
scaffold design - A. Lafont
▸ Questions & answers
▸ Biotronik - Dreams - Drug-eluting absorbable metal scaffold: concept,
product, clinical experience - B. Warnack
▸ Questions & answers
▸ Concept Medical - Magictouch: a sirolimus based nano carrier eluting
balloon catheter for treatment of coronary artery disease - M. Doshi
▸ Questions & answers
▸ Micell Technologies - MiStent DES: a novel third generation DES with a
fully-absorbable coating and enhanced drug delivery capabilities
J. McClain
▸ Questions & answers
▸ Meril Life Sciences - Novel nanotechnology based Mitsu: merilimus
eluting coronary stent system
▸ Questions & answers
91
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page91
15:00-16:30 Room 343 Clinic
Abstract session
TAVI: clinical outcomes and complicationsSession comprising selected EuroPCR 2011 abstract submissionsChairpersons: G. Sorropago, P. Wenaweser
▸ Introduction - G. Sorropago
▸ Single centre TAVI experience reported according to the criteria newly
established by the Valve Academic Research Consortium - B. Staehli
▸ The impact of periprosthetic aortic regurgitation on outcome after TAVIJ.M. Sinning
▸ Predictors of moderate-to-severe paravalvular aortic regurgitation
immediately after CoreValve implantation and the impact of postdilatationK. Takagi
▸ Release patterns of cardiac markers after TAVI as compared to surgicalaortic valve replacement - S. Bleiziffer
▸ Transcatheter aortic valve replacement decreases acutely secondary
pulmonary hypertension, with prognostic implications on in-hospitalmortality - C. Stoicescu
▸ Can the formal assessment of frailty predict outcome in patients
undergoing TAVI? - C. Raphael
▸ Take-home message - P. Wenaweser
15:00-16:30 Room 353 Technique
Forum
Technical challenges in primary PCISession comprising selected EuroPCR 2011 clinical case submissionsChairpersons: P. Widimsky, S.A. Bin Yahaya
▸ Introduction - P. Widimsky
▸ Stent dislodgement in a patient with a STEMI resulting in dissection of left
main and left circumflex - S. Kohli
▸ Self-expanding stent for mobile ostial left anterior descending lesioncausing STEMI - R.J. Van Geuns
▸ Geographical miss of ostial right coronary artery because of aorticdissection during primary PCI - lessons to be learned - A.J. Peace
▸ Paradoxical coronary embolus - a rare cause of acute myocardialinfarction on positive pressure ventilation - J. Bennett
▸ STEMI caused by stent fracture with aneurysmal change - J.Y. Yang
▸ Take-home message - S.A. Bin Yahaya
STENT
FOR LIFE
Wednesday 18th
92
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page92
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
15:30-16:30 Room 351 Technique
Forum
PCI in heavily calcified coronary artery lesions
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: P. Kala, B. Merkely
▸ Introduction - P. Kala
▸ Transradial PCI with rotablation in critical calcified lesion - W.J. Chung
▸ Multi device approach for a complex highly tortuous and calcified severe
disease of right coronary artery - S. Tarbine
▸ RASER PCI: a novel debulking technique - M. Egred
▸ Guideliner, child-in-a-mother catheter for successful retrieval of an
entrapped rotablator burr - M. Egred
▸ Take-home message - B. Merkely
16:30-18:30 Theatre Bleu
Tech News & Trends (TNT) session
Percutaneous mitral valve repair therapy: building a successful
programme
With an unrestricted educational grant from ABBOTT VASCULAR and
CROSSROADS, the Abbott Vascular Education Network
Chairpersons: K.H. Kuck, S. Kar
Objective:
▸ To learn about the indications for and the technique of percutaneous mitral
valve repair
▸ Introduction and objectives - K.H. Kuck
16:35-17:20 Recorded case
▸ Which patients can be treated - J. Hausleiter
▸ Which patients should not be treated - F. Maisano
▸ The importance of imaging - N. Wunderlich
▸ The heart team, a must! - J. van der Heijden
17:40-18:25 Live demonstration from The National Hospital, The Heart
Center, Copenhagen - Denmark
▸ Take-home message - S. Kar
93
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page93
16:30-18:00 Theatre Bordeaux
Symposium
Potential advantages of stent platform on biodegradable polymerbiolimus-eluting stents in complex patient populations?With an unrestricted educational grant from BIOSENSORS INTERNATIONALChairpersons: B. Meier, M.C. Morice
Objectives:▸ To evaluate the benefit of DES with biodegradable polymers in complex
lesion/patient populations
▸ To understand differences among patients included in all-comers randomised clinical trials as opposed to registry studies
▸ To understand the lessons learned from long-term optical coherencetomography and its clinical implications
▸ Introduction and objectives - B. Meier
▸ Benefits of biodegradable polymer DES technology in complex patientpopulations enrolled in an all-comers trials - M.C. Morice
▸ Biolimus A9: your solution for treating bifurcation lesions - Dedicatedstent designs vs. workhorse DES designs! - S. Verheye
▸ Are results from an all-comers randomised clinical trial comparable withthe results from an all-comers registry? First report of the primaryendpoint of the eBioMatrix registry - P. Urban
▸ What do we learn from long-term optical coherence tomography? Can wecorrelate the findings with clinical outcomes? - A. Abizaid
▸ Discussion
▸ Take-home message - B. Meier
16:30-18:00 Theatre Havane
Symposium
Interventional cardiology in perspective: evidence-based application of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndrome PCIWith an unrestricted educational grant from ELI LILLYChairpersons: D. Antoniucci, G. Montalescot
Objectives:▸ To understand when to use glycoprotein IIb/IIIa inhibitors for patients with
an acute coronary syndrome undergoing PCI in the setting of improvedantiplatelet and anticoagulation therapy
▸ To identify acute coronary syndrome patients undergoing PCI suitable forcombined triple antiplatelet therapy
▸ To find the right balance between bleeding and thrombosis in high-riskacute coronary syndrome patients undergoing PCI
STENT
FOR LIFE
Wednesday 18th
94
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page94
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction and objectives - G. Montalescot
▸ Understanding the kinetics of platelet activation and aggregation: a rational
approach to treatment selection and combination - P. Coste
▸ Use of glycoprotein IIb/IIIa inhibitors in modern antiplatelet and
anticoagulation regimens: an evidence-based overview - S. Savonitto
▸ Putting bleeding risk into perspective: patient stratification to improve
outcomes - M. Levi
▸ Applying the evidence: clinical cases to guide practice - P. Sinnaeve
▸ Discussion
▸ Take-home message - D. Antoniucci
16:30-18:00 Room Maillot
Symposium
Advancing the Paccocath technology and the future of drug-eluting
balloon angioplasty
With an unrestricted educational grant from B. BRAUN and MEDRAD
INTERVENTIONAL/POSSIS
Chairpersons: J.F. Granada, B. Scheller
Objectives:
▸ To understand the concept and the basic principals of the Paccocath
balloon coating technology
▸ To get an overview/summary of the pre-clinical and clinical drug-eluting
balloon evaluation for coronary and peripheral applications
▸ To learn about the possible coronary and peripheral indications of the
Paccocath drug-eluting balloon technology
▸ To learn about procedural treatment recommendations and how the drug-
eluting balloon should be used to achieve optimal long-term results
▸ To take home practical tips & tricks for the drug-eluting balloon usage
▸ Introduction to the Paccocath technology - J.F. Granada
▸ Comprehensive review of clinical data with the Paccocath technology
B. Scheller
▸ Treatment recommendations of the German Consensus Group - D. Mathey
▸ Paccocath technology advances: insights into pre-clinical studies of the
latest generation Cotavance drug-eluting balloon - J.F. Granada
▸ A new look into Paccocath clinical data: THUNDER trial and beyond - G. Tepe
▸ Current Cotavance clinical trial status and future study designs - N. Diehm
▸ Discussion
▸ Take-home message - B. Scheller
95
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page95
16:30-18:00 Room 241
How should I treat?
Primary PCI for high-risk acute coronary syndrome:
the unexpected and the dramatic
With an unrestricted educational grant from MEDTRONIC
Chairpersons: M. Gilard, P. Urban
Objectives:
▸ To understand what can be the approach regarding thrombus aspiration
for NSTEMI patients
▸ To understand what can be the approach for a patient in cardiogenic shock
▸ Introduction and objectives - M. Gilard
▸ NSTEMI patient with visible thrombus
- Case presentation - B. De Smet
- How would I treat? - J. Goicolea
- How would I treat? - L. Hellsten
- How did I treat? - B. De Smet
- Discussion
- Consensus - M. Gilard
▸ Patient in cardiogenic shock
- Case presentation - J.C. Stauffer
- How would I treat? - B. Chevalier
- How would I treat? - M. Mason
- How did I treat? - J.C. Stauffer
- Discussion
- Consensus - M. Gilard
▸ Take-home message - M. Gilard
STENT
FOR LIFE
Wednesday 18th
96
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page96
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
16:30-18:00 Room 242B Clinic
Abstract session
TAVI and coronary artery disease
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: V. Bapat, C. Kaiser
▸ Introduction - V. Bapat
▸ Impact of coronary artery disease in elderly patients undergoing TAVI:
insight the Italian CoreValve registry - C. Tamburino
▸ Does previous coronary bypass surgery increase the risk for patients
undergoing TAVI? - O. Wendler
▸ TAVI in patients after previous CABG: feasibility and outcome
A. Narayana
▸ The effects of pre-existing significant coronary artery disease upon
outcome after TAVI using the Edwards bioprosthesis - M. Khawaja
▸ The impact of coronary artery disease on clinical outcomes in patients
undergoing TAVI - T. Pilgrim
▸ Impact of pre-procedural percutaneous coronary intervention on
outcomes after TAVI - G. Richardt
▸ Take-home message - C. Kaiser
16:30-18:00 Room 243 Technique
Abstract session
Accuracy of IVUS and optical coherence tomography to quantify coronary
artery disease and evaluate PCI results
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: A. Pichard, H.M. Garcia-Garcia
▸ Introduction - A. Pichard
▸ The prediction of severity and risk profile of coronary artery disease assed
by IVUS and virtual histology from non-invasive examinations and genetic
analysis - T. Kovarnik
▸ Single and repeated endovascular imaging cause significant but equal
acute endothelial injury of a temporary nature as opposed to stent
induced injury - H.M. Van Beusekom
▸ Optimal IVUS criteria and their accuracy for defining the functional significance
of intermediate coronary stenoses of different locations - S.J. Tahk
▸ Absence of a relation between plaque composition in proximal non-target
coronary vessels vs. cardiovascular event risk: a pilot study with
volumetric radiofrequency-based IVUS - J. Huisman
▸ Impact of anemia on coronary plaque components: virtual histology-IVUS
analysis - Y.J. Hong
▸ Optical coherence tomography assessment of vessel trauma after stent
implantation with long-term outcomes - K. Bouki
▸ Take-home message - H.M. Garcia-Garcia
97
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page97
16:30-18:00 Room 251 Technique
All you need to know about bifurcation stenting
Chairpersons: Y. Louvard, J. Ormiston
Objective:
▸ At the end of this 90-minute ‘All you need to know about...’
session the audience should have an up-to-date knowledge
of the field, relevant for their clinical practice. They should be
familiar with the current evidence base, existing guidelines
and have an understanding of the open questions that need
addressing in the near future.
▸ Introduction - Y. Louvard
▸ Background - All you need to know about bifurcation before treatment
G. Stankovic
▸ Clinical data - All about randomised clinical trials, meta-analysis,
registries... - N. Curzen
▸ Technical aspects - Stenting the main vessel first across the side branch,
practical aspects - J.F. Lassen
▸ Guidelines - Recommendations from the ESC guidelines and the European
Bifurcation Club - R. Albiero
▸ Unresolved issues - Role for double stenting strategies, role for dedicated
devices - M. Ferenc
▸ Questions & answers - M. Pan, G. Stankovic
Wednesday 18th
98
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page98
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
16:30-18:00 Room 252AB
How should I treat?
Complex bifurcation and chronic total occlusion lesions: Asia meets Europe
With an unrestricted educational grant from TERUMO
Chairpersons: E. Barbato, M.A. Rosli
Objectives:
▸ To share knowledge and experience between experts from different
geographic areas on the challenges and current solutions for treating
complex bifurcation and chronic total occlusion lesions
▸ To improve understanding of the technical issues in complex bifurcation
and chronic total occlusion lesion management
▸ Introduction and objectives - M.A. Rosli
▸ Complex chronic total occlusion lesion
- Case presentation - N. Inoue
- How would I treat? - D. Hildick-Smith
- How would I treat? - S. Soerianata
- How did I treat? - N. Inoue
- Discussion
- Consensus - E. Barbato
▸ Complex bifurcation lesion
- Case presentation - O. Darremont
- How would I treat? - S. Soerianata
- How would I treat? - D. Hildick-Smith
- How did I treat? - O. Darremont
- Discussion
- Consensus - M.A. Rosli
▸ Take-home message - E. Barbato
99
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page99
16:30-18:00 Room 253
How should I treat?
What treatment is best for the acutely compromised acute myocardialinfarction patient: door to balloon or door to device?With an unrestricted educational grant from MAQUET CARDIOVASCULARChairperson: N.H. Pijls
Objectives:▸ To know how to handle cardiogenic shock during primary PCI
▸ To understand the principles of left ventricular unloading prior to reperfusion
▸ To learn how to choose and insert a support device during PCI-related
calamities
▸ Introduction and objectives - N.H. Pijls
▸ Cardiogenic shock
- Case presentation - M. Abdel-Wahab
- How would I treat? - D. Fraser
- How would I treat? - H. Thiele
- How did I treat? - M. Abdel-Wahab
- Discussion
- Consensus - N.H. Pijls
▸ Main vessel PCI after cardiac arrest
- Case presentation - T. Schwab
- How would I treat? - D. Fraser
- How would I treat? - H. Thiele
- How did I treat? - T. Schwab
- Discussion
- Consensus - N.H. Pijls
▸ Take-home message - N.H. Pijls
Wednesday 18th
100
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page100
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
16:30-18:00 Room 341 Innovation
Plenary session
ABC for inventors
Chairpersons: P. Bonhoeffer, J. Simpson
Objectives:
▸ To understand the pros and cons of different types of funding for the
development of ideas
▸ To understand concepts of patent protection
▸ To get insights into the strategy of moving an idea from conception to
commercialisation
▸ Introduction and objectives - P. Bonhoeffer
▸ Concepts and opportunities of research funding - A. Kastrati
▸ Questions & answers
▸ Concepts and opportunities of commercial funding - P. Marco
▸ Questions & answers
▸ How and why to protect ideas - intellectual property - M.B. Leon
▸ Questions & answers
▸ The regulators interest in developing ideas or stopping them
M.W. Krucoff
▸ Questions & answers
▸ Transition from academic projects to commercial exploitation
S. Hoerstrup
▸ Questions & answers
▸ Pros and cons to develop technology in Europe, US, Asia - S. Oesterle
▸ Questions & answers
▸ My personal experience with TAVI - A. Cribier
▸ Questions & answers
▸ Panel discussion: how can we make life easier for inventors
101
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page101
16:30-18:00 Room 342AB
Symposium
Vascular access and medical management of acute coronary syndrome:
what does the future hold?
With an unrestricted educational grant from SANOFI AVENTIS
Chairperson: S.R. Mehta
Objectives:
▸ To explore the risks and benefits associated with radial and femoral access
for the treatment of acute coronary syndrome
▸ To review the results of recently completed trials of new antithrombotics
and anticoagulants in acute coronary syndrome
▸ To highlight ongoing Phase III trials, focusing on treatment of acute
coronary syndrome with Otamixaban
▸ Introduction and objectives - S.R. Mehta
▸ Radial vs. femoral access: US approach - M. Cohen
▸ Radial vs. femoral access: European approach - C. Cavalini
▸ Questions & answers
▸ What does the future hold?
- New antiplatelets and antithrombotics - C. Cavalini
- SEPIA-acute coronary syndrome results - M. Cohen
- TAO trial - S.R. Mehta
▸ Take-home message - S.R. Mehta
16:30-18:00 Room 351
How should I treat?
Practical experience in bifurcation stenting: is there a simple solution?
With an unrestricted educational grant from TRYTON MEDICAL
Chairperson: T. Lefèvre
Objectives:
▸ To review the treatment options of the real-world patients with bifurcation
disease
▸ To discuss recent clinical data that motivates for the best available treatment
▸ Introduction and objectives - T. Lefèvre
▸ Patient treated on left main disease
- Case presentation - R.J. Van Geuns
- How would I treat? - E. Garcia
- How would I treat? - J.W. Park
- How did I treat? - R.J. Van Geuns
- Discussion
- Consensus - T. Lefèvre
Wednesday 18th
102
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page102
We
dn
esd
ay 1
8th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Patient treated on a complex bifurcation (Medina 1.1.1)
- Case presentation - G. Tarantini
- How would I treat? - E. Garcia
- How would I treat? - J.W. Park
- How did I treat? - G. Tarantini
- Discussion
- Consensus - T. Lefèvre
▸ Take-home message - T. Lefèvre
16:30-18:00 Room 352AB
Symposium
Precision guided therapy: simple techniques to go beyond angiography ineveryday practice With an unrestricted educational grant from VOLCANOChairperson: J. Fajadet
Objectives:▸ To raise the importance of fractional flow reserve and prospect data in
intermediate lesion assessment: "a simple start to the PCI strategy"
▸ To clarify the positioning of advanced diagnostics using fractional flowreserve and imaging during coronary interventions
▸ Introduction and objectives - J. Fajadet
▸ Different guidance tools do different things: how the indication can helpdecide between fractional flow reserve, IVUS and optical coherencetomography - G. Guagliumi
▸ Precision guided acute myocardial infarction and the role of IVUS, virtualhistology IVUS and VIBE - D. Dudek
▸ Fractional flow reserve guided SYNTAX scores - K.G. Oldroyd
▸ Discussion
▸ Take-home message - J. Fajadet
17:00-18:00 Room 242A Clinic
Abstract session
Registries of new generation of bare metal stentsSession comprising selected EuroPCR 2011 abstract submissionsChairpersons: R. Byrne, M. Awata, B.K. Goyal
▸ Introduction - R. Byrne
▸ Effect on clinical restenosis of an ultra-thin strut cobalt chromium stentvs. a thin strut stainless steel stent - P. Grossi
▸ Coronary angioplasty with bare metal stents: are there any differences?F. Costa
▸ Nine-month outcomes with a second generation cobalt chromium baremetal stent in the treatment of stenotic coronary artery lesions: resultsfrom the PIONIR study - S. Hoffmann
▸ Long-term comparison of stainless steel and cobalt-chromium bare metal stents:clinical impact of the metallic alloy in a real world scenario - A.G. Spadaro
▸ Take-home message - M. Awata103
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page103
08:00-12:00 Main arena Clinic
Main session
Current challenges with TAVI for severe aortic stenosis
Chairpersons: A. Vahanian, T. Walther
Panellists: M. Bunc, P. de Jaegere, J. Fajadet, E. Garcia, U. Gerckens,
R. Hoedl, A.P. Kappetein, R. Virmani, W. Wisser
Objectives:
▸ To provide an update on the indications for TAVI
▸ To understand PCI indications and timing in patient candidates for TAVI and
suffering from severe coronary artery disease
▸ To understand how to prevent and treat major procedure-related
complications during TAVI
▸ Introduction and objectives - A. Vahanian
▸ How shoud I treat - Under the auspices of the Austrian Working Group on
Interventional Cardiology and the Slovenian Working Group of Invasive and
Interventional Cardiology
- Introduction and objectives - W. Wisser
- Case presentation - R. Hoedl
- How would I treat? - J. Aichinger
- How would I treat? - D. Zorman
- How did I treat? - R. Hoedl
- Discussion/Consensus - M. Bunc
▸ Keynote lecture - Reflect together on the means and strategies to improve
current outcomes with TAVI - U. Gerckens
09:05-09:55 Live demonstration from St Thomas Hospital, London - United
Kingdom
▸ Complication case - Severe paravalvular aortic regurgitation after TAVI
T. Schmitz
▸ Complication case - TAVI complicated by common femoral artery rupture
and occlusion. Endovascular repair with Viabahn endoprosthesis
A. Silvestro
10:50-11:40 Live demonstration from St Thomas Hospital, London - United
Kingdom
▸ The vision of the pathologist - R. Virmani
▸ Final key remarks - J. Fajadet
Thursday 19th
104
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page104
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
08:00-12:00 Theatre Bleu Innovation
Glimpse into the future
Glimpse into the future - Bioresorbable scaffolds: a new era in clinical
interventional cardiology
Chairpersons: P.W. Serruys, R.J. van Geuns
Panellists: A. Abizaid, Y. Onuma, J. Ormiston, R. Waksman
Objectives:
▸ To understand the potential of bioresorbable scaffolds in the treatment of
coronary artery disease
▸ To learn the principles of biodegradation and vascular restoration in
response to bioresorbable scaffolds
▸ To gain insight into pre-clinical and clinical data with bioresorbable
scaffolds
▸ Introduction: 10 reasons why metallic DES should be replaced by
bioresorbable scaffold - P.W. Serruys
▸ ABC's of bioresorption of metallic scaffolds and how to design them
B. Warnack
▸ The bioresorption process of polylactide devices: tissue and cellular
mechanisms - R. Virmani
08:40-09:10 Live demonstration from Erasmus University Medical Center,
ThoraxCenter, Rotterdam - The Netherlands
▸ Bioresorption and new materials - M. Vert
▸ Pre-clinical and clinical evaluation of poly-tyrosine carbonate scaffold
A. Abizaid
▸ Pre-clinical and clinical evaluation of drug-eluting resorbable metallic stent
R. Waksman
▸ Biosolve I - S. Verheye
▸ Five-year clinical and non-invasive angiographic follow-up of Absorb
Cohort A trial - J. Ormiston
▸ Six-month and one-year follow-up of Absorb Cohort B trial: clinical results
and multi-imaging modality assessment - P.W. Serruys
▸ Tips & tricks for implantation of bioresorbable scaffold: why is vessel
sizing important? - R.J. van Geuns
11:00-11:40 Live demonstration from Erasmus University Medical Center,
ThoraxCenter, Rotterdam - The Netherlands
▸ Preliminary results of Absorb Extend - A. Abizaid
▸ Take-home message - R.J. van Geuns
105
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page105
08:00-12:00 Theatre Bordeaux Technique
Plenary session
Complex coronary chronic total occlusion interventions:
live from Toyohashi Heart Center, Japan and CCT
meeting@EuroPCR
Chairpersons: M. Ochiai, E. Tsuchikane
Panellists: A. Galassi, M. Kimura, G. Sianos, G. Werner
With continuous live demonstration from Toyohashi Heart Center, Toyohashi -
Japan
Objectives:
▸ To step up to the next level in antegrade approach
▸ To learn the latest techniques in retrograde approach
▸ To understand pathophysiology of coronary chronic total occlusion
lesions: images for coronary chronic total occlusion procedures
▸ Introduction and objectives - M. Ochiai
▸ Retrograde approach - What are the new guidewires and devices - S. Saito
▸ Complex antegrade approach - What are the new guidewires and devices
M. Yamane
▸ Retrograde approach - Tips & tricks for increased success - K. Igarashi
▸ Concluding remarks and take-home message - E. Tsuchikane
08:00-09:30 Room 241 Clinic
Forum
Saphenous vein graft interventions
Session comprising selected EuroPCR 2011 clinical case submissions
Chairperson: M. Strozzi
▸ Introduction - M. Strozzi
▸ Saphenous vein graft angioplasty with rotablation - K. Longman
▸ Left internal mammary artery graft intervention - K. Chhatrapati
▸ Angioplasty of single surviving degenerated venous graft without distal
protection device using dumb-bell technique - A. Dhall
▸ It was a complete stitch-up post-CABG PCI left internal mammary artery -
left anterior descending anastamosis - R.T. Gerber
▸ The dilemma of treating an undilatable stenosis in a giant saphenous vein
graft - R. Sachdeva
▸ Take-home message - M. Strozzi
Thursday 19th
106
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page106
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
08:00-09:00 Room 242B Technique
Forum
PCI in thrombotic saphenous vein graft lesions
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons : P. Vermeersch, K-H. Sim
▸ Introduction - P. Vermeersch
▸ Thrombosis and in-stent restenosis in saphenous vein graft-OM treated
with TAXUS stent - an optical coherence tomography perspective
M. Chan
▸ A case of STEMI at the site of graft after Piehler operation - T. Shibasaki
▸ Saphenous vein graft acute occlusion intervention - K. Poon
▸ Take-home message - K-H. Sim
08:00-09:00 Room 243 Innovation
Abstract session
Optical coherence tomography: revealing the results of PCI with DES and
bioresorbable stents
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: H.M. Garcia-Garcia, P. Motreff, F. Prati
▸ Introductory lecture - Value and limitations of optical coherence tomography
for the evaluation of coronary implants: current status - H.M. Garcia-Garcia
▸ Optical coherence tomography assessment of early strut coverage in
patients treated with the pro-kinetic Probio-coated bare cobalt-chromium
stent - P. Stella
▸ Tissue coverage of a hydrophilic polymer-coated Zotarolimus-eluting stent
vs. a fluoropolymer-coated Everolimus-eluting stent at 13-month
follow-up: an optical coherence tomography substudy from the
RESOLUTE all-comers trial - J.L. Gutiérrez-Chico
▸ Long-term tissue coverage of a bioresorbable polylactide polymer-coated
Biolimus-eluting stent: comparative sequential assessment with optical
coherence tomography till complete resorption of the polymer
J.L. Gutiérrez-Chico
▸ Take-home message - P. Motreff
107
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page107
08:00-09:00 Room 251 Technique
Forum
Coronary aneurysms and fistulae
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: P. Ruygrok, N.Q. Nguyen
▸ Introduction - P. Ruygrok
▸ Successful revascularisation by using 5Fr delivery catheter with
Kawasaki's disease combined with acute myocardial infarction
Y. Nomura
▸ Gigantic coronary arteriovenous fistula embolisation - D. Hazarbasanov
▸ High cardiac output heart failure treated with covered stent
S. Yaroslavtsev
▸ Take-home message - N.Q. Nguyen
08:00-09:00 Room 252AB Technique
Forum
Bifurcation techniques
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: G. Stankovic, S. Dutta
▸ Introduction - G. Stankovic
▸ Successful percutaneous coronary stent explantation by caged sidebranch
wire - S.E. Hardt
▸ Reverse wire technique with double port microcatheter in treating severe
angulated left anterior descending stenosis lesion - Y. Nozaki
▸ Double-kissing crush technique for treatment of an unprotected left main
lesion in a high-risk patient - V. Kushwaha
▸ Take-home message - S. Dutta
Thursday 19th
108
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page108
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
08:00-09:00 Room 253 Technique
Abstract session
Impact of lesion morphology and deployement technique on DES
outcomes
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: H. Eteiba
▸ Introduction - H. Eteiba
▸ Stent balloon inflation duration is a critical factor for optimal stent
deployment - D. Mylotte
▸ Very small vessels (<2.5mm) treated with Nobori DES: two-year clinical
outcomes - D. Carrié
▸ Charlson comorbidity index as a predictor of clinical outcomes after PCI
P. Urban
▸ Five-year clinical outcome in patients with small vessel disease treated
with drug-eluting vs. bare metal stenting - E. Puymirat
▸ Take-home message - H. Eteiba
08:00-09:00 Room 341 Clinic
Abstract session
DES and endothelial function: a difficult relationship?
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: M. Hamilos, A. Lerman, M. Ostojic
▸ Introduction - M. Hamilos
▸ Endothelial Nitric Oxide Synthase (eNOS) activity and Vasomotor
dysfunction of coronary Aateries after DES: link or chance?
A. Perez de Prado
▸ Incomplete neointimal coverage is correlated with coronary endothelial
dysfunction after DES implantation - Y. Mitsutake
▸ A prospective randomised comparison of vasodilation after implantation
of everolimus-eluting stents and bioactive titanium-nitrid-oxide-coated
stents in acute coronary syndromes - association to stent strut coverage
T. Kiviniemi
▸ Effects of angiotensin-converting enzyme inhibitor and angiotensin
receptor blocker on coronary endothelial function after DES implantation
Y. Mitsutake
▸ Take-home message - A. Lerman
109
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page109
08:00-09:00 Room 343 Clinic
Abstract session
Devices and imaging the results
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: E. Eeckhout, P. Bonhoeffer
▸ Introduction - E. Eeckhout
▸ Percutaneous closure of multiple paravalvular leaks with amplatzer
vascular plug III device - J. Dutary
▸ Atrial septostomy in patients with end-stage pulmonary hypertension:
novel approach to transseptal puncture - A. Amaducci
▸ Rotational angiography (DYNA-CT) for mitral valve imaging: a work in
progress - J. Seeburger
▸ Magnetic resonance imaging for optimized implantation and long-term
monitoring of patients receiving a left atrial appendage occluder - A. Sinha
▸ Take-home message - P. Bonhoeffer
08:00-09:00 Room 352AB Clinic
Forum
Management of coronary perforations during PCI - Part II
Session comprising selected EuroPCR 2011 complication submissions
Chairpersons: B. Meier, D. Deleanu
▸ Introduction - B. Meier
▸ A case of coronary rupture when deploying Cypher select+ - Y. Fujimoto
▸ Delayed cardiac tamponade following rotational atherectomy and PCI to
severely calcified ostial left anterior descending lesion - Y. Malaiapan
▸ A horrible coronary rupture during rotational atherectomy which was
succesfully sealed with three covered stents into a long bare metal stent
as a substitute of vessel wall - S. Otsuji
▸ Take-home message - D. Deleanu
08:00-09:00 Room 353 Clinic
Abstract session
DES registries - Part I
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: F. Alfonso, D. Echeverri, A. Ernst
Thursday 19th
110
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page110
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction - F. Alfonso
▸ How does the Everolimus-drug eluting coronary stent Xience V; work for
the treatment of patients with non ST elevation acute coronary syndrome
with coronary angioplasty in the daily practice - A. Iniguez
▸ Exploring the possible clinical impact of polymer coating in DES
technology: clinical outcome of consecutive patients treated by
Zotarolimus-eluting Endeavor stent and Zotarolimus-eluting Resolute
stent - G.P. Talarico
▸ Head-to-head comparison of Everolimus- vs. Zotarolimus- and Sirolimus-
eluting stents: one-year clinical outcomes from the ProEnCy registry
G. Richardt
▸ Off label use of DES with biodegradable polymer at two years - G.B. Danzi
▸ Take-home message - D. Echeverri
08:30-10:00 Room 242A
How should I treat?
Strategies of treatment in patients with complex multivessel coronary
artery disease
Under the auspices of the Danish Working Group of Interventional
Cardiology and the Lebanese Working Group of Interventional Cardiology
Chairpersons: A. Sarkis, L. Thuesen
Objectives:
▸ To learn the risk stratification in the multivessel disease patient
▸ To understand the optimal treatment strategy in the multivessel patient
▸ To discuss prioritisation, staging and different technical skills with
percutaneous revascularisation in multivessel patient
▸ Introduction and objectives - L. Thuesen
▸ Diabetic patient with three vessel disease including a complex left anterior
descending lesion
▸ Case presentation - G. Ghanem
- How would I treat? - Z. Ghazzal
- How would I treat? - P. Hostrup
- How did I treat? - G. Ghanem
- Discussion
- Consensus - A. Sarkis
▸ Elderly patient with three vessel disease including a coronary chronic total
occlusion lesion
- Case presentation - M. Maeng
- How would I treat? - P. Hostrup
- How would I treat? - Z. Ghazzal
- How did I treat? - M. Maeng
- Discussion
- Consensus - L. Thuesen
▸ Take-home message - A. Sarkis 111
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page111
09:00-12:00 Theatre Havane Technique
LTT - How to treat a patient with multivessel coronary
disease
Facilitators: M. Haude, M. Heigert, M. Gilard
Panellists: D. Carrié, M. Deshpande, A. Elsässer, M. Oberhoff
Media driver: L.A. Malek
Live in-a-box®
09:00-10:30 Room 242B Technique
Plenary session
Computed tomography for coronary and structural heart disease:
interactive case reading
Chairpersons: J.J. Bax, F. Civaia
Panellist: C. Van Mieghem
Objectives:
▸ To acquire a systematic and practical approach for reading cardiac
computed tomography
▸ To understand tips, tricks and artefacts, as well as common pitfalls
▸ To take home which are currently "good" and "poor" indications for cardiac
computed tomography in the various common clinical scenarios
(coronary and valvular disease)
▸ Introduction and objectives - F. Civaia
▸ Case reading 1 - C. Van Mieghem
▸ Case reading 2 - C. Van Mieghem
▸ Case reading 3 - F. Civaia
▸ Case reading 4 - V. Delgado
▸ Case reading 5 - V. Delgado
▸ Case reading 6 - F. Civaia
▸ Final key remarks: appropriate clinical indications for cardiac computed
tomography in 2011 - J.J. Bax
09:00-10:30 Room 243 Clinic
Abstract session
PCI for bifurcation lesions: clinical results
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: G. Pavlides, B. Farah, K. Niemela
Thursday 19th
112
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page112
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction - G. Pavlides
▸ Challenging bifurcation stenting: two-year clinical outcomes after
treatment with a new generation DES - A. Serra
▸ A multicentre randomised comparison of drug-eluting balloon plus bare
metal stent vs. bare metal stent vs. DES in bifurcation lesions treated with
a single-stenting technique: 6-month angiographic and 12-month clinical
results of the DEBIUT (Drug-Eluting - A. Belkacemi
▸ Final kissing balloon dilatation in simple stenting of coronary bifurcation
lesions: pooled analysis of the BBC ONE study and the Nordic-Baltic
bifurcation studies - N.R. Holm
▸ Initial results of BLAST: bifurcation lesion analysis and stenting of thin cap
fibroatheroma (TCFA/FA) as measured by VH-intravascular ultrasound - a
global multicentre, prospective, randomised study - T. Lefèvre
▸ Improving clinical risk prediction for PCI for bifurcation lesions: the ACEF
(age, creatinine, ejection fraction) score - G.M. Sangiorgi
▸ Take-home message - K. Niemela
09:00-10:30 Room 251 Evidence
All you need to know about gender differences
in percutaneous intervention
Chairpersons: A. Chieffo, A. Hoye
Panellists: F. Malik, A.S. Petronio, D.O. Williams
Objective:
▸ At the end of this 90-minute ‘All you need to know about...’ session the
audience should have an up to date knowledge of the field, relevant for
their clinical practice. They should be familiar with the current evidence
base, existing guidelines and have an understanding of the open questions
that need addressing in the near future
▸ Introduction and objectives - A. Hoye
▸ Background - Clinical problem: scope of the problem, gender biases
C. Rihal
▸ Clinical data - Coronary and carotid revascularisation in women
M.C. Morice
▸ Issues in practice - Pharmacological management in acute coronary
syndrome - R. Mehran
▸ Recommendations - Do we need specific recommendations for the
treatment of women with cardiovascular disease? - G. Mikhail
▸ Unresolved issues - Approach to percutaneous valve treatment in women,
aortic and mitral - T. Feldman
▸ Questions & answers with the panellists
113
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page113
09:00-10:30 Room 252AB Clinic
Forum
Unusual cases in primary PCI
Session comprising selected EuroPCR 2011 clinical
case submissions
Chairpersons: D. Dudek, S. Chen
▸ Introduction - D. Dudek
▸ Percutaneous treatment of giant coronary aneurysm - J. Dutary
▸ Acute anterior myocardial infarction and sudden death caused by tumoral
myocardial invasion - E. Gutierrez
▸ Chest pain in a post-partum woman - S. Chia
▸ Unusual case of primary angioplasty - S. Basavarajaiah
▸ A "Ball-Valve" thrombus causing STEMI - S.S. Kalra
▸ Take-home message - S. Chen
09:00-10:30 Room 253 Technique
Abstract session
Radial or femoral access: revisiting an old dispute
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: M.A. Rosli, V. Dangoisse
▸ Introduction - M.A. Rosli
▸ Safety and efficacy of transradial vs. transfemoral arterial primary
coronary angioplasty for acute myocardial infarction single-centre
experience - A. Youssef
▸ Early invasive strategy for acute coronary syndromes: clinical impact of
radial vs. femoral approach in the era of triple antiplatelet therapy
J. Delgado Silva
▸ Comparison of radial vs. femoral approach with drug-eluting stenting for
coronary bifurcations: results from the COBIS (coronary bifurcation
stenting) registry - S.H. Her
▸ Left radial approach for coronary artery catheterisation: a comparison with
right radial approach - R. Diletti
▸ A randomised study of transradial vs. transulnar artery approach for
coronary interventions - G. Hahalis
▸ Same wrist intervention via the cubital (ulnar) artery in case of radial
puncture failure for percutaneous cardiac catheterisation or intervention:
the multicentre prospective SWITCH registry - P. Agostoni
▸ Take-home message - V. Dangoisse
STENT
FOR LIFE
Thursday 19th
114
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page114
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
09:00-10:30 Room 341 Technique
Abstract session
Management of arterial access in TAVI
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: F. Casselman, N. van Mieghem
▸ Introduction - F. Casselman
▸ Feasibility and safety of percutaneous management of vascular access site
complications - implications for transfemoral aortic valve implantation
S. Stortecky
▸ Transaortic TAVI using Edwards Sapien valve: a novel approach for the
O. Nawaytou
▸ One-year results of the subclavian access for TAVI with the CoreValve
bioprosthesis in 132 consecutive patients - M. De Carlo
▸ Are there differences in clinical outcomes between patients treated
through a transaxillary vs. a transfemoral access route for TAVI?
S. Bleiziffer
▸ Transfemoral aortic valve implantation: new criteria to predict vascular
complications - K. Hayashida
▸ Large calibre arterial access device closure for percutaneous aortic valve
interventions: use of the Prostar system in 118 cases - J. Cockburn
▸ Take-home message - N. van Mieghem
115
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page115
09:00-12:00 Room 342AB Clinic
Plenary session
Invasive strategies for STEMI initially treated with fibrinolysis:
a case-based discussion
Chairpersons: C.K. Naber, J.J. Piek
Panellists: M. Alameda, J. Belardi, F. Fernandez-Aviles, J. Goicolea,
S.M. Hiremath, A. Leitao-Marques, F. Van de Werf
Objectives:
▸ To understand time-related issues and trade-offs
▸ To understand the specifics of performing PCI after fibrinolysis
▸ To learn how to avoid complications during PCI for STEMI post-fibrinolysis
▸ Introduction and objectives - C.K. Naber
▸ Case presentation and practical interactive discussion - S.M. Hiremath
▸ Discussion - F. Fernandez-Aviles, F. Van de Werf
▸ Concluding remarks - S.M. Hiremath
▸ Keynote lecture - Reflect together on how to manage STEMI patients who
are referred for PCI after thrombolysis - F. Fernandez-Aviles
▸ Stent dislodged from its balloon and stuck in left main and left anterior
descending ostium - Case presentation and practical interactive
discussion - V. Sardana
▸ Discussion - S.M. Hiremath
▸ Case presentation and practical interactive discussion - S.M. Hiremath
▸ Discussion - F. Fernandez-Aviles, F. Van de Werf
▸ Concluding remarks - S.M. Hiremath
▸ How should I treat case - Under the auspices of the Portuguese
Association of Interventional Cardiology and the Working Group on
Percutaneous Coronary Interventions of the Spanish Society of Cardiology
- Introduction and objectives - A. Leitao-Marques
- Case presentation - J.M. Ruiz Nodar
- How would I treat? - H. Pereira
- How would I treat? - M. Masotti
- How did I treat - J.M. Ruiz Nodar
- Discussion & consensus - J. Goicolea
▸ Reanimator II - L. Davin
▸ Discussion - M. Alameda, J. Belardi
▸ Consensus and final key remarks - J.J. Piek
STENT
FOR LIFE
Thursday 19th
116
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page116
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
09:00-10:30 Room 343 Technique
Abstract session
DES and bioactive stents for STEMI
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: D. Iosseliani, J. Koolen, P. Yan
▸ Introduction - D. Iosseliani
▸ Sustained patency of Paclitaxel-eluting stents vs. bare metal stents 4 years
after implantation in acute STEMI - M.A. Vink
▸ DES with biodegradable polymers in acute myocardial infarction
F. Fath-Ordoubadhi
▸ Comparison between Zotarolimus-eluting stents and first generation DES
in the treatment of patients with acute STEMI - K.W. Park
▸ One-year clinical safety and efficacy study on acute STEMI patients
undergoing primary PCI using Endeavour Resolute Zotarolimus-eluting
stent vs. driver bare metal stent: a single-centre study - S.H. Ong
▸ HEBE-III randomised trial: A Zwolle sub-study with the Genous stent
H. Suryapranata
▸ Take-home message - J. Koolen
09:00-10:30 Room 352AB Clinic
Forum
Mitral valve interventions
Session comprising selected EuroPCR 2011 clinical case & complication
submissions
Chairpersons: O. Franzen, F. Maisano
▸ Introduction - O. Franzen
▸ Chordal rupture and leaflet tear after MitraClip implantation - T. Gorgadze
▸ Use of the MitraClip to treat mitral regurgitation in a patient with an
amplatzer patent foramen ovale occluder - M. Neuss
▸ Novel percutaneous closure of a mitral paravalvular leak - T. Keeble
▸ Surgical bailouts in complicated transcatheter repair of severe mitral
paravalvular leak - N. Al-Attar
▸ Perioperative STEMI during mitral valve annuloplasty: role of early
angiography - B. Vaquerizo
▸ Take-home message - F. Maisano
117
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page117
09:00-10:30 Room 353 Technique
Abstract session
3D coronary angiography and novel imaging techniques: implications
for PCI
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: A. Linke, J. Escaned, S. Nanto
▸ Introduction - A. Linke
▸ Feasibility of a new C-arm angiography (DYNA-CT) based three-
dimensional coronary reconstruction algorithm in combination with
myocardial perfusion assessment - A. Sinha
▸ Clinical validation of a new 3-dimensional imaging system for quantitative
and qualitative judgement of coronary artery stenoses - A. Sinha
▸ The impact of acquisition angle differences on three-dimensional
quantitative coronary angiography - S. Tu
▸ Accuracy of device localisation in PCI based on the IC-PRO guidance
system - A. Sinha
▸ New image processing system improves coronary artery anatomy
assessment, device selection, positioning and post-deployment analysis
A. Frimerman
▸ Percutaneous recanalisation of coronary chronic total occlusion:
pre-procedural road mapping with MDCT coronary angiography (MDCT-CA)
D. Tavella
▸ Take-home message - J. Escaned
10:00-12:00 Room 351
How should I treat?
Fractional flow reserve in unstable or myocardial infarction patients with
multivessel coronary artery disease
Under the auspices of the Working Group of Interventional Cardiology of
the Croatian Cardiac Society, the Working Group for Interventional
Cardiology of the Cyprus Society of Cardiology, the Working Group of
Hemodynamics and Intervention of the Hellenic Cardiological Society and
the Working Group on Interventional Cardiology of the Cardiology Society
of Serbia
Chairpersons: L. Michalis, P. Avraamides, A. Ernst, M. Ostojic
Objectives:
▸ To understand the role of fractional flow reserve in post myocardial
infarction patients with multivessel coronary artery disease
▸ To assess the myocardial viability and subsequently the need for
revascularisation in post myocardial infarction patients with moderate
coronary artery stenosis
▸ To understand the role of non invasive and invasive tests in identifying
coronary lesions responsible for myocardial ischemia
Thursday 19th
118
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page118
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction and objectives - L. Michalis
▸ Post myocardial infarction with moderate stenosis in the infarct-related
artery. Assessment of myocardial ischemia and viability using a pressure
wire. Comparison with other non-invasive modalities
- Case presentation - M. Hamilos
- How would I treat? - K. Toutouzas
- How would I treat? - M. Strozzi
- How did I treat? - M. Hamilos
- Discussion
- Consensus - L. Michalis
▸ Patients with stable angina and multivessel multilesion coronary
angiography. Percutaneous treatment based upon coronary pressure
measurements
- Case presentation - J. Bulum
- How would I treat? - M. Strozzi
- How would I treat? - K. Toutouzas
- How did I treat? - J. Bulum
- Discussion
- Consensus - A. Ernst
▸ PCI in acute coronary syndrome patient with borderline stenosis of left
anterior descending artery as assessed with non invasive coronary flow
reserve and invasive fractional flow reserve
- Case presentation - T. Komodromos
- How would I treat? - G. Georgiou
- How would I treat? - D. Orlic
- How did I treat? - T. Komodromos
- Discussion
- Consensus - P. Avraamides
▸ Take-home message - M. Ostojic
10:30-12:00 Room 242B
Forum
China meets EuroPCR
With the collaboration of China Interventional Therapeutics (CIT)
Facilitators: E. Grube, J. Marco
Panellists: M. Buchbinder, R. Gao 高润霖, J.B. Ge 葛均波, P. Urban
Participants: J. Chen 陈纪言, S. Chen 陈绍良, Y. Chen 陈韵岱, G. Fu 傅国胜,
S. Lu 吕树铮, S. Qiao 乔树宾, W. Wang 王伟民
119
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page119
10:30-12:00 Room 243 Clinic
Abstract session
Clinical outcome after TAVI: mid-term follow-up Session comprising selected EuroPCR 2011 abstract submissionsChairpersons: I. Lang, G. Manoharan, T. Modine
▸ Introduction - T. Modine
▸ Survival and predictors of late mortality after TAVI of severe symptomatic
aortic stenosis with the CoreValve prosthesis - A.J. Munoz-Garcia
▸ Final one-year outcomes of >2,300 patients in the source of registry, usingthe Edwards Sapien bioprostesis for TAVI in Europe - O. Wendler
▸ Three years of TAVI: results of a single centre experience with the
Medtronic CoreValve prosthesis in 111 patients - M. Abdel-Wahab
▸ Outcomes following TAVI with both Edwards SAPIEN and CoreValvedevices in a single centre: the on-going Milan experience - C. Godino
▸ Procedural, 30-day, 6 month and one-year outcome following Corevalve orEdwards TAVI: results of the Belgian Registry - J. Bosmans
▸ Improvements in TAVI outcomes in lower surgical risk patients: a glimpseinto the future - N. Piazza
▸ Take-home message - I. Lang
10:30-12:00 Room 251 Innovation
Hot Line session
Late breaking scienceChairpersons: B. De Bruyne, R. Kornowski, M.W. Krucoff
▸ Introduction - B. De Bruyne
▸ STIB trial - V. Legrand
▸ Late vascular healing after implantation of sirolimus-eluting and paclitaxel-eluting stents: an optical coherence tomography study - S. Windecker
▸ Incidence and prognostic significance of new-onset atrial fibrillation
recorded by an implantable cardiac monitor in post acute myocardialinfarction patients - P.E. Bloch Thomsen
▸ Single high-dose erythropoietin administration immediately after
reperfusion in STEMI: primary results of the randomised EPOMI trialF. Prunier
▸ HEBE-III randomised trial: a Zwolle sub-study with the Genous stentH. Suryapranata
▸ The effect of exenatide on reperfusion injury in patients with acute
myocardial infarction - T. Engstroem
▸ Rosuvastatin pre-treatment in patients undergoing elective PCI to reducethe incidence of myocardial periprocedural necrosis (ROMA trial): one-year follow-up - G. Sardella
▸ Post-conditioning during coronary angioplasty in acute myocardialinfarction: the POST-AMI trial - G. Tarantini
Thursday 19th
120
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page120
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
10:30-12:00 Room 252AB Technique
LTT - How to perform optical coherence tomography
imaging
Facilitators: G. Guagliumi, M. Radu
Panellists: T. Akasaka, P. Motreff, L. Räber
Media driver: E. Sorbets
Live in-a-box® from Clinique Pasteur, Toulouse - France
10:30-12:00 Room 253 Technique
Abstract session
Testing antiplatelet reactivity in daily practice
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: M. Valgimigli, T. Cuisset, P. Sinnaeve
▸ Introduction - M. Valgimigli
▸ Routine tailoring of antiplatelet therapy after coronary stent implantation
has the potential to eradicate early definite stent thrombosis in compliant
patients - G. Christ
▸ Peri-procedural variations of platelet function in patients undergoing PCI
F. Mangiacapra
▸ Individualising clopidogrel therapy according to the multiplate
aggregometry test reduces the ischemic complications in patients after
PCI and stenting - D. Hazarbasanov
▸ Platelet aggregation in stable angina patients treated with aspirin and
clopidogrel is modulated by a 6.3 / 6.7 kb polymorphism of the platelet
Alpha2A-adrenergic receptor - A.J. Peace
▸ Real-time clopidogrel gain-of-function and loss-of function genotype
screening with NanosphereVerigene2C19/CBSNucleic Acid - M. Tebaldi
▸ Closing lecture: testing antiplatelet reactivity in daily practice
F.J. Neumann
▸ Take-home message - T. Cuisset
10:30-12:00 Room 341 Technique
Abstract session
Fractional flow reserve: additional or complementary to coronary
invasive imaging?
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: P. MacCarthy
121
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page121
▸ Introduction - P. MacCarthy
▸ Comparison of different strategies to obtain maximal hyperaemia in the
assessment of fractional flow reserve for intermediate coronary stenosis:
intravenous adenosine vs incremental dosages of intracoronary adenosine
vs intracoronary nitroprusside (Nitrop) - A.M. Leone
▸ Development and validation of the fractional flow reserve angiographic scoring
tool (FAST) to improve the angiographic grading and selection of intermediate
lesions that require fractional flow reserve assessment - S.P. Hoole
▸ Non-invasive computation of fractional flow reserve in patients with
multivessel coronary artery disease - A. Erglis
▸ Defer PCI on fractional flow reserve basis: 4-year follow-up in single-
centre retrospective study - S. Uguccioni
▸ Optical coherence tomography parameters are only moderately predictive
of fractional flow reserve, suggesting complimentary roles of these
technologies in intermediate coronary lesion assessment - S.P. Hoole
▸ Performance of three-dimensional vs. two-dimensional quantitative
coronary angiography in discriminating functionally significant coronary
stenoses according to fractional flow reserve - F. Mangiacapra
▸ Take-home message - P. MacCarthy
10:30-12:00 Room 343 Clinic
Abstract session
Cross-talk between PCI and surgery
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: G. Fournial, A. Jonsson, K. Niemela
▸ Introduction - G. Fournial
▸ Is there any impact of borderline significant non-coronary lesions on long-
term outcomes of CABG surgery? - K. Shafranskaya
▸ The "2nd Italian CABG Project" - short-term outcomes in patients with
CABG - S. Rosato
▸ PCI in patients with coronary artery disease and previous CABG: acute and
long-term results - A. Sanchez
▸ Intraoperative shuntography for immediate control of coronary bypass
surgery - B. Alekyan
▸ Prophylactic placement of percutaneous LVAD for high risk PCI in patients
with systolic dysfunction - K. Shah
▸ Perioperative cardiac risk of non-cardiac surgery after Sirolimus eluting
stent - 5-year follow-up - Y. Ohno
▸ Take-home message - A. Jonsson
Thursday 19th
122
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page122
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
10:30-12:00 Room 352AB Technique
Forum
Complications during primary PCI for STEMI
Session comprising selected EuroPCR 2011 complication submissions
Chairpersons: N. van Mieghem, F. Mauri
▸ Introduction - N. van Mieghem
▸ Guideliner catheter; friend or foe? - M. Spence
▸ Iatrogenic coronary pseudoaneurysm: what to do? - A. Gomez Menchero
▸ Right coronary artery perforation during primary angioplasty in a patient
with IIb/IIIa inhibitors - T. Gorgadze
▸ Coronary stent avulsion caused by thrombectomy catheter entrapment
A. Tommasino
▸ No-reflow phenomenon complicating acute left heart failure, cardiogenic
pulmonary edema, lethal ventricular arrhythmia, cardiac arrest during
delayed PCI in a patient with acute myocardial infarction - Q. Wang
▸ Take-home message - F. Mauri
10:30-12:00 Room 353 Clinic
Abstract session
PCI in STEMI patients: biochemical markers and clinical outcome
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: P. Clemmensen, M. Sabate
▸ Introduction - M. Sabate
▸ Clinical impact of high sensitivity C-reactive protein on twelve-month
mortality in overweight/obese patients with acute myocardial infarction
undergoing PCI - K. Ahmed
▸ Neutrophil to lymphocyte ratio predicts long-term clinical outcomes in
patients with STEMI undergoing primary PCI with DES - T.H. Yang
▸ Association of interleukin-10 level with increased 30-day mortality in
patients with STEMI undergoing primary coronary intervention
A. Youssef
▸ Clinical utility of biomarkers to predict major bleeding events after STEMI:
a Horizons-AMI substudy with 3-year follow-up - R. Mehran
▸ C-reactive protein as a predictor of major adverse cardiovascular events in
primary PCI - K.S. Rathod
▸ Association between admission blood glucose level and in-hospital
cardiovascular mortality and prognosis in patients with acute myocardial
infarction - M. Ardeshiri
▸ Take-home message - P. Clemmensen
123
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page123
12:00-13:30 Main arena
Symposium
Clinical evidence and technological advances in the evolution of TAVI
With an unrestricted educational grant from EDWARDS LIFESCIENCES
Chairpersons: F.W. Mohr, S. Windecker
Objectives:
▸ To understand the impact of the PARTNER trial in aortic stenosis treatment
▸ To understand the impact of SOURCE/SOURCE XT registries on daily
clinical practice
▸ To highlight how Europe is further improving outcomes by driving product
evolution
▸ Introduction and objectives - S. Windecker
▸ Deep dive into clinical data: difference in mortality and quality of life
factors in PARTNER and impact on clinical community - M.B. Leon
▸ Deep dive into clinical data: impact on clinical TAVI options and role of
surgical aortic valve replacement - T.M. Dewey
▸ SOURCE/SOURCE XT Registries expanding the TAVI horizon - How real-life
clinical practice is evolving clinical indications and complication
management - H. Baumgartner
▸ How key development iterations in valve design, performance and access
impact ease of use and procedural success - A. Colombo
▸ Discussion
▸ Take-home message - F.W. Mohr
12:00-14:00 Theatre Bleu
Tech News & Trends (TNT) session
Complex bifurcations and coronary chronic total occlusion
With an unrestricted educational grant from TERUMO
Chairpersons: M.C. Morice, A. Chieffo
Panellists: B. Chevalier, E. Christiansen, K. Igarashi, Y. Louvard, A. Osiev,
S. Soerianata
Objectives:
▸ To learn how to optimise outcome for the patients presenting with
complex bifurcation lesions by applying contemporary state-of-the-art
technique
▸ To learn when and how best to open chronic total occlusion lesions
▸ To discuss best options for treatment modalities in daily routine for those
patients
Thursday 19th
124
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page124
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction and objectives - M.C. Morice
12:05-12:55 Live in-a-box® from Institut Cardiovasculaire Paris Sud, Massy -
France
▸ Clinical outcome of Nobori DES in bifurcation and coronary chronic total
occlusion lesions - A. Serra
13:05-13:55 Live in-a-box® from Institut Cardiovasculaire Paris Sud, Massy -
France
▸ Take-home message - A. Chieffo
12:00-13:30 Theatre Bordeaux
Symposium
Risk stratification and antithrombotic therapy during
high-risk PCI
With an unrestricted educational grant from
THE MEDICINES COMPANY
Chairperson: S.D. Kristensen
Objectives:
▸ To apply 2010 European Society of Cardiology guidelines to treatment
choices of anticoagulant and antiplatelet therapies
▸ To describe the challenges involved in high-risk PCI procedures and
identify predictors of vascular complications
▸ To identify strategies to improve survival and health economic outcomes
for high-risk PCI procedures
▸ Introduction and objectives - S.D. Kristensen
▸ Matching anticoagulant with antiplatelet therapy: implementing the ESC
2010 Guidelines - P.G. Steg
▸ Bleeding risk, registries and the radial approach - G. Musumeci
▸ High-risk NSTEMI intervention: which antithrombotic when? - F.J. Neumann
▸ Improving survival and health economic outcomes - A. Gershlick
▸ Discussion
▸ Take-home message - S.D. Kristensen
STENT
FOR LIFE
125
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page125
12:00-13:30 Theatre Havane
Symposium
Treating STEMI patients successfully: a case-based approachWith an unrestricted educational grant from ABBOTT VASCULAR and CROSSROADS, the Abbott VascularEducation NetworkChairpersons: M. Noc, T. Majwal
Objectives:▸ To provide insight in the complexity of STEMI patients
▸ To provide an overview on the different treatment options
▸ To provide an algorithm for STEMI treatment
▸ Introduction and objectives - M. Noc
▸ The high-risk STEMI patient - B. Farah
▸ Thrombo-aspiration or not - A. Kastrati
▸ DES or not - M. Lee
▸ The patient in cardiogenic shock - B. Merkely
▸ Discussion
▸ Take-home message - T. Majwal
12:00-13:30 Room Maillot
Symposium
How to assess and treat patients who are not suitable candidates forprolonged dual antiplatelet therapyWith an unrestricted educational grant from ORBUSNEICHChairpersons: M. Haude, S. Silber
Objectives:▸ To explore the potential of imaging tools to assess stent apposition and
arterial healing
▸ To evaluate the benefits of endothelial progenitor cell-capture technology
in patient outcomes
▸ To discuss treatment options for complex patients who are not suitablecandidates for prolonged dual antiplatelet therapy
▸ Introduction and objectives - M. Haude
▸ Endothelial progenitor cell-capture technology: mechanism of action and
potential benefits - H.J. Duckers
▸ Which patients are not candidates for dual antiplatelet therapy? What arealternative treatment options for such patients? - J. Hill
▸ How can we assess arterial healing after PCI? - S. Lee
▸ What are the requirements for an optimal stent platform in the future?
R.J. De Winter
▸ Discussion
▸ Take-home message - S. Silber
STENT
FOR LIFE
Thursday 19th
126
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page126
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
12:00-13:00 Room 242B
Forum
India meets EuroPCR
Facilitators: E. Grube, P. Urban
Panellists: D. Blanchard, J. Dugal, P. Grant, J. Shivkumar
12:00-13:30 Room 243 Technique
Abstract session
Primary PCI in STEMI: thrombus aspiration or filter devices
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: F. Malik, M. Claeys, D. Dudek
▸ Introduction - F. Malik
▸ Impact of thrombus aspiration on myocardial perfusion and left ventricle
function in patients with anterior STEMI treated with primary angioplasty
M. Lelek
▸ Predictors of short-term mortality in patients with STEMI undergoing
primary percutaneous transluminal coronary angioplasty - S. Pyxaras
▸ Impact of thrombus aspiration on plasma levels of platelet-derived growth
factor in patients with STEMI - T. Koizumi
▸ Non-obstructive coronary disease leading to STEMI: assessment of
residual stenosis after thrombus aspiration - J. Brito
▸ Rheolytic thrombetcomy for acute coronary thrombotic occlusion of left
main in patients with acute myocardial infarction complicated by
cardiogenic shock - G. Parodi
▸ Impact of PercuSurge guidewire device on prevention and reduction of
recovery time from complete heart block in patients with acute inferior
myocardial infarction undergoing primary PCI - A. Youssef
▸ Take-home message - D. Dudek
127
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page127
12:00-13:30 Room 253 Clinic
Abstract session
Secondary prevention after PCI: evidence for plaque regression
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: L. Mauri, J.J. Piek
▸ Introduction - L. Mauri
▸ Impact of patient and procedural characteristics for appropriate secondary
prevention therapy after PCI - Analysis from Japanese prospective
multicentre registry - A. Endo
▸ Effects of low dose Pioglitazone on restenosis and atheroma plaques in
patients with diabetes mellitus undergoing PCI - H.W. Lee
▸ Effect of high-dose lipid lowering treatment compared to low-dose lipid
lowering treatment with Rosuvastatin on carotid intima media thickness in
high-risk patients - R. Egede
▸ Influence of high-dose lipid lowering treatment compared to low-dose
lipid lowering treatment on plaque composition assessed by intravascular
ultrasound virtual histology in patients with STEMI: the VIRHISTAMI trial
R. Egede
▸ Take-home message - J.J. Piek
12:00-13:30 Room 341 Clinic
Abstract session
PCI for acute coronary syndromes in the elderly
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: Z. Siudak, S. Aziz, J. Mehilli
▸ Introduction - Z. Siudak
▸ The impact of increased age on outcome from an early invasive strategy in
patients with acute coronary syndromes: the ACACIA registry - C.J. Malkin
▸ Predictors of treatment in acute coronary syndromes in the elderly: impact
on decision making and clinical outcome after interventional vs.
conservative treatment - S. Schnupp
▸ In-hospital mortality in the octogenarians in the primary PCI era in
comparison to thrombolysis - M. Egred
▸ PCI for acute coronary syndrome in elderly patients: results from a high
volume centre - R. Showkathali
▸ PCI outcomes in nonagenarians: data from a systematic review
I. Sheiban
▸ Prognosis after PCI in elderly patients - L. Antonsen
▸ Take-home message - S. Aziz
Thursday 19th
128
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page128
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
12:00-13:30 Room 342AB
Symposium
Does size matter? Stentys self-apposing stent for STEMI and complex
anatomy
With an unrestricted educational grant from STENTYS
Chairpersons: P.W. Serruys, M. Buchbinder
Panellists: G. Amoroso, C. Tamburino, R.J. van Geuns, S. Verheye,
R. Wessely
Objectives:
▸ To learn about today's shortfalls in primary PCI for acute myocardial
infarction and complex anatomy
▸ To learn about Stentys self-apposing technology and to be updated on the
clinical strategy
▸ To learn about the long-term safety and efficacy of the Stentys self-apposing
stent
▸ Introduction and objectives - P.W. Serruys
▸ Challenging thrombus and malapposition in STEMI - R. Wessely
▸ Stentys self-apposing technology and the new approach to acute
myocardial infarction treatment - G. Amoroso
▸ Discussion
▸ Long-term behaviour of Nitinol stents in coronary arteries: two-year IVUS
follow-up of the Stentys stent - S. Verheye
▸ Discussion
▸ Building on early successes: one-year follow-up of the Stentys stent in
STEMI patients (APPOSITION programme) - R.J. van Geuns
▸ Discussion
▸ Panel discussion
▸ Take-home message - M. Buchbinder
12:00-13:30 Room 351
How should I treat?
How to avoid, detect and treat complications in a TAVI procedure
With an unrestricted educational grant from MEDTRONIC
Chairperson: S.J.D. Brecker
Objectives:
▸ To understand how to detect and anticipate some major complications
during a TAVI procedure
▸ To understand how to treat these complications and avoid similarities in
the future, "implement lessons learned"
129
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page129
▸ Introduction and objectives - S.J.D. Brecker
▸ Redo case
- Case presentation - U. Gerckens
- How would I treat? - J.C. Laborde
- How would I treat? - N. Moat
- How did I treat? - U. Gerckens
- Discussion
- Consensus - S.J.D. Brecker
▸ Vascular access and closure
- Case presentation - H. Danenberg
- How would I treat? - M. van Sambeek
- How would I treat? - P. Wenaweser
- How did I treat? - H. Danenberg
- Discussion
- Consensus - S.J.D. Brecker
▸ Take-home message - S.J.D. Brecker
12:00-13:30 Room 352AB
Symposium
Treating bifurcation: the Nile concept for a safe and efficient approach
With an unrestricted educational grant from MINVASYS
Chairpersons: A. Abizaid, J. Fajadet
Objectives:
▸ To assess safety and efficacy of the concept
▸ To understand the value of the provisional approach
▸ To review and discuss achievements of the concept in challenging
bifurcation lesions
▸ Introduction and objectives - J. Fajadet
▸ Principles and current understanding of the bifurcation lesion - A. Medina
▸ The Nile concept and Medina (1.1.1) - P. Motreff
▸ The Nile concept and Medina (1.0.1) - P. Brunel
▸ The Nile concept and the left main - I. Petrov
▸ The Nile concept in acute coronary syndrome - B. Garcia Del Blanco
▸ Discussion
▸ Take-home message - A. Abizaid
Thursday 19th
130
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page130
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
12:00-13:30 Room 353 Technique
Abstract session
Optical coherence tomography: to assess the results of PCI
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: G. Guagliumi, K.T. Chan, J. Escaned
▸ Introduction - G. Guagliumi
▸ Correlation of optical coherence tomography in the clinical and pre-clinical
setting - C. Malle
▸ Reliable assessment of stent healing in the rabbit iliac artery model by
optical coherence tomography - K. Steigerwald
▸ The use of 3-dimensional reconstruction of optical frequency domain
imaging to improve our understanding of conventional PCI: the potential
for clinical application - V. Farooq
▸ Optical coherence tomography findings of plaque rupture occurred by
balloon angioplasty - H. Ishimori
▸ Late expansion of thin-strut self expanding stents designed for non-
obstructive vulnerable plaque as imaged by intravascular ultrasound and
optical coherence tomography - H.M. van Beusekom
▸ An automated algorithm for identification and quantification of clusters of
malapposed stent struts in optical coherence tomography images
K. Onsea
▸ Take-home message - K.T. Chan
13:00-14:30 Room 242B
Forum
Taiwan meets EuroPCR
With the collaboration of the Taiwan Society of Cardiology
Facilitators: D. Blanchard, S.B. King III
Panellists: J.J. Cheng, J.S. Hung, C.D. Tseng
Participants: I.C. Hsieh, P.M. Ku, W.L. Lee, S.C. Liu, H.L. Huang
13:30-17:30 Main arena Clinic
Main session
Primary PCI in STEMI - towards optimal results in complex
lesions
Chairpersons: P. MacCarthy, M. Noc
Panellists: G. Brueren, H. Danenbert, S. Dani, V. Guetta, D. Iosseliani,
S.D. Kristensen, M. Lesiak, J. McLenachan, T. Pawlowski, D. Tresukosol,
D.O. Williams
Objectives:
▸ To provide an update on optimal PCI strategy and device selection in
complex angiographic scenarios
▸ To provide practical procedural tips and tricks
▸ To learn about prevention and management of complications that may
occur when treating complex lesions
STENT
FOR LIFE
131
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page131
▸ Introduction and objectives - P. MacCarthy
13:35-14:25 Live in-a-box® from Catharina Ziekenhuis, Eindhoven -
The Netherlands
▸ Keynote lecture - Reflect together on how to resolve obstacles to
myocardial reperfusion in patients undergoing timely primary PCI
J. McLenachan
▸ How should I treat case - Under the auspices of the the Israeli Working
Group on Interventional Cardiology and the Polish Association of
Cardiovascular Interventions
- Case presentation - T. Pawlowski
- How would I treat? - R.J. Gil
- How would I treat? - C. Lotan
- How did I treat? - T. Pawlowski
- Discussion
- Consensus - M. Lesiak
▸ How should I treat case - Under the auspices of the the Israeli Working
Group on Interventional Cardiology and the Polish Association of
Cardiovascular Interventions
- Case presentation - V. Guetta
- How would I treat? - C. Lotan
- How would I treat? - R.J. Gil
- How did I treat? - V. Guetta
- Discussion/Consensus - H. Danenberg
16:05-16:55 Live in-a-box® from Catharina Ziekenhuis, Eindhoven -
The Netherlands
▸ Complication case - Coronary stent avulsion caused by thrombectomy
catheter entrapment - A. Tommasino
▸ Final key remarks - M. Noc
13:30-16:30 Theatre Bordeaux Clinic
Plenary session
Where cardiologists and cardiac surgeons can meet: the beginning
of a great future
Chairpersons: J-L. Pomar, P. Kolh
Panellists: A. Colombo, M. de Belder, J. Marco, T. Modine, F.W. Mohr,
L. Torracca
Objectives:
▸ To explore the potential for a common future between
interventionalists and surgeons
▸ To discuss pros and cons of hybrid procedures
▸ To share the experience of hybrid teams
Thursday 19th
132
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page132
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction and objectives - J-L. Pomar
Revascularisation in patients at high surgical risk
▸ How to define high surgical risk - M. Kohonen, K. Niemelä
▸ Discussion / Consensus from the panel
▸ How should I treat?
- Presentation - K. Niemelä
- How would I treat? - P. Kolh
- How would I treat? - A. Colombo
- How did we treat? - M. Kohonen, K. Niemelä
- Discussion & consensus from the panel
Hybrid coronary revascularisation
▸ Which patients may be considered for myocardial revascularisation using
a hybrid procedure - E. Barbato, F. Casselman
▸ How should I treat?
- Presentation - E. Barbato
- How would I treat? - T. Modine
- How would I treat? - S. Kedev
- How did we treat? - E. Barbato, F. Casselman
- Discussion & consensus from the panel
Integrated training in interventional cardiology and cardiac surgery
▸ My personal experience - T. Modine, J. Sadaba Sagredo, R. Lange,
A. Jonsson, F.W. Mohr
▸ Roundtable discussion
▸ Take-home message - P. Kolh
13:30-16:30 Theatre Havane Clinic
LTT - How to treat a patient with coronary bifurcation
lesions
Facilitators: J. Fajadet, T. Lefèvre, G. Stankovic
Panellists: O. Darremont, J. Ormiston, M. Pan
Media driver: A.A. Fassa
Live in-a-box® from Institut Cardiovasculaire Paris Sud,
Massy - France
133
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page133
13:30-15:00 Room 242A
How should I treat?
PCI after thrombolysis in STEMI
Under the auspices of the Portuguese Association of
Interventional Cardiology and the Working Group on PCI of
the Spanish Society of Cardiology
Chairpersons: P. Farto E Abreu, M. Valdés Chávarri
Objectives:
▸ To understand the role of PCI after thrombolysis for acute myocardial
infarction in order:
- to reduce major adverse cardiac events
- to decrease recurrences
- to improve patient risk stratification and clinical management
▸ Introduction and objectives - P. Farto E Abreu
▸ Invasive approach after successful thrombolysis
- Case presentation - P. Mota
- How would I treat? - P. Braga
- How would I treat? - J.A. Gomez-Hospital
- How did I treat? - P. Mota
- Discussion
- Consensus - P. Farto E Abreu
▸ Pharmaco-invasive approach
- Case presentation - I. Lozano
- How would I treat? - J.A. Gomez-Hospital
- How would I treat? - P. Braga
- How did I treat? - I. Lozano
- Discussion
- Consensus - M. Valdés Chávarri
▸ Take-home message - M. Valdés Chávarri
STENT
FOR LIFE
Thursday 19th
134
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page134
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
13:30-15:00 Room 243 Innovation
Abstract session
Advances in cell-based regenerative therapy post-STEMI
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: F. Fernandez-Aviles, J. Bartunek, M. Ostojic
▸ Introduction - F. Fernandez-Aviles
▸ Percutaneous, intra-myocardial injection of unselected bone marrow-
derived mononuclear cells via NOGA-XP significantly improves ejection
fraction in post-infarct patients: ALSTER STEM CELL - M.W. Bergmann
▸ Randomised controlled clinical trial of the use of autologous bone marrow
derived progenitor cells to salvage myocardium in patients with acute
anterior myocardial infarction - D. Locca
▸ G-CSF induced arteriogenesis in humans: molecular insights into a
randomised controlled trial - P. Meier
▸ Level and value of circulating endothelial progenitor cells in patients with
acute myocardial infarction undergoing primary coronary angioplasty
H.Y. Fang
▸ Clinical registry follow-up of endothelial progenitor cell capture stent in
patients suffering from non ST-segment elevation acute coronary
syndrome - I.J. Amat
▸ Intracoronary delivery of allogeneic mesenchymal precursor cells directly
after acute myocardial infarction improves cardiac function and
myocardial perfusion and decreases left ventricular remodeling in sheep
J. Houtgraaf
▸ Take-home message - J. Bartunek
13:30-15:00 Room 251 Technique
All you need to know about intracoronary imaging
Chairpersons: J. Escaned, C. Di Mario
Objective:
▸ At the end of this 90-minute ‘All you need to know about...’ session the
audience should have an up-to-date knowledge of the field, relevant for
their clinical practice. They should be familiar with the current evidence
base, existing guidelines and have an understanding of the open questions
that need addressing in the near future
▸ Introduction and objectives - J. Escaned
▸ Background - R. Erbel
▸ Technical aspects - M. Gilard
▸ Clinical data - H.M. Garcia-Garcia
▸ Guidelines and recommendations
▸ Unresolved issues and outlook - F. Prati
▸ Clinical cases - K-H. Sim
▸ Wrap-up - C. Di Mario135
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page135
13:30-15:00
Incidence and treatment of in-stent restenosis
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: L. Thuesen, B. He
▸ Introduction -
▸ In-stent restenosis is not simply a benign clinical entity as it presents as
acute coronary syndromes in 40% of cases -
▸ Repeated DES vs. balloon angioplasty for management of DES associated
restenosis in de novo and in-stent restenosis lesions -
▸ Serial morphological and functional assessment of in-stent restenosis
P. Agostoni
▸ Long-term clinical outcome after treatment of restenotic lesions with a
new generation DES -
▸ Comparison of restenosis patterns in 1st and 2nd generation DES
Y. Sakamoto
▸ Stent recoil varies with DES type and influences long-term luminal loss. A
comparative longitudinal study using a novel methodology for in vivo
assessment of stent recoil -
▸ Take-home message -
13:30-15:00
Valve malpositioning and procedural refinement during TAVI procedures
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: U. Gerckens
▸ Introduction -
▸ Procedural valve dislodgment with the Medtronic CoreValve: incidence,
predictors and how to overcome -
▸ Correction of prosthesis malpostitioning during TAVI with CoreValve
M. Vavuranakis
▸ The valve-in-valve technique for treatment of aortic bioprosthesis
malposition: an analysis of incidence and 1-year clinical outcomes from
the Italian CoreValve registry -
▸ Management of ventricular embolisation in TAVI -
▸ Manual mini-aortography during pre-implantation balloon aortic
valvuloplasty: a simple tool for successful TAVI -
▸ A high dose of adenosine to induce transient asystole for valvuloplasty in
patients undergoing TAVI: is it a valid alternative to rapid pacing? A
prospective pilot study -
▸ Take-home message -
13:30-15:00 Room 252AB Technique
LTT - How to use pressure-derived fractional flow reserve
Facilitators: B. De Bruyne, N. Melikian, A.J. Peace
Panellist: P. Grant
Media driver: F. Mangiacapra
Live in-a-box® from Cardiovascular Center, Aalst - Belgium
13:30-15:00 Room 253 Technique
Abstract session
Transradial access: safety and complications
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: V. Dangoisse, L. Grinfeld
▸ Introduction - V. Dangoisse
▸ Safety of transradial approach in 10,676 consecutive percutaneous
coronary procedures - A. Tommasino
▸ Transradial approach in patients with post-catheterisation occlusion of
radial artery - C. Trani
▸ Transradial coronary angiography: predictors of adversity - F. Costa
▸ Management of access site vascular complications in patients undergoing
transradial percutaneous coronary procedures - M. Brancati
▸ Recanalisation and re-use of late occluded radial artery after transradial
coronary interventions: a new technique for interventionalists, practicising
radial artery approach - A. Babunashvili
▸ Avoid radial approach in little old ladies: myth or fact? - P. Mota
▸ Take-home message - V. Dangoisse
Thursday 19th
136
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page136
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
13:30-15:00 Room 341 Technique
Abstract session
Incidence and treatment of in-stent restenosis
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: L. Thuesen, B. He
▸ Introduction - L. Thuesen
▸ In-stent restenosis is not simply a benign clinical entity as it presents as
acute coronary syndromes in 40% of cases - K.S. Rathod
▸ Repeated DES vs. balloon angioplasty for management of DES associated
restenosis in de novo and in-stent restenosis lesions - M.A.F. Abdelmegid
▸ Serial morphological and functional assessment of in-stent restenosis
P. Agostoni
▸ Long-term clinical outcome after treatment of restenotic lesions with a
new generation DES - N. West
▸ Comparison of restenosis patterns in 1st and 2nd generation DES
Y. Sakamoto
▸ Stent recoil varies with DES type and influences long-term luminal loss. A
comparative longitudinal study using a novel methodology for in vivo
assessment of stent recoil - J. Escaned
▸ Take-home message - B. He
13:30-15:00 Room 343 Technique
Abstract session
Valve malpositioning and procedural refinement during TAVI procedures
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: U. Gerckens
▸ Introduction - U. Gerckens
▸ Procedural valve dislodgment with the Medtronic CoreValve: incidence,
predictors and how to overcome - N. van Mieghem
▸ Correction of prosthesis malpostitioning during TAVI with CoreValve
M. Vavuranakis
▸ The valve-in-valve technique for treatment of aortic bioprosthesis
malposition: an analysis of incidence and 1-year clinical outcomes from
the Italian CoreValve registry - M. Barbanti
▸ Management of ventricular embolisation in TAVI - M. Ferrari
▸ Manual mini-aortography during pre-implantation balloon aortic
valvuloplasty: a simple tool for successful TAVI - B. Borz
▸ A high dose of adenosine to induce transient asystole for valvuloplasty in
patients undergoing TAVI: is it a valid alternative to rapid pacing? A
prospective pilot study - G. Davidavicius
▸ Take-home message - U. Gerckens
137
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page137
13:30-15:00 Room 351
Plenary session
Best of AsiaPCR/SingLive 2011
Chairpersons: T.H. Koh, S. Saito, W. Wijns
Panellists: P. Chandra, J.B. Ge, R. Zambahari
▸ Introduction - T.H. Koh
▸ The best abstract - Transapical aortic valve implantation: first-in-man
experience with the Symetis Acurate - J. Kempfert
▸ The 2nd best abstract - Five-year clinical and angiographic outcome after
primary stenting of totally occluded native coronary arteries (PRISON II -
Late Study): a randomised comparison of bare metal stent implantation
with Sirolimus-eluting stent implantation for the treatment of total
coronary occlusions - M.J. Suttorp
▸ The 3rd best abstract - Outcome of coronary interventions in octo and
nanogenarians - M. Liang
▸ The best clinical case - A juvenile with severe stenosis at the bilateral
coronary artery ostium - Y. Mitsutake
▸ The most educational complication case - Run-away stent. Off-label use of
biopsy forceps - E. Merkulov
▸ The best How should I treat? - Left main stenosis and two CTOs in a
patient with NSTEMI and shock - K.L. Tsui
▸ PCI tips & tricks - Coronary wire pacing technique - S.T. Lim
▸ PCI tips & tricks - Crossing the uncrossable lesion after successful wiring
N. Inoue
▸ Closing remarks - S. Saito
13:30-16:30 Room 352AB Innovation
Glimpse into the future
Glimpse into the future - Novel approaches to treatment of mitral valve
disease
Chairpersons: O. Franzen, C. Ruiz
Panellists: D. Adams, T. Feldman, F. Maisano, A. Vahanian
Objectives:
▸ To understand the pathophysiology and clinical relevance of mitral
regurgitation
▸ To become familiar with novel techniques of mitral valve repair
▸ To learn about percutaneous techniques of mitral valve replacement
Thursday 19th
138
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page138
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction and objectives - O. Franzen
▸ Overview of new surgical options for mitral valve repair - D. Adams
▸ Glimpse into future transcatheter mitral valve repair devices
- New devices for mitral valve leaflet repair - T. Feldman
- Mitral valve intervention using combined transcatheter devices
A. Vahanian
- New devices for direct mitral valve annuloplasty - L. Buellesfeld
- Other new concepts for transcatheter mitral valve repair - C. Ruiz
- New devices for transcatheter mitral valve replacement - G. Lutter
- Catheter-based access to the mitral valve in the future - Venous, arterial or
transapical? - M. Buchbinder
14:50-15:05 Recorded case on transcatheter mitral valve replacement and
commentary by L. Sondergaard
▸ Panel discussion
▸ Glimpse into future transcatheter mitral valve repair indications
- Expanding indications for transcatheter mitral valve repair - The
interventional cardiologist's point of view - O. Franzen
- Expanding indications for transcatheter mitral valve repair - The surgeon's
point of view - F. Maisano
▸ Presentation of two cases and panel discussion
- Case 1 - O. Franzen
- Case 2 - F. Maisano
▸ Panel discussion
▸ Take-home message - C. Ruiz
13:30-15:00 Room 353 Technique
Abstract session
DES/protection devices in saphenous vein graft PCI
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: F. Airoldi, H. Bueno, J.W. Moses
▸ Introduction - F. Airoldi
▸ DES offer limited benefit over bare metal stents inserted during vein graft
PCI - M. Akhtar
▸ Long-term follow-up of DES vs. bare metal stents in the treatment of
saphenous vein graft lesions: a single centre study - L.F. Ybarra
▸ Two-year clinical outcomes after treatment of saphenous vein graft with a
new generation DES - R. Wessely
▸ Comparative analysis of a distal protection system and the new stent M-Guard
for the treatment of complex lesions in saphenous vein grafts - V. Esteves
▸ Intravascular ultrasound predictors of no-reflow after percutaneous
saphenous vein graft intervention with distal protection devices - Y.J. Hong
▸ Long-term clinical outcomes of PCI in grafts vs. native vessels in patients
with previous coronary artery bypass grafting - I. Xanthopoulou
▸ Take-home message - H. Bueno139
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page139
14:00-16:00 Rooms 101/102/103
Meet with the trialists
Objective:
▸ To allow in-depth questions and answers with the principal investigators
of trials presented at the 2011 EuroPCR late breaking trial sessions
▸ A prospective, randomised and multicentre trial comparing Titan-2 BAS
and Xience-V stent: the BASE-ACS trial - P. Karjalainen
▸ Vascular healing in response to Sirolimus-eluting stents during five year
follow-up: an optical coherence tomography study - L. Räber
▸ Diagnosis of ischemia-causing stenoses obtained via non-invasive
fractional flow reserve (DISCOVER-FLOW): a prospective multicentre first-
in-man study - B.K. Koo
14:00-16:30 Theatre Bleu
Forum
Complication forum
Chairpersons: A. Lerman, E. Eeckhout
Panellists: M.J. Kern, M. Lee, T. Mabin, A. Mehta, C. Rihal
Objectives:
▸ To learn how to anticipate and treat common complications during PCI
▸ To demonstrate exceptional complication cases
▸ To show novel techniques to treat these complications
▸ Introduction - A. Lerman
▸ Case 1 - S. Takeshi
▸ Case 2 - M. Mohandes
▸ Case 3 - A. Qasim
▸ Case 4 - J. Tan
▸ Case 5 - R. Sachdeva
▸ Case 6 - W. Kehasukcharoen
▸ Conclusion - E. Eeckhout
Thursday 19th
140
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page140
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
14:30-16:00 Room 242B
Plenary session
EuroIntervention / European Heart Journal @ EuroPCR
Chairpersons: T. Lüscher, P.W. Serruys
Objective:
▸ The authors of the three best TAVI papers selected by the Editorial Board
of EuroIntervention and three best TAVI papers selected by the Board of
European Heart Journal present their work accompanied by an invited
commentary
▸ Introduction - T. Lüscher, P.W. Serruys
▸ EuroIntervention Journal 1: Comments as reviewer of “Outcomes and
complications of TAVI using a balloon expandable valve according to the
Valve Academic Research Consortium (VARC) guidelines” - N. Piazza
▸ Author comments and update - D. Tchétché
▸ Discussion
▸ European Heart Journal 2: Comments as reviewer of “Percutaneous
transarterial aortic valve implantation. ‘What do we know?’ (Clinical
review article)” - P. de Jaegere
▸ Author comments and update - A. Cribier
▸ Discussion
▸ EuroIntervention Journal 3: Comments as reviewer of “Reappraisal of
percutaneous aortic balloon valvuloplasty as a preliminary treatment
strategy in the TAVI area” - H. Eltchaninoff
▸ Author comments and update - D. Himbert
▸ Discussion
▸ European Heart Journal 4: Comments as reviewer of “One year follow-up
of the multi-centre European Partner transcatheter heart valve study (Fast
track clinical paper)” - S. Windecker
▸ Author comments and update - P. Nataf
▸ Discussion
▸ EuroIntervention Journal 5: Comments as reviewer of “Prevalence an
prognostic implications of baseline anemia in patients undergoing TAVI”
J-P. Bassand
▸ Author comments and update - N. van Mieghem
▸ Discussion
▸ European Heart Journal 6: Comments as reviewer of “TAVI - First results
from a multicentre real world registry (Clinical paper)” - F.A. Flachskampf
▸ Author comments and update - R. Zahn
▸ Discussion
▸ Take-home message - P.W. Serruys
141
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page141
15:00-16:30 Room 242A
How should I treat?
Native and induced coronary aneurysm: from the imaging to the
treatment
Under the auspices of the Italian Society of Invasive Cardiology (GISE)
and the Working Group on Interventional Cardiology and Acute Coronary
Syndrome of the Swiss Society of Cardiology
Chairpersons: G. Guagliumi, G. Pedrazzini
Objectives:
▸ To understand the prognostic role of native and DES induced coronary
aneurysm
▸ To learn about pathophysiology of native (giant) and DES induced
coronary aneurysm
▸ To define the optimal treatment for native and DES induced aneurysm
▸ Introduction and objectives - G. Guagliumi
▸ Unusual treatment of a giant aneurysm
- Case presentation - S. Cook
- How would I treat? - C. Kaiser
- How would I treat? - C. Trani
- How did I treat? - S. Cook
- Discussion
- Consensus - G. Pedrazzini
▸ Asymptomatic coronary aneurysm after DES: progression and imaging
use for decision-making process
- Case presentation - E. Piccaluga
- How would I treat? - C. Trani
- How would I treat? - C. Kaiser
- How did I treat? - E. Piccaluga
- Discussion
- Consensus - G. Guagliumi
▸ Take-home message - G. Pedrazzini
15:00-16:30 Room 243 Clinic
Abstract session
Functional and clinical impact of successful coronary chronic total
occlusion recanalisation
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: G. Heyndrickx, M. Ochai, N. Reifart
Thursday 19th
142
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page142
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction - G. Heyndrickx
▸ Long-term clinical outcome of patients with coronary chronic total
occlusion treated with new generation DES - B. Chevalier
▸ Clinical and procedural outcome of PCI for coronary chronic total
occlusion with DES: a large single-centre experience - T. Hamid
▸ Prognostic role of successful vs. unsuccessful revascularisation in 'true'
coronary chronic total occlusions treated by DES - G. Niccoli
▸ A randomised comparison of the efficacy and safety of Zotarolimus-
eluting stents vs. Sirolimus-eluting stents for PCI in coronary chronic
total occlusions: the catholic total occlusion study (CATOS) trial - H.Y. Kim
▸ Efficacy on cardiac function in PCI for coronary chronic total occlusions
analysed by echocardiography - H. Takimura
▸ Successful recanalisation of chronic total occlusions is associated with
increased long term survival - R. Weerackody
▸ Take-home message - M. Ochiai
15:00-16:30 Room 251 Technique
All you need to know about percutaneous assist-devices
Chairpersons: J.J. Piek, P. Leprince
Objective:
▸ At the end of this 90-minute ‘All you need to know about...’ session the
audience should have an up-to-date knowledge of the field, relevant for
their clinical practice. They should be familiar with the current evidence
base, existing guidelines and have an understanding of the open questions
that need addressing in the near future
▸ Introduction - P. Leprince
▸ Background - Introduction on the available percutaneous assist-devices
currently evaluated in clinical trials - C.J. Vrints
▸ Clinical data - Assist devices in elective high-risk PCI, emergency PCI and
cardiogenic shock - P. Vranckx
▸ Issues in clinical practice - Practical experience and technical aspects with
the use of intra aortic balloon pumping - F. Eberli
▸ Guidelines - What do the guidelines tell us on the use of percutaneous
assist-devices - H. Thiele
▸ Unresolved issues - Limitations of available assist-device and expectations
from new devices - J. Henriques
▸ Questions & answers - J.J. Piek
143
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page143
15:00-16:25 Room 252AB Technique
Forum
Toys or tools for unusual PCI
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: A. Baumbach, F.Y. Kuo
▸ Introduction - A. Baumbach
▸ Application of Guideliner in difficult angulated right coronary artery PCI,
with failure of previous attempt - H.Y. Fang
▸ Guideliner microcatheter in order to improve back-up support during a
complex coronary stenting procedure through a tortuous left internal
mammary graft - C.I. Park
▸ A successful PCI case that was used 4 in 6 system for right coronary
artery lesion with anomalous origin - S. Kumazaki
▸ Sheathless transradial PCI with rotablation in critical calcified lesion
H.Y. Fang
▸ Take-home message - F.Y. Kuo
15:00-16:30 Room 253 Technique
Abstract session
Platelet reactivity in patient subsets
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: G. Montalescot
▸ Introduction - G. Montalescot
▸ Drastic increase in residual platelet reactivity under clopidogrel therapy in
hemodialysis patients with coronary artery disease - O. Morel
▸ Early determination of clopidogrel responsiveness by platelet-reactivity-
index identifies patients at risk for cardiovascular events after myocardial
infarction - A. Schaefer
▸ Evaluation of feasible timing of elective non-cardiac procedure after antiplatelet
discontinuation in patients who previously underwent PCI - J.R. Cho
▸ High residual platelet reactivity after clopidogrel loading and long-term
thrombotic events in patients with acute coronary syndrome undergoing
invasive treatment: the RECLOSE-ACS trial - D. Antoniucci
▸ Lack of correlation between platelet reactivity and glycaemic control in
type 2 diabetes mellitus patients treated with aspirin and clopidogrel
F. Mangiacapra
▸ The impact of glycemic control on platelet reactivity in type II diabetes
mellitus - D. Mylotte
▸ Take-home message - G. Montalescot
Thursday 19th
144
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page144
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
15:00-16:30 Room 341 Innovation
Abstract session
Bioabsorbable scaffold: animal and human observations
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: R.J. van Geuns
▸ Introduction - R.J. van Geuns
▸ Evaluation of preclinical safety of Absorb cohort b bioresorbable vascular
scaffold by employing multiple modalities - J. Powers
▸ Preclinical insights into clinical safety and delivery of vascular restoration
therapy by a bioresorbable vascular scaffold - L. Perkins
▸ Angiographic geometric changes of the lumen vessel wall after
bioresorbable vascular scaffolds and metallic platform stents at one-year
follow-up - J. Gomez-Lara
▸ Can we oversize bioresorbable scaffolds? The art experience - A. Lafont
▸ Spatial distribution and temporal evolution of scattering centers by optical
coherence tomography in the poly(L-lactide) backbone of a bioresorbable
vascular scaffold - J.L. Gutiérrez-Chico
▸ 540-days follow-up of fully bioabsorbable salicylate-based Sirolimus-
eluting stent evaluated by optical coherence tomography - R. Jabara
▸ Take-home message - R.J. van Geuns
15:00-16:30 Room 343 Clinic
Abstract session
TAVI: clinical outcome in various patient subsets
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: G. Fournial, A.S. Petronio
▸ Introduction - G. Fournial
▸ 30-day all-cause mortality after surgical aortic valve replacement and
TAVI for the treatment of severe aortic stenosis in high-risk patients:
a two-centre study - N. Dumonteil
▸ A comparison of transfemoral TAVI and surgical aortic valve replacement
in high-risk elderly patients with severe aortic stenosis - A. Giacomini
▸ A United Kingdom-based cost utility analysis of TAVI for inoperable
patents with severe aortic stenosis treated by medical management
S. Mealing
▸ TAVI in low-flow low-gradient aortic stenosis: early experience - C. Fiorina
▸ TAVI in low-gradient aortic stenosis - A. Lauten
▸ Clinical outcome of high-risk patients with severe aortic stenosis and
reduced left ventricular ejection fraction undergoing conservative
treatment or TAVI - T. Pilgrim
▸ Take-home message - A.S. Petronio
145
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page145
15:00-16:30 Room 351 Clinic
Plenary session
Imaging valvular disease: clinical and pathologic correlates. Lessons for
TAVI and transcatheter therapies
Chairpersons: R. Virmani, V. Delgado
Panellists: G. Manoharan, V. Schächinger
Objectives:
▸ To confront pathological findings with clinical presentation
▸ To review how pathology helps in understanding clinical imaging
▸ To understand biological interactions with implanted cardiovascular devices
▸ Welcome and session objectives - R. Virmani
▸ Aortic valve: aortic stenosis by etiology, aortic regurgitation by etiology,
relationship of the conduction system to LVOT, role of the size of the
membraneous valve to the conduction system location - E. Ladich
▸ Mitral valve: degenerative and functional, rheumatic valve stenosis,
relationship of valve annulus to coronary sinus and left circumflex artery,
importance of chordae tendinae - N. Carter-Monroe
▸ Tricuspid valve incompetence - N. Carter-Monroe
▸ Percutaneous valve procedures in animals and man (TAVI, mitral devices)
N. Carter-Monroe, E. Ladich
▸ Take-home message - V. Delgado
16:00-17:00 Room 242B
Plenary session
How to write a paper? Joint session EuroIntervention / Journal of the
American College of Cardiology
Chairpersons: P.W. Serruys, P. Cummins, S.B. King III, R.J. van Geuns
Objective:
▸ Tips & tricks for a successful publication
▸ Introduction - P.W. Serruys
▸ Impact factor is not the whole story - N. Bruining
▸ Discussion
▸ Common downfalls for medical papers - G. Biondi-Zoccai
▸ Discussion
▸ Statistics tips and tricks - A. Kastrati
▸ Discussion
▸ How to review a medical paper? - S.B. King III
▸ Discussion
▸ The future of medical publishing - F. Doncieux
Thursday 19th
146
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page146
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
16:30-19:00 Theatre Bleu
Tech News & Trends (TNT) session
Advancing TAVI for optimal patient outcomes: new product
advancements, tips & tricks
With an unrestricted educational grant from EDWARDS LIFESCIENCES
Chairpersons: H. Reichenspurner, A. Vahanian
Objectives:
▸ To share real-world insights on critical success factors (e.g. patient
selection, annulus sizing, access choice)
▸ To show recent advances in product design and procedural technique
▸ Introduction and objectives - H. Reichenspurner
16:35-17:20 Live demonstration from St Thomas Hospital, London - United
Kingdom
▸ Accurate valve placement with new transfemoral and transapical delivery
systems - E. Garcia
▸ Discussion
▸ Edwards SAPIEN XT 29mm valve-benefits to new size options - T. Walther
▸ Discussion
17:40-18:25 Live demonstration from St Thomas Hospital, London - United
Kingdom
▸ Access trade-offs and determining best strategy - G. Isabella
▸ Discussion
▸ What is unique about the Edwards SAPIEN XT valve design and key
learnings regarding valve performance? - H. Eltchaninoff
▸ Discussion
▸ Take-home message - A. Vahanian
16:30-18:00 Theatre Bordeaux
Symposium
Applied novel antiplatelet therapy in acute coronary
syndrome/PCI
With an unrestricted educational grant from DAIICHI
SANKYO EUROPE GmbH and ELI LILLY & COMPANY
Chairpersons: D. Ardissino, P. Clemmensen
Objectives:
▸ To describe recent efficacy and safety data on new antiplatelet therapies
for acute coronary syndrome patients treated with PCI
▸ To provide rationale and practical recommendations for differential
treatments to improve acute coronary syndrome patient outcomes
▸ To discuss the importance of long-term antiplatelet inhibition to protect
acute coronary syndrome/PCI patients against ischemic complications
STENT
FOR LIFE
147
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page147
▸ Introduction and objectives - D. Ardissino
▸ Reliable protection from stent thrombosis in acute coronary
syndrome/PCI patients: best practice - T. Cuisset
▸ Morbidity and mortality benefit for STEMI/PCI patients: evidence and
interactive cases - G. Montalescot
▸ Predictable antithrombotic protection for diabetic patients with acute
coronary syndrome/PCI - P. Widimsky
▸ Risk stratification and management of unstable angina patients/NSTEMI in
PCI patients - P. Sinnaeve
▸ Discussion
▸ Take-home message - P. Clemmensen
16:30-18:00 Theatre Havane
Symposium
Cre8: future DES technology, today
With an unrestricted educational grant from CID
Chairpersons: A. Colombo, R. Mehran
Objectives:
▸ To highlight the drawbacks of durable polymers
▸ To understand how CID has combined a polymer-free DES with a
controlled drug elution
▸ To learn about the latest data from the NEXT study
▸ Introduction and objectives - R. Mehran
▸ Limitations of contemporary polymeric DES - S. Verheye
▸ Cre8: the new polymer-free, reservoirs based and bio inducer DES
A. Abizaid
▸ The NEXT study: the first international randomised trial with Cre8
J. Schofer
▸ Unmet patients clinical needs and CID innovative DES technology - F. Prati
▸ Discussion
▸ Take-home message - A. Colombo
Thursday 19th
148
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page148
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
16:30-18:00 Room Maillot
Symposium
Drug-eluting balloons: current status and new perspectives With an unrestricted educational grant from MEDTRONICChairpersons: G. Tepe, B. Scheller
Objectives:▸ To provide a comprehensive overview of the span of potential clinical
indications for drug-eluting balloons in the coronary and peripheral areas
and understand where and why drug-eluting balloons should be
considered to address unmet needs
▸ To provide attendees with results of Medtronic drug-eluting balloons(IN.PACT) within coronary and peripheral applications
▸ To share current limitations and future needs to further establish drug-
eluting balloon clinical evidence
▸ Introduction and objectives - G. Tepe
▸ Drug-eluting balloons in coronary in-stent restenosis: insights fromoptical coherence tomography - P. Stella
▸ Discussion
▸ Drug-eluting balloons in very long and diffuse coronary lesions
G.M. Sangiorgi
▸ Discussion
▸ Drug-eluting balloons in peripheral hemodialysis fistulas - D. Patanè
▸ Discussion
▸ Drug-eluting balloons for lower limb arterial diseas - A. Schmidt
▸ Discussion
▸ Take-home message - G. Tepe
16:30-18:00 Room 242A Technique
Forum
Coronary chronic total occlusion: current techniques - Part ISession comprising selected EuroPCR 2011 clinical case submissionsChairpersons: M. Ochiai, G. Heyndrickx, A. Protopopov
▸ Introduction - M. Ochiai
▸ Retrograde recanalisation via an ipsilateral intraseptal collateral for chronic
total occlusion of a left anterior descending artery - S. Mizuno
▸ Post CABG; failed saphenous vein graft intervention or native vesselcoronary chronic total occlusion recanalisation? - G. Sianos
▸ PCI to left anterior descending coronary chronic total occlusion antegradeand retrograde approach from the same guiding catheter - H.Y. Fang
▸ Subintima tracking or just undersizing? Lessons from a right coronaryartery coronary chronic total occlusion case - F.Y. Kuo
▸ Modify mother and child technique for coronary chronic total occlusionA. Goldsmit
▸ Take-home message - G. Heyndrickx 149
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page149
16:30-18:00 Room 243 Clinic
Abstract session
Conduction abnormalities after TAVI
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: M. Schalij
▸ Introduction - M. Schalij
▸ Frequency of conduction abnormalities after TAVI with the Medtronic-
CoreValve and the effect on left ventricular ejection fraction - A. Tzikas
▸ Predictors of permanent pacemaker implantation after transcatheter
CoreValve implantation - M. De Carlo
▸ Timing and potential mechanisms of new conduction abnormalities during
the implantation of the Medtronic CoreValve system in patients with aortic
stenosis - R.J. Nuis
▸ Impact on the need for permanent pacemaker requirement after CoreValve
prosthesis implantation with the new Accutrak delivery Catheter System
A.J. Munoz-Garcia
▸ Factors affecting need for permanent pacemaker insertion following
CoreValve transcatheter aortic valve implantation - the UK CoreValve
Collaborative - M. Khawaja
▸ Low implantation of the CoreValve prosthesis transcatheter is a predictor
for the need of a pacemaker only in patients in sinus rhythm - F. Guerrero
▸ Take-home message - M. Schalij
16:30-18:00 Room 251
How should I treat?
Unexpected complex lesions in patients with STEMI
With an unrestricted educational grant from TERUMO
Chairpersons: S. Saito, B. Chevalier
Objectives:
▸ To share knowledge and experience about technical solutions for patients
with complex lesions in the course of STEMI
▸ To discuss tips & tricks to improve procedure and patients outcome
▸ To better understand to whom, when and how to use some specific
devices and techniques
▸ Introduction and objectives - S. Saito
▸ Case 1 - Unexpected complex lesion in patient with STEMI
- Case presentation - M. Valgimigli
- How would I treat? - A. Iniguez
- How would I treat? - C.K. Naber
- How did I treat? - M. Valgimigli
- Discussion
- Consensus - B. Chevalier
STENT
FOR LIFE
Thursday 19th
150
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page150
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Case 2 - Unexpected complex lesion in patient with STEMI
- Case presentation - J. Koolen
- How would I treat? - A. Iniguez
- How would I treat? - C.K. Naber
- How did I treat? - J. Koolen
- Discussion
- Consensus - S. Saito
▸ Take-home message - B. Chevalier
16:30-18:00 Room 253 Clinic
Abstract session
Non-invasive and invasive coronary imaging prior to PCI
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: J.J. Bax, R. Erbel, L. Lam
▸ Introduction - J.J. Bax
▸ Non-invasive evaluation of coronary flow reserve with transthoracic
doppler echocardiography predicts the presence of significant stenosis in
coronary arteries - I. Haraldsson
▸ High coronary calcium score assessed by multislice coronary computed
tomography does not predict the periprocedural outcome in patients
undergoing elective PCI - A. Ntalianis
▸ Evaluation of the diagnosis accuracy of coronary computed tomographic
angiography - W. Pimentel
▸ Complex assessment of coronary plaques using Cardio-computed
tomography multislice 64 and intravascular ultrasound - T. Benedek
▸ Does 3-dimensional quantitative coronary angiography confer additional
advantage over traditional 2-dimensional-quantitative coronary
angiography in the assessment of intermediate left main coronary artery
stenoses - a comparison with intravascular ultras - I. Porto
▸ Radiation dose of three diagnosis tests: myocardial perfusion
scintigraphy, invasive coronary angiography and cardiac computed
tomography - P. Sousa
▸ Take-home message - L. Lam
151
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page151
16:30-18:00 Room 341 Clinic
Abstract session
Acute coronary syndromes: risk stratification and outcomes
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: I. Kranjec
▸ Introduction - I. Kranjec
▸ Acute myocardial infarction: long-term predictive value of thrombolysis in
myocardial infarction (TIMI) and global registry of acute coronary events
global registry of acute coronary events (GRACE) risk scores - K. Jansen
▸ Early vs. delayed invasive strategy in patients with acute coronary
syndromes without ST-segment elevation: a meta-analysis of randomised
studies - E.P. Navarese
▸ Acute coronary syndrome in patients with non-obstructive coronary artery
disease: long-term prognosis - R. Rossini
▸ Acute myocardial infarction with normal coronary arteries: a benign
entity? - C. Jorge
▸ Impact of revascularisation on longer term survival of patients presenting
with troponin positive acute coronary syndrome: a real world experience
M.F. Khan
▸ Tomography angiography in acute coronary syndrome: the TIACS study
S. Hascoet
▸ Take-home message - I. Kranjec
16:30-18:00 Room 342AB
How should I treat?
How to overcome troubles in left main and bifurcations
With an unrestricted educational grant from ABBOTT VASCULAR and
CROSSROADS, the Abbott Vascular Education Network
Chairperson: T. Lefèvre
Objectives:
▸ To better understand the technical aspects of treating bifurcations
▸ To discuss the choice between bifurcation techniques and dedicated side
branch access stents
▸ To discuss the technicity of distal left main stenting
▸ Introduction and objectives - T. Lefèvre
▸ Difficulties in accessing the side branch
- Case presentation - E. Christiansen
- How would I treat? - O. Darremont
- How would I treat? - G. Stankovic
- How did I treat? - E. Christiansen
- Discussion
- Consensus - T. Lefèvre
Thursday 19th
152
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page152
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ A complex distal left main
- Case presentation - R. Albiero
- How would I treat? - O. Darremont
- How would I treat? - G. Stankovic
- How did I treat? - R. Albiero
- Discussion
- Consensus - T. Lefèvre
▸ Take-home message - T. Lefèvre
16:30-18:00 Room 343 Clinic
Abstract session
DES registries - Part II
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: L. Gonçalves
▸ Introduction - L. Gonçalves
▸ Xience V registry - Study of Xience V Everolimus-eluting and Vision
cobalt-chromium coronary stent - B. Berta
▸ Xience Nile, a prospective multicentre Egyptian real life Xience V stent
registry - H. Ragy
▸ Biodegradable polymer coated DES registry, with three-year follow-up
L. Mimish
▸ Clinical evaluation of the Everolimus drug-eluting coronary stent Xience V;
for the treatment of de novo coronary lesions in a real practice scenario -
multicentre international SPAREX registry - A. Iniguez
▸ e-BioMatrix PMS Registry - A post market surveillance registry for the
BioMatrixTM DES - P. Urban
▸ The DIVERGE trial (DES Intervention for treating side branches
effectively): three-year clinical results - P. Agostoni
▸ Take-home message - L. Gonçalves
153
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page153
16:30-18:30 Room 351 Evidence
Plenary session
Interactive meeting with the principal investigators of essential ongoing
or future clinical trials
Chairpersons: L. Mauri, T. Lüscher
Objectives:
▸ To provide in-depth understanding of trial design
▸ To expose potential trialists to first hand information
▸ To allow high level interactive questions and answers
▸ Introduction and objectives - L. Mauri
EXCEL
▸ Summary and status of the trial - P.W. Serruys, A.P. Kappetein
▸ Discussion
Euro SURTAVI
▸ Summary and status of the trial - P.W. Serruys, A.P. Kappetein
▸ Discussion
IBIS 4
▸ Summary and status of the trial - L. Räber, S. Windecker
▸ Discussion
TROFI
▸ Summary and status of the trial - P.W. Serruys, L. Thuesen
▸ Discussion
ABSORB Proof
▸ Summary and status of the trial - Y. Onuma
▸ Discussion
▸ Take-home message - T. Lüscher
Thursday 19th
154
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page154
Thu
rsday 1
9th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
16:30-18:00 Room 353 Clinic
Abstract session
Risk of stent thrombosis and new generation DES
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: M. Strozzi
▸ Introduction - M. Strozzi
▸ Incidence of stent thrombosis in two large registries in Europe and Japan:
a patient level data analysis from the Bern-Rotterdam and J-CYPHER
registries - Y. Onuma
▸ Biodegradable polymers, dual antiplatelet therapy and very late stent
thrombosis: review of Nobori 2 study - G.B. Danzi
▸ Impact of stent thrombosis on clinical outcomes among patients
undergoing PCI with newer generation DES - G.G. Stefanini
▸ Thrombosis in real practice with second generation DES in special
settings: myocardial infarction and left main coronary artery - results from
the ESTROFA-2 Spanish registry - J.M. De La Torre Hernandez
▸ Clinical performance of DES with biodegradable polymeric coating, a
meta-analysis and systematic review - T. Ahmed
▸ Safety of dual antiplatelet therapy interruption after Resolute stent
implantation: an Italian multicentre observational evaluation
A. Tommasino
▸ Take-home message - M. Strozzi
155
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page155
09:00-13:00 Main arena Evidence
Main session
Cardiovascular interventions: intercontinental crossfire - With LIVE from
Asia-Pacific
Chairpersons: P.W. Serruys, M.B. Leon, R. Ng
Panellists : S. Aziz, P. Chandra, M. Deshpande, J. Fajadet, J. Gao, M. Kimura,
T.H. Koh, Y.L. Lim, J. Marco, O. Mendiz, P. Sergeant, M. Thomas, P. Wong
Objectives:
▸ To highlight the contribution of the Asia-Pacific region to the present and
future of the field
▸ To comprehend worldwide variations in the delivery of life-saving PCI
▸ To understand how the future of cardiovascular interventions worldwide
will be influenced by intercontinental cross-talk
▸ Introduction and objectives - P.W. Serruys
09:05-10:00 Live demonstration from Cardiovascular Institute and Fu Wai
Hospital, Beijing - China
▸ Keynote lecture - Treatment of STEMI in the Asia-Pacific region - P. Wong
▸ Keynote lecture - PCI or CABG for myocardial revascularisation in the
Asia-Pacific region - Y.L. Lim
▸ Intercontinental crossfire discussion
11:15-12:15 Live demonstration from Cardiovascular Institute and Fu Wai
Hospital, Beijing - China
▸ Keynote lecture - Evolving trends in the treatment of structural heart
disease - my vision - M.B. Leon
▸ International crossfire discussion
▸ The world is flat and education is the solution! - R. Ng, J. Marco
▸ Final key remarks and take-home message - P.W. Serruys
Presentation of the 2011 Ethica Award - P.W. Serruys
Friday 20th
156
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page156
Friday 2
0th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
09:00-12:30 Theatre Bleu
Forum
Complication forum
Chairpersons: S.T. Lim, E. Eeckhout
Panellists: A. Erglis, J.B. Ge, T. Lefèvre, M.A. Rosli, T. Santoso
Objectives:
▸ To learn how to anticipate and treat common complications during PCI
▸ To demonstrate exceptional complication cases
▸ To show novel techniques to treat these complications
▸ Introduction - S.T. Lim
▸ Case 1 - A. Panneerselvam
▸ Case 2 - Y. Watanabe
▸ Case 3 - G. Aprigliano
▸ Case 4 - C.A. Murphy
▸ Case 5 - M. Bedossa
▸ Case 6 - I. Ntarladimas
▸ Case 7 - M. Cardenas Manilla
▸ Conclusion - E. Eeckhout
09:00-12:30 Theatre Havane Technique
LTT - How to treat a patient with coronary chronic total
occlusion
Facilitators: N. Reifart, D. Tchétché, G. Werner
Panellists: S. Kedev, A. Mehta, C. Wolf
Media driver: F. Mangiacapra
Live in-a-box® from Medizinische Klinik I, Darmstadt - Germany
157
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page157
09:10-12:10 Room 342AB Evidence
Hot Line session
Late breaking registries and trial updates
Chairpersons: C. Di Mario, M. Sabate, D.O. Williams
▸ Lower mortality with transradial PCI compared to transfemoral PCI in
14,000 patients with acute myocardial infarction - Results from the
SCAAR database - G. Olivecrona
▸ Cost-effectiveness and public health/budget - Impact of fractional flow
reserve-guided PCI in multivessel patients in Europe - Analysis of the
FAME study data - U. Siebert
▸ PROTECT II: prospective multicentre trial comparing Impella to intra-aortic
balloon pump in high-risk PCI - W. O'Neill
▸ One-year clinical outcome of the 2,000 patients enrolled in the coronary
angioplasty with the Titan2 bioactive stents in acute myocardial infarction
(CATS-AMI) registry - M. Angioi
▸ The Nevo RES-ELUTION I study, a randomised multicentre comparison of the
Nevo reservoir-based sirolimus-eluting stent with the Taxus Liberté
paclitaxel-eluting stent - First presentation of 2-year outcomes - C. Spaulding
▸ Nobori 1, phase 1, final 5-year results - B. Chevalier
▸ Five-year clinical outcomes of a polymer-free sirolimus-eluting stent
versus a polymer-based paclitaxel-eluting stent - The ISAR-test trial
L. King
▸ Five-year follow-up of diabetes trial: the final results - P. Jimenez-Quevedo
▸ A prospective multicentre registry, evaluating a real world usage of the
Tryton side branch stent: results of the e-Tryton study - P. Stella
▸ Nine-month clinical and angiographic clinical and angiographic follow-up
of de novo coronary bifurcation lesions treated with the novel Nile Pax
dedicated bifurcation polymer-free paclitaxel-coated stent: results from
the prospective multicentre, non-randomised BIPAX clinical trial
B. Garcia Del Blanco
▸ Long-term follow-up after treatment of coronary in-stent restenosis with a
paclitaxel-coated balloon catheter - Paccocath ISR I/II - B. Scheller
▸ Impact of the everolimus-eluting stent on stent thrombosis and adverse
cardiac events: a meta-analysis of 10 randomised trials including 16,593
patients - U. Baber
▸ Biodegradable polymer versus durable polymer drug-eluting stents for
patients with coronary artery disease: 3 years pooled analysis of
individual patient data from the ISAR-TEST 4, LEADERS and ISAR-TEST 3
randomised trials - R. Byrne
▸ Treatment with the Resolute zotarolimus-eluting stent in subjects with
diabetes mellitus: pooled analysis from the Resolute clinical programme
L. Mauri
▸ Final 1 year outcomes of more than 2,300 patients in the SOURCE registry
O. Wendler
Friday 20th
158
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page158
Friday 2
0th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ SPIRIT WOMEN randomised clinical trial - S. Windecker
▸ Clinical outcomes of MitraClip therapy in high-risk patients and in
functional mitral regurgitation patients: results of the EVEREST clinical
trial - T. Feldman
▸ Left atrial appendage closure and the PROTECT AF trial: results at 1,500
patient-years of follow-up - S. Kar
▸ FRANCE II - FRench Aortic National CoreValve and Edwards registry
M. Gilard
▸ A weighted meta-analysis of early and late clinical outcomes after
CoreValve percutaneous aortic valve replacement in seven national
registries - C. Ruiz
09:30-11:00 Room 242A Evidence
Plenary session
2010 ESC - EACTS guidelines on myocardial revascularisation: some
debated issues - A case-based discussion
Chairpersons: P. Kolh, W. Wijns
Panellists: K. Huber, M. Ostojic, J.L. Pomar, F. Ribichini, S. Silber
Objectives:
▸ To discuss to which extent guidelines apply to "real life" cases
▸ To understand barriers to guideline implementation
▸ To review some debated issues such as ad hoc PCI or preferred mode of
revascularisation for proximal left anterior descending stenosis
▸ Introduction and objectives - W. Wijns
▸ Case presentation 1 - Severe and calcified coronary artery disease.
Indication for "ad hoc" PCI or deferred revascularisation - F. Ribichini
▸ Panel discussion & audience interaction
▸ Case presentation 2 - Revascularisation strategy in hemodynamically
unstable patient with acute coronary syndrome - A.J. Peace
▸ Panel discussion & audience interaction
▸ Case presentation 3 - Complex proximal left anterior descending stenosis:
ad hoc or defer? Stent or internal mammary artery? - E. Sorbets
▸ Panel discussion & audience interaction
▸ Take-home message - P. Kolh
159
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page159
09:30-10:30 Room 242B
Forum
India meets EuroPCR
Facilitators: A. Colombo, E. Grube, P. Urban
Panellists: N. Deshpande, S.M. Kalarickal, K. Prathap
09:30-11:00 Room 243 Technique
Abstract session
Imaging DES results: optical coherence tomography and other techniques
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: E. Regar
▸ Introduction - E. Regar
▸ Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap
segments in DES 9-13 months after implantation: in vivo-assessment with
optical coherence tomography - J.L. Gutiérrez-Chico
▸ Optical coherence tomography assessment of the acute effect of high-
pressure non-compliant balloon postdilation on underexpansion and
malapposition in DES - T. Adriaenssens
▸ Does a last generation thin-strut DES produce a better vascular response
compared with a first generation thick-strut DES? - H. Ikejima
▸ Arterial repair 4 to 8 months after Zotarolimus-eluting Endeavor stent
implantation: angioscopic evaluation in patients - T. Ishihara
▸ Angioscopic assessment of arterial repair of biodegradable
polymer-coated Biolimus A9-eluting stent: comparison with durable
polymer-coated Sirolimus-eluting stent in patients - M. Awata
▸ Impact of arterial injury on neointimal hyperplasia after Zotarolimus-
eluting stent implantation: an IVUS study - C. Collet
▸ Take-home message - E. Regar
09:30-11:00 Room 251 Clinic
Abstract session
PCI outcomes in specific patient subsets
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: I. Al-Rashdan, A. Chieffo, G. Pedrazzini
Friday 20th
160
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page160
Friday 2
0th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction - I. Al-Rashdan
▸ Gender disparity in 7,545 consecutive patients undergoing PCI - analysis
from a single university centre - R. Jibran
▸ PCI in women - clinical and angiographic differences - in-hospital results
M. Cantarelli
▸ Gender difference in the effect of obesity on prognosis for patients
undergoing PCI - Z.J. Wang
▸ Clinical and angiographic outcomes following PCI with DES in patients of
chronic kidney disease - H. Takimura
▸ The increasing cohort of patients older than 85 years: challenges for
intervention cardiologists - N. Cabanelas
▸ The impact of anemia on long-term clinical outcome in patients
undergoing PCI - T. Pilgrim
▸ Take-home message - G. Pedrazzini
09:30-11:00 Room 253 Clinic
Abstract session
Evaluation of thrombus aspiration during primary PCI in STEMI patients
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: M. Sobhy, T. Mabin
▸ Introduction - M. Sobhy
▸ Clinical impact of thrombus aspiration during primary PCI: results from
Korea acute myocardial infarction registry - D. Hachinohe
▸ Aspiration thrombectomy during primary PCI as adjunctive therapy to
early (in-ambulance) abciximab administration in patients with acute
STEMI - T. Ahmed
▸ Effectiveness of thrombectomy using the export aspiration catheter during
primary PCI in STEMI - P. Anthopoulos
▸ Thrombus aspiration with a tip-cut balloon angioplasty catheter may be
useful in young patients with STEMI - M. Celik
▸ Combined intracoronary Tirofiban and manual thrombus extraction during
primary PCI in patients with STEMI - D. Natarajan
▸ Thrombectomy vs. no thrombectomy before stenting in acute myocardial
infarction: an optical coherence tomographic evaluation - M. Magro
▸ Take-home message - T. Mabin
161
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page161
09:30-11:00 Room 341 Clinic
Plenary session
Cardiogenic shock: an update
With the collaboration of the Working Group on Acute
Cardiac Care of the European Society of Cardiology
Chairpersons: C.J. Vrints, H. Bueno
Panellists: D. Ardissino, R.J. de Winter, R. Ferrari, S. Savonitto, M. Tubaro,
P. Vranckx
Objectives:
▸ To provide an update on:
- the diagnosis and therapeutic management of patients presenting with
cardiogenic shock
- the pharmacological management of patients with cardiogenic shock
- the preferred revascularisation strategy in patients with cardiogenic shock
- the available systems for hemodynamic support: indications and results
▸ Introduction and objectives - C.J. Vrints
▸ Case 1: a patient with an anterior wall STEMI with a cardiogenic shock
with multivessel disease. PCI vs. CABG? - H. Bueno
▸ Lecture 1: revascularisation in cardiogenic shock - C.J. Vrints
▸ Case 2: a patient with a recent myocardial infarction presenting with
cardiogenic shock and a systolic heart murmur - H. Thiele
▸ Lecture 2: role of non-invasive imaging and cardiogenic shock - J.J. Bax
▸ Case 3: a patient with persisting cardiogenic shock after rescue PCI and
intra-aortic balloon pump placement - P. Vranckx
▸ Lecture 3: hemodynamic support - J. Henriques
▸ Take-home message - H. Bueno
09:30-11:00 Room 343 Technique
Forum
Complications encountered during coronary chronic total occlusion
interventions
Session comprising selected EuroPCR 2011 complication submissions
Chairpersons: A. Galassi, J. Chen
STENT
FOR LIFE
Friday 20th
162
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page162
Friday 2
0th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
▸ Introduction - A. Galassi
▸ Delayed perforation (after 2 hrs) of 1st retrograde coronary chronic total
occlusion recanalisation in Bangladesh - K.N. Khan
▸ Coronary artery perforation and dissection during a long and uncrossable
balloon coronary chronic total occlusion PCI using multiple parallel wire
technique and tornus - M. Mohandes
▸ Dilation of the septal collateral artery and subsequent cardiac tamponade
during retrograde PCI using a microcatheter for coronary chronic total
occlusion - H. Hashidomi
▸ Coronary dissection of donor artery in retrograde approach for coronary
chronic total occlusion PCI is a fatal complication, but a procedure could
succeed through this complication - Y. Hamazaki
▸ The nightmare of donor artery closure not once but twice during
retrograde technique - P.K. Goel
▸ Take-home message - J. Chen
09:30-11:00 Room 351 Clinic
Forum
Treating left main: when every minute counts
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: F. Mauri, D. Hasdai
▸ Introduction - F. Mauri
▸ He is still alive - M. Nab
▸ Reposition and correction of stent disarrange during left main stenting
C. Costantini
▸ Rescue PCI using rotational atherectomy for left main ostial lesion in a
cardiogenic shock octogenarian - L.W. Chen
▸ NSTEMI with cardiogenic shock due to ostial left main stenosis - A. Fleig
▸ Planned bifurcation angioplasty complicated by a broken stent and an
extensive dissection of the left main - S. Manzo-Silberman
▸ Take-home message - D. Hasdai
163
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page163
09:30-11:00 Room 352AB Technique
Forum
Complications encountered during secondary revascularisation
Session comprising selected EuroPCR 2011 complication submissions
Chairpersons: J. Escaned, A. Ernst
▸ Introduction - J. Escaned
▸ The predicament of saphenous vein graft - R. Sachdeva
▸ A case of stent occlusion after removal of a stuck buddy wire and a
balloon at PCI for in-stent restenosis - T. Iwaki
▸ Unravelling a DES - a tentative to retrieve a dislodged coronary stent
A. Burlacu
▸ Left main coronary artery aneurysm with thrombotic ostial stenosis 2
years after implantation of paclitaxel eluting stents - M. Schroeder
▸ CABG pseudoaneurysm as a late-complication after percutaneous
intervention: successful treatment with covered stents - O. Breithardt
▸ Take-home message - A. Ernst
09:30-11:00 Room 353 Technique
Forum
Unusual PCI complications - Part II
Session comprising selected EuroPCR 2011 complication submissions
Chairpersons: J.J. Piek, P. Avraamides
▸ Introduction - J.J. Piek
▸ Acute bypass intervention: aortic dislocation and retrieval of a coronary
stent - M. Möckel
▸ A case of severe stent shortening - J. Bennett
▸ A case of cuting balloon rupture causing unwrapped blades from right
radial artery approach managed successfully - R. Anantharaman
▸ Successful treatment of jailed guidewire rupture after left anterior
descending PCI, complicated by left main dissection, acute stent
thrombosis and retroperitoneal bleeding: it never rains but it pours
F. Economou
▸ Recurrent left anterior descending perforation management - S. Mansour
▸ Take-home message - P. Avraamides
Friday 20th
164
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page164
Friday 2
0th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
10:30-11:30 Room 242B
Forum
South Korea meets EuroPCR
Facilitators: M. Buchbinder, M.C. Morice
Panellists: H.S. Kim, S.J. Park
11:00-12:30 Room 242A Clinic
Abstract session
Percutaneous mitral valve intervention from balloon to replacement
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: O. Franzen, F. Maisano, K.H. Srinivasa
▸ Introduction - O. Franzen
▸ Inoue technique for balloon mitral valvuloplasty in patients with
uncomplicated mitral stenosis - M. Zufarov
▸ Inoue balloon versus single balloon techniques in mitral valvuloplasty:
long-term follow-up - E. Peixoto
▸ Percutaneous mitral valvuloplasty clinical efficacy of balloon sizing based
on echocardiographic commissural diameter - A. Zahedmehr
▸ A post market study of the MitraClip system for the treatment of mitral
regurgitation in Europe: analysis of outcomes in a 6-month patient cohort
W. Schillinger
▸ Percutaneous mitral valve repair with the MitraClip system: 30-day
outcome in the initial Milan experience - C. Godino
▸ Antegrade transcatheter mitral valve implantation: a short-term experience
in swine model - A. Quadri
▸ Take-home message - K. Srinivasa
11:00-12:00 Room 243 Evidence
Abstract session
Randomised clinical trials - Update
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: M.W. Krucoff, J. Belardi
▸ Introduction - M.W. Krucoff
▸ The platinum small vessel trial: evaluation of the novel thin-strut platinum-
chromium promus element small vessel everolimus-eluting stent
I. Meredith
▸ Two-year reports of efficacy and safety end points from the randomised,
multicentre and controlled Eucatax trial - J. Mieres
▸ Pooled analysis of the Resolute programme clinical safety results
L. Mauri
▸ Take-home message - J. Belardi
165
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page165
11:00-12:00 Room 251 Clinic
Forum
Management of giant coronary aneurysms
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: M. de Belder, V. Legrand
▸ Introduction - M. de Belder
▸ Two cases of giant coronary aneurysm of the left coronary artery
bifurcation - S.E. Lee
▸ Exclusion of right coronary artery aneurysm with pericardial stent, within
drug-eluting stent - D. Austin
▸ Large mycotic coronary pseudoaneurysm and drug eluting stent fracture
P. Jimenez-Quevedo
▸ Take-home message - V. Legrand
11:00-12:30 Room 253 Clinic
Abstract session
Is stent thrombosis still an issue?
Session comprising selected EuroPCR 2011 abstract submissions
Chairperson: A.C.Y. Yeung
▸ Introduction - A.C.Y. Yeung
▸ Acute stent thrombosis resulting in STEMI is associated with worse
clinical outcomes than STEMI, due to native coronary thrombosis - T. Pain
▸ Incidence and predictors of coronary stent thrombosis: evidence from an
international collaborative meta-analysis including 30 studies, 225,536
patients and 4,203 thromboses - F. D'Ascenzo
▸ Prevalence of hyporesponsiveness to aspirin and clopidogrel in patients
with stent thrombosis: is it time for tailored therapy? - N. Sambu
▸ Incidence, predictors and outcome of stent thrombosis - up to 8-year
follow-up in real-world patients undergoing DES implantation - R. Costa
▸ Evaluating the safety of very short-term dual antiplatelet therapy after
Genous stent implantation: the multicentre pilot GENOUS trial
G.M. Sangiorgi
▸ Late and very late coronary stent occlusion: intravascular ultrasound
analysis of a series of consecutive patients - F. Ribichini
▸ Take-home message - A.C.Y. Yeung
Friday 20th
166
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page166
Friday 2
0th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
11:00-12:30 Room 341 Innovation
Abstract session
New stent technology and first-in-man
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: A. Lansky, C. Young
▸ Introduction - A. Lansky
▸ First-in-man, multicentre assessment of the novel Acrobat Svelt balloon-
expandable stent-on-a-wire system - J.R. Costa Jr
▸ Randomised comparison of the efficacy and safety of a novel DES with
biodegradable polymer and cobalt-chromium alloy - Inspiron I trial
E.E. Ribeiro
▸ Preliminary results of the multicentric, double-blinded, randomised,
Vestasync II trial - J.R. Costa Jr
▸ One-year follow-up of the ProNOVA XR polymer free Sirolimus-eluting
coronary stent system in the treatment of patients with de novo coronary
artery lesions: the EURONOVA study - J. Legutko
▸ First-in-man experience with the DES Orsiro in the treatment of patients
with single de novo coronary artery lesions (BIOFLOW-I) - M. Hamon
▸ De novo coronary lesions treated with the novel polymer-free Biolimus-A9
coated stents: four- and twelve-month angiographic results from the
prospective, randomised, multicentre BIOFREEDOM clinical trial
R. Costa
▸ Take-home message - C. Young
11:00-12:30 Room 343 Technique
Forum
Coronary chronic total occlusion: current techniques - Part II
Session comprising selected EuroPCR 2011 clinical case & complication
submissions
Chairpersons: E. Barbato, G. Sianos
▸ Introduction - E. Barbato
▸ STEMI as a complication of retrograde chronic total occlusion
recanalisation - R. Sachdeva
▸ Corsair tip-in rendezvous technique is useful for every interventionist
M. Atsushi
▸ Successful use of the GuideLiner catheter in a chronic total occlusion case
A. Ntatsios
▸ A case of successful coronary chronic total occlusion intervention utilising
CrossBoss and Stingray - M. Chan
▸ False lumen stenting - the sword of Damocles - T. Koppara
▸ Take-home message - G. Sianos
167
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page167
11:00-12:30 Room 351 Clinic
Forum
Role of non-invasive imaging in PCI
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: V. Schächinger, J. Schofer
▸ Introduction - V. Schächinger
▸ Large perfusion defect on scintigraphy - explained by severe
microcirculatory dysfunction - F. Cuculi
▸ Cardiovascular magnetic resonance to guide revascularisation in acute
coronary syndromes - E. McAlindon
▸ The role of cardiovascular magnetic resonance in troponin positive acute
coronary syndromes with unobstructed coronary arteries - E. McAlindon
▸ Recurrent Takotsubo cardiomyopathy in a 78 year-old lady -
characterisation using cardiac magnetic resonance imaging and the index
of microcirculatory resistance - F. Cuculi
▸ Pre-catheterisation treatment planning using coronary computed
tomography angiography and computational assessment of fractional
flow reserve - B.K. Koo
▸ Take-home message - J. Schofer
11:00-12:00 Room 353 Clinic
Forum
TAVI complications - Part II
Session comprising selected EuroPCR 2011 complication submissions
Chairperson: U. Gerckens
▸ Introduction - U. Gerckens
▸ Corevalve embolisation causing catastrophic coronary obstruction
C. Eftychiou
▸ Successful reposition by snaring of a corevalve prosthesis eight days after
implantation to correct severe aortic regurgitation - A. Medina
▸ Severe aortic regurgitation following Medtronic core-valve implantation
V. Voudris
▸ Take-home message - U. Gerckens
Friday 20th
168
Don’t forget to check the Training programme, page 170.
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page168
Friday 2
0th
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
11:30-12:30 Room 242B
Forum
Russia meets EuroPCR
With the collaboration of the Russian Scientific Society of Interventional
Cardioangiology (RSICA)
Facilitators: H. Eltchaninoff, D. Iosseliani
Participant: S. Semitko
Panellists: V. Ganyukov, K. Niemela, A. Osiev
12:00-13:00 Room 251 Clinic
Forum
Solutions for coronary spasm
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: A. Lerman, M.J. Kern
▸ Introduction - A. Lerman
▸ Devastating coronary spasm - A. Javed
▸ Severe coronary artery vasospasm appearing as severe 3 vessel disease
causing cardiogenic shock - M.J. Jaluague
▸ A case in which cardiopulmonary arrest occurred during PCI for the
chronic total occlusion of right coronary artery - F. Hajime
▸ Take-home message - M.J. Kern
13:00-14:00 Main arena
Main session
Presentation of 2011 EuroPCR/EAPCI awards
and closing ceremony
Chairperson: W. Wijns
Panellists: J. Marco, P.W. Serruys, J. Fajadet, M.C. Morice,
B. De Bruyne, A. Vahanian, M. van Sambeek, E. Eeckhout, A. Cremonesi,
H. Sievert, D. Scheinert, C. Ruiz, P. Bonhoeffer, T.H. Koh, M. Thomas
▸ Introduction - W. Wijns
▸ 2011 EuroPCR innovation award - S. Windecker
▸ Best abstract - J. Fajadet
▸ Abstract presentation by the awardee
▸ Best clinical case - A. Baumbach
▸ Case presentation by the awardee
▸ Most educational complication case - E. Eeckhout
▸ Case presentation by the awardee
▸ EAPCI training awards - C. Di Mario
▸ Closing remarks - P.W. Serruys
169
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page169
Training villag
e - Level 3
Corona
ry and
stru
ctural hea
rt disease
Nurses & te
chnician
s
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
8h30
Vascular closure
p. 173
Bifurcation lesions
p. 173
Tuesday 17
th
CORDIS CARDIAC
& VASCULAR INSTITUTE
CROSSROADS, The Abbott
Vascular Education Network
EDWARDS LIFESCIENCES
MEDTRONIC ACADEMIA
ST. JUDE MEDICAL
Radial approach
p. 173
AMI for nurses
p. 227
Bifurcation lesions
p. 174
Transcatheter heart valves
p. 174
Transcatheter heart valves
p. 174
MVD
p. 174
Hemostasis
management
p. 175
Hemostasis
management for
nurses
p. 227
Hemostasis
management
for nurses
p. 227
Hemostasis
management for
nurses
p. 227
Training villag
e - Level 3
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page170
Coro
nary a
nd
structu
ral h
eart d
isease
Corona
ry and
stru
ctural hea
rt disease
Nurses & te
chnician
sTraining villag
e - Level 3
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
8h30
Vascular closure
p. 175
Radial approach
p. 175
Wednesday 18th
CORDIS CARDIAC
& VASCULAR INSTITUTE
CROSSROADS, The Abbott
Vascular Education Network
EDWARDS LIFESCIENCES
MEDTRONIC ACADEMIA
ST. JUDE MEDICAL
Bifurcation lesions
p. 176
Intracardiac echocardiography in TAVI
p. 176
Vascular closure
p. 175
AMI for nurses
p. 228
CTO
p. 177
Transcatheter heart valves
p. 177
Transcatheter heart valves
p. 177
MVD
p. 178
FFR for physicians
p. 178
STEMI
p. 176
Transcatheter heart valves
p. 177
Transcatheter heart valves
p. 177
Transcatheter heart valves
p. 177
Bifurcation lesions
p. 177
MVD
p. 178
MVD for nurses
p. 228
AMI for nurses
p. 228
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for physicians
p. 178
FFR for physicians
p. 178
FFR for physicians
p. 178
FFR for physicians
p. 178
Train
ing
village
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page171
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
8h30
TAVI
p. 183
Friday 20th
MEDTRONIC ACADEMIA
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
8h30
Radial approach
p. 179
FFR for nurses
p. 229
AMI
p. 180
CORDIS CARDIAC
& VASCULAR INSTITUTE
CROSSROADS, The Abbott
Vascular Education Network
EDWARDS LIFESCIENCES
MEDTRONIC ACADEMIA
ST. JUDE MEDICAL
Vascular closure
p. 179
Intracardiac echocardiography
in TAVI
p. 179
Radial approach
p. 180
CTO
p. 180
Bifurcation lesions
p. 181
AMI
p. 180
Transcatheter heart valves
p. 181
Transcatheter heart valves
p. 181
Transcatheter heart valves
p. 181
Transcatheter heart valves
p. 181
TAVI
p. 182
TAVI
p. 182
TAVI
p. 182
TAVI
p. 182
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
FFR for nurses
p. 229
OCT for physicians
p. 182
OCT for physicians
p. 182
OCT for physicians
p. 182
OCT for physicians
p. 182
OCT for physicians
p. 182
Training villag
e - Level 3
Thursday 19th
Corona
ry and
stru
ctural hea
rt disease
Nurses & te
chnician
s
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page172
Coro
nary a
nd
structu
ral h
eart d
isease
173
Tuesday 17th May
Room CORDIS CARDIAC & VASCULAR INSTITUTE
13:00-14:00 Training Village
Vascular closure with ExoSeal
With an unrestricted educational grant from CORDIS CARDIAC
& VASCULAR INSTITUTE
Trainer: M. el Omar
Objectives:
▸ To be able to discuss the pros and cons of vessel closure devices
▸ To understand how to reduce the risk of bleeding complications following
vessel closure
▸ To complete at least one vessel closure procedure with a training tool
14:30-16:00 Training Village
The challenge of treating bifurcation lesions
With an unrestricted educational grant from CORDIS CARDIAC
& VASCULAR INSTITUTE
Trainers: M. Ferenc, J.F. Lassen, G. Stankovic
Objectives:
▸ To provide delegates with the latest information on the treatment of
bifurcation lesions
▸ To provide practical sessions incorporating both bench models and
simulators to evaluate the various bifurcation techniques
16:30-18:00 Training Village
Radial approach for coronary diagnostic and interventions
With an unrestricted educational grant from CORDIS CARDIAC
& VASCULAR INSTITUTE
Trainers: T. Comberg, L. Hellsten
Objectives:
▸ To share the pros and cons of radial versus femoral approach
▸ To understand the technique of radial artery puncture, sheet insertion and
the different steps to successfully reach the coronary ostium access
▸ To review the evidence on radial approach for coronary interventions
Train
ing
village
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page173
Room CROSSROADS, the Abbott Vascular Education Network
16:00-18:00 Training Village
Strategies for treatment of bifurcated lesions - Hands-on session
With an unrestricted educational grant from CROSSROADS, the Abbott
Vascular Education Network
Trainers: M. De Benedictis, G. Stankovic
Objectives:
▸ To give an update on how to build a bifurcation procedure strategy based
on patient assessment
▸ To give an update on procedure techniques and device choices
▸ To provide hands-on experience on hybrid flow models
Room EDWARDS LIFESCIENCES
15:00-16:30 Training Village
16:30-18:00
Transcatheter heart valves for patients with severe aortic stenosis
With an unrestricted educational grant from EDWARDS LIFESCIENCES
Trainers: A. Cribier, D. Himbert
Objectives:
▸ To provide a review of TAVI procedure steps, as well as valve and delivery
system preparation
▸ To train on new generation transfemoral and transapical delivery systems
using simulators with real cases examples
▸ To provide educational materials on patient screening, selection and
referral materials
Room MEDTRONIC ACADEMIA
15:00-17:00 Training Village
Multivessel disease
With an unrestricted educational grant from MEDTRONIC ACADEMIA
Trainers: M. Heigert, P. Joly, P. Musialek, M. Oberhoff
Objectives:
▸ To review simulated case scenarios integrating Syntax
score/Euroscore/fractional flow reserve
▸ To discuss and plan treatment strategy with peers and experts
▸ To implement the chosen strategy during the simulation session
174
Training village
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page174
Train
ing
village
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
175
Room ST JUDE MEDICAL
12:30-13:30 Training Village
Hemostasis management
With an unrestricted educational grant from ST. JUDE MEDICAL
Trainers: A. Bortone, G.M. Sangiorgi
Objectives:
▸ To highlight the benefits of combined use of vascular closure devices and
bivaluridine in clinical practice
▸ To provide scientific evidence through research analysis of the
performance of intra and extra vascular closure devices
Wednesday 18th May
Room CORDIS CARDIAC & VASCULAR INSTITUTE
09:00-10:00 Training Village
17:00-18:00
Vascular closure with ExoSeal
With an unrestricted educational grant from CORDIS CARDIAC
& VASCULAR INSTITUTE
Trainer: M. el Omar
Objectives:
▸ To be able to discuss the pros and cons of vessel closure devices
▸ To understand how to reduce the risk of bleeding complications following
vessel closure
▸ To complete at least one vessel closure procedure with a training tool
10:30-12:00 Training Village
Radial approach in challenging cases
With an unrestricted educational grant from CORDIS CARDIAC
& VASCULAR INSTITUTE
Trainers: Y. Louvard, J. Nolan
Objectives:
▸ To share the pros and cons of radial versus femoral approach
▸ To review and discuss challenging cases and be able to understand
strategy options on radial approach
▸ To review the evidence on radial approach for coronary interventions
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page175
13:30-15:00 Training Village
The challenge of treating bifurcation lesions
With an unrestricted educational grant from CORDIS CARDIAC
& VASCULAR INSTITUTE
Trainers: M. Ferenc, J.F. Lassen, G. Stankovic
Objectives:
▸ To provide delegates with the latest information on the treatment of
bifurcation lesions
▸ To provide practical sessions incorporating both bench models and
simulators to evaluate the various bifurcation techniques
15:15-16:45 Training Village
Intracardiac echocardiography in TAVI: fast and easy - safe and simple
With an unrestricted educational grant from CORDIS CARDIAC
& VASCULAR INSTITUTE
Trainers: T. Bartel, L. Van Garsse, N. Vejlstrup
Objectives:
▸ To learn how and why use intracardiac echocardiography. Tips & tricks for
a quick navigation
▸ To learn how to acquire with intracardiac echocardiography the same
measurements as with transoesophageal echocardiography
▸ To learn how to perform the procedure faster and easier
▸ To learn how to perform the procedure safer and simpler
Room CROSSROADS, the Abbott Vascular Education Network
08:30-10:30 Training Village
Emergency strategies for acute myocardial infarction-STEMI
patients - Hands-on session
With an unrestricted educational grant from
CROSSROADS, the Abbott Vascular Education Network
Trainers: J. Greenwood, O. Varenne
Objectives:
▸ To give a short update on latest primary PCI procedure guidelines and
clinical practice
▸ To give an update on drug management pre-, per- and post-procedure
▸ To provide hands-on experience on simulators: an emergency scenario
developed for PCR
STENT
FOR LIFE
176
Training village
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page176
Train
ing
village
Coro
nary a
nd
structu
ral h
eart d
isease
Coronary and structural heart disease
177
11:00-13:00 Training Village
Strategies for treatment of bifurcated lesions - Hands-on session
With an unrestricted educational grant from CROSSROADS, the Abbott
Vascular Education Network
Trainers: M. De Benedictis, T. Lefèvre
Objectives:
▸ To give an update on how to build a bifurcation procedure strategy based
on patient assessment
▸ To give an update on procedure techniques and device choices
▸ To provide hands-on experience on hybrid flow models
16:00-18:00 Training Village
Strategies for coronary chronic total occlusion procedures - Hands-on
session
With an unrestricted educational grant from CROSSROADS, the Abbott
Vascular Education Network
Trainers: A. Serra, G. Werner
Objectives:
▸ To give a short review on how to build coronary chronic total occlusion
procedure strategies based on patient assessment
▸ To give an update on procedure techniques and device choices
▸ To provide hands-on experience on hybrid flow models
Room EDWARDS LIFESCIENCES
08:30-10:00 Training Village
10:30-12:00
12:30-14:00
14:30-16:00
16:30-18:00
Transcatheter heart valves for patients with severe aortic stenosis
With an unrestricted educational grant from EDWARDS LIFESCIENCES
Trainers: H. Eltchaninoff, E. Garcia, M. Kasel, K. Spargias,
P. Wenaweser
Objectives:
▸ To provide a review of TAVI procedure steps, as well as valve and delivery
system preparation
▸ To train on new generation transfemoral and transapical delivery systems
using simulators with real cases examples
▸ To provide educational materials on patient screening, selection and
referral materials
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page177
Training village
178
Room MEDTRONIC ACADEMIA
09:00-11:00 Training Village
11:30-13:30
Multivessel disease
With an unrestricted educational grant from MEDTRONIC ACADEMIA
Trainers: J. Goicolea, P. Joly, M. Heigert, J. Koolen, V. Ninios, F. Tarantino,
F. Tomai, C. Wolf
Objectives:
▸ To review simulated case scenarios integrating Syntax
score/Euroscore/Fractional flow reserve
▸ To discuss and plan treatment strategy with peers and experts
▸ To implement the chosen strategy during the simulation session
Room ST JUDE MEDICAL
09:30-10:45 Training Village
11:00-12:15
14:00-15:15
15:30-16:45
PCI optimisation- fractional flow reserve - Case discussions through
virtual reality cases and wetlab demonstrations
With an unrestricted educational grant from ST. JUDE MEDICAL
Trainer: C. Vermeire
Objectives:
▸ To provide expertise on fractional flow reserve as an exact and effective
method to measure the hemodynamic impairment induced by a coronary
lesion
▸ To improve daily clinical practice through a more accurate decision
process
12:30-13:30 Training Village
PCI optimisation: fractional flow reserve - Practical tips & tricks: case
review session
With an unrestricted educational grant from ST. JUDE MEDICAL
Trainers: M. J. Kern, S.J. Park
Objectives:
▸ To spread awareness on fractional flow reserve wider indications and the
impact of the clinical evidence on the daily practice
▸ To present case studies showing the higher accuracy of fractional flow
reserve vs. IVUS in supporting the physician's decision-making process
for the treatment strategy
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page178
179
Coronary and structural heart disease
Coro
nary a
nd
structu
ral h
eart d
isease
Thursday 19th May
Room CORDIS CARDIAC & VASCULAR INSTITUTE
09:00-10:30 Training Village
Radial approach for coronary diagnostic and interventions
With an unrestricted educational grant from CORDIS CARDIAC
& VASCULAR INSTITUTE
Trainers: T. Comberg, L. Hellsten
Objectives:
▸ To share the pros and cons of radial versus femoral approach
▸ To understand the technique of radial artery puncture, sheet insertion and
the different steps to successfully reach the coronary ostium access
▸ To review the evidence on radial approach for coronary interventions
11:00-12:00 Training Village
Vascular closure with ExoSeal
With an unrestricted educational grant from CORDIS CARDIAC
& VASCULAR INSTITUTE
Trainer: M. el Omar
Objectives:
▸ To be able to discuss the pros and cons of vessel closure devices
▸ To understand how to reduce the risk of bleeding complications following
vessel closure
▸ To complete at least one vessel closure procedure at a training tool
13:00-14:30 Training Village
Intracardiac echocardiography in TAVI: fast and easy - safe and simple
With an unrestricted educational grant from CORDIS CARDIAC
& VASCULAR INSTITUTE
Trainers: T. Bartel, L. Van Garsse, N. Vejlstrup
Objectives:
▸ To learn how and why use intracardiac echocardiography. Tips & tricks for
a quick navigation
▸ To learn how to acquire with intracardiac echocardiography the same
measurements as with transoesophageal echocardiography
▸ To learn how to perform the procedure faster and easier
▸ To learn how to perform the procedure safer and simpler
Train
ing
village
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page179
Training village
180
15:00-16:30 Training Village
Radial approach in challenging cases
With an unrestricted educational grant from CORDIS CARDIAC
& VASCULAR INSTITUTE
Trainers: Y. Louvard, J. Nolan
Objectives:
▸ To share the pros and cons of radial versus femoral approach
▸ To review and discuss challenging cases and be able to understand
strategy options on radial approach
▸ To review the evidence on radial approach for coronary interventions
Room CROSSROADS, the Abbott Vascular Education Network
08:30-10:30 Training Village
16:30-18:30
Emergency strategies for acute myocardial
infarction-STEMI patients - Hands-on session
With an unrestricted educational grant from
CROSSROADS, the Abbott Vascular Education Network
Trainers: J. Greenwood, O. Varenne
Objectives:
▸ To give a short update on latest primary PCI procedures guidelines and
clinical practice
▸ To give an update on drug management pre-, per- and post-procedure
▸ To provide hands-on experience on simulators: an emergency scenario
developed for PCR
11:00-13:00 Training Village
Strategies for coronary chronic total occlusion procedures - Hands-on
session
With an unrestricted educational grant from CROSSROADS, the Abbott
Vascular Education Network
Trainers: E. Barbato, J. Spratt
Objectives:
▸ To give a short review on how to build coronary chronic total occlusion
procedure strategies based on patient assessment
▸ To give an update on procedure techniques and device choices
▸ To provide hands-on experience on hybrid flow models
STENT
FOR LIFE
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page180
181
Coronary and structural heart disease
Coro
nary a
nd
structu
ral h
eart d
isease
14:00-16:00 Training Village
Strategies for treatment of bifurcated lesions - Hands-on session
With an unrestricted educational grant from CROSSROADS, the Abbott
Vascular Education Network
Trainers: B. Farah, C.K. Naber
Objectives:
▸ To give an update on how to build a bifurcation procedure strategy based
on patient assessment
▸ To give an update on procedure techniques and device choices
▸ To provide hands-on experience on hybrid flow models
Room EDWARDS LIFESCIENCES
08:30-10:00 Training Village
10:30-12:00
14:30-16:00
16:30-18:00
Transcatheter heart valves for patients with severe aortic stenosis
With an unrestricted educational grant from EDWARDS LIFESCIENCES
Trainers: V. Bapat, A. Fabbri, M. Lins, G. Olivecrona, W. Wisser
Objectives:
▸ To provide a review of TAVI procedure steps, as well as valve and delivery
system preparation
▸ To train on new generation transfemoral and transapical delivery systems
using simulators with real cases examples
▸ To provide educational materials on patient screening, selection and
referral materials
Train
ing
village
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page181
Training village
182
Room MEDTRONIC ACADEMIA
09:00-11:00 Training Village
11:30-13:30
14:00-16:00
16:30-18:30
TAVI
With an unrestricted educational grant from MEDTRONIC ACADEMIA
Trainers: J. Bosmans, H. Danenberg, H. Eggebrecht, R. Hernandez Antolin,
H. Ince, A. Khattab, J. Kovac, A.S. Petronio, M. Spence, P. Wenaweser,
M. Zelizko
Objectives:
▸ To provide attendees with the opportunity to familiarise themselves with
the fundamentals and basic principles of TAVI using the CoreValve device
through presentations and simulation
▸ To understand CoreValve implantation technique by a step-by-step
approach using simulation sessions
▸ To discuss and plan implant strategies in different anatomical scenarios
with peers and experts
Room ST JUDE MEDICAL
09:30-10:45 Training Village
11:00-12:15
14:00-15:15
15:30-16:45
PCI optimisation- optical coherence tomography - Case discussions
through virtual reality cases
With an unrestricted educational grant from ST. JUDE MEDICAL
Trainer: C. Vermeire
Objectives:
▸ To discuss the usage of optical coherence tomography as a diagnostic tool
in different clinical cases
▸ To provide expertise on optical coherence tomography image reading
12:30-13:30 Training Village
PCI optimisation- optical coherence tomography focus
With an unrestricted educational grant from ST. JUDE MEDICAL
Trainers: T. Adriaenssens, T. Akasaka
Objectives:
▸ To discuss optical coherence tomography in acute coronary syndromes
▸ To understand and discuss the role of optical coherence tomography for
stent optimisation
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page182
183
Coronary and structural heart disease
Coro
nary a
nd
structu
ral h
eart d
isease
Friday 20th May
Room MEDTRONIC ACADEMIA
09:00-11:00 Training Village
TAVI
With an unrestricted educational grant from MEDTRONIC ACADEMIA
Trainers: L. Buellesfeld, H. Danenberg, J. Kovac
Objectives:
▸ To provide attendees with the opportunity to familiarise themselves with
the fundamentals and basic principles of TAVI using the CoreValve device
through presentations and simulation
▸ To understand CoreValve implantation technique by a step-by-step
approach using simulation sessions
▸ To discuss and plan implant strategies in different anatomical scenarios
with peers and experts
Train
ing
village
11T0768_PCRpocket_03_coro 18/04/11 12:10 Page183
scientific programme
Endovascular programme
PART II
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page185
10:00-11:00 Main arena Innovation
Main session
Welcome and live demonstration from Frankfurt
Chairperson: W. Wijns
Panellists: A. Cremonesi, T. Lüscher, C. Rihal, C. Ruiz,
P.W. Serruys, R. Whitbourn
With continuous live demonstration from CardioVascular Center Frankfurt -
Germany
▸ Introduction - W. Wijns
▸ Renal denervation: a new treatment option in hypertension and beyond?
T. Lüscher
11:00-12:30 Main arena
Main session
PCR Family: Innovation in education at work
Chairperson: W. Wijns
Panellists: E. Eeckhout, J.B. Ge, T.H. Koh, J. Marco,
M.C. Morice, R. Ng, P.W. Serruys, M. Thomas, A. Vahanian
▸ Introduction - W. Wijns
European Society of Cardiology: a word from the President - M. Komajda
PCR courses
▸ EuroPCR - W. Wijns
▸ AsiaPCR/SingLive - T.H. Koh
▸ PCR London Valves - M. Thomas
PCR communications
▸ PCRonline - A. Vahanian
▸ PCR Publishing: impact factors in the digital era - P.W. Serruys
▸ Percutaneous interventional cardiovascular medicine. The PCR-EAPCI
textbook - E. Eeckhout
PCR educative solutions - J. Marco
PCR trials - P.W. Serruys
EAPCI: vision of the future - J. Fajadet, EAPCI President-Elect 2011-2013
and the EAPCI President-Elect 2013-2015
Tuesday 17th
186
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page186
Tue
sday 1
7th
End
ova
scula
r
Endovascular
12:00-14:30 Room Maillot Break-out
Plenary session
What's new in endovascular interventions?
Chairperson: A. Cremonesi
Panellists: F. Ribichini, M. Roffi, D. Scheinert, M. van Sambeek
With continuous live demonstration from CardioVascular Center Frankfurt -
Germany
▸ Opening and introduction - A. Cremonesi
▸ Major steps in endovascular interventions in 2010/2011 - M. Roffi
▸ Endovascular Late breaking trials
- DESERVE study: diffusion weighted - magnetic resonance imaging based
evaluation of the effectiveness of endovascular clamping during carotid
artery stenting with the Mo.Ma device. Results from a prospective,
multicentre study - A. Cremonesi
- Transascending aortic approach for TAVI - a step toward cerebral protection
S. Papadatos
- MARIS - 1,000 patient superficial femoral artery registry - H. Krankenberg
- Drug-eluting balloon for the treatment of femoro-popliteal arterial disease:
mid-term results from a multicentre Italian registry - A. Micari
- CONNECT IDE study - chronic total occlusion crossing with the Wildcat
catheter - J.P. Pigott
- TriVascular Ovation - global clinical experience with a Novel, 14FR
abdominal stent graft system - H. Krankenberg
▸ Take-home message - A. Cremonesi
13:30-15:00 Room 242A Clinic
Abstract session
Carotid artery stenting patient and lesion characterisation
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: S. MacDonald, R. Vijayvergiya
▸ Introduction - S. MacDonald
▸ Sex-related differences in carotid plaque features: are men at higher risk of
carotid instability and inflammation? - G.M. Sangiorgi
▸ Comparison of angiography and computer tomography-angiography (CTA)
with B-flow (BF) ultrasound (US) in carotid stenoses: improved pre-interventional
evaluation of carotid stenoses by B-flow ultrasound - R. Macharzina
▸ Carotid artery stenting improves neurocognitive function only in severe
internal carotid occlusive disease with objective cerebral ischemia - M.S. Lin
▸ Plaque analysis of femoral and carotid atherectomy samples - I. Ott
▸ Treatment stratification of carotid artery stenosis: novel duplex-
sonographic velocity cut-off values - R. Macharzina
▸ Carotid artery ultrasound findings can predict intermediate and high
SYNTAX score patients - N. Ikeda
▸ Take-home message - R. Vijayvergiya 187
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page187
14:30-16:30 Room Maillot How to...
Plenary session
How to do endovascular interventions: imaging, vascular access and
equipment selection
Chairpersons: M. Schillinger, M. Roffi
Objectives:
▸ To define what imaging equipment is required for endovascular
interventions
▸ To learn about wires, catheters, stents and other devices
▸ To promote a basis of reasoning for selecting appropriate devices and
techniques
▸ To acquire tips & tricks for vascular access
▸ Introduction and objectives - M. Schillinger
▸ Imaging: what is necessary, what is helpful - R. Dave
▸ What materials do I need for endovascular interventions? - A. Schmidt
▸ Cross-over: tips & tricks - H. Krankenberg
▸ When and how to do antegrade femoral puncture? - T. Zeller
▸ Brachial and radial approach for peripheral interventions - P. Pattynama
▸ Popliteal and pedal approach - D. Scheinert
▸ Discussion
▸ Take-home message - M. Roffi
15:00-16:30 Room 253 Clinic
Forum
Endovascular treatment for abdominal aortic aneurysm
Session comprising selected EuroPCR 2011 clinical case & complication
submissions
Chairperson: P. Peeters
▸ Introduction - P. Peeters
▸ Challenging endovascular aneurysm repair case - E. Janakiraman
▸ Infra-renal abdominal aortic aneurysm with LT iliac occlusion in a
leukemic patient - modified aorto-uni-iliac stenting - R. Vijayvergiya
▸ Spondylodiscitis associated with paravertebral abscess complicated with
aortic rupture - F. Martino
▸ Endovascular treatment of ruptured abdominal aortic aneurysm
complicated with subacute graft thrombosis - J. Trebacz
▸ Take-home message - P. Peeters
Tuesday 17th
188
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page188
Tue
sday 1
7th
End
ova
scula
r
Endovascular
16:30-19:00 Room Maillot How to...
Plenary session
How to do endovascular interventions: carotid
and supra-aortic interventions
Chairpersons: N. Hopkins, M. van Sambeek
With continuous live demonstration from CardioVascular Center Frankfurt -
Germany
Objectives:
▸ To review the knowledge required to perform carotid and supra-aortic
interventions
▸ To demonstrate a step-by-step approach
▸ To learn how to avoid and manage complications
▸ Introduction and objectives - N. Hopkins
▸ What you need to know before you start - K. Mathias
▸ Carotid and supra-aortic interventions step-by-step - F. Castriota
▸ Supra-aortic interventions step-by-step - R. Dave
▸ How to avoid and manage complications - S. Myla
▸ Take-home message - M. van Sambeek
16:30-18:00 Room 243 Technique
Forum
Femoral and below the knee interventions
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: F. Ribichini, A. Sauguet
▸ Introduction - F. Ribichini
▸ Below the knee angioplasty in elderly patient with critical limb ischemia
A. Goldsmit
▸ Manual thrombectomy in acute limb ischemia - D. Dandrea
▸ Usefulness of trans-collateral method for chronic total occlusion of
superficial femoral artery - T. Suzuki
▸ Echo-guided treatment of a long superficial femoral artery chronic
total occlusion and sheathless stent delivery via below the knee vessel
H. Sakai
▸ Take-home message - A. Sauguet
189
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page189
17:00-18:30 Room 352AB
How should I treat?
Multivessel infrapopliteal occlusions in critical limb ischemia
With an unrestricted educational grant from MEDTRONIC
Chairperson: T. Zeller
Objectives:
▸ To understand the most clinically meaningful treatment strategy in
presence of multiple vessel occlusion of infrapopliteal vessels in critical
limb ischemia
▸ To prioritise and decide which and how many vessels should be
recanalised and to which extent
▸ To discuss the best technique for recanalisation and for achieving and
maintaining vessel patency
▸ Introduction and objectives - T. Zeller
▸ Case 1 - Below the knee three vessel occlusion
- Case presentation - S. Bartus
- How would I treat? - R. Ferraresi
- How would I treat? - M. Fusaro
- How did I treat? - S. Bartus
- Discussion
- Consensus - T. Zeller
▸ Case 2 - Below the knee three vessel occlusion
- Case presentation - E. Blessing
- How would I treat? - D-D. Do
- How would I treat? - M. Brodmann
- How did I treat? - E. Blessing
- Discussion
- Consensus - T. Zeller
▸ Take-home message - T. Zeller
Tuesday 17th
190
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page190
08:30-12:00 Room Maillot How to...
Plenary session
How to do endovascular interventions: femoro-popliteal interventions
Chairpersons: R. Dave, M. Schillinger
With continuous live demonstration from Universität Leipzig Herzzentrum,
Leipzig - Germany
Objectives:
▸ To review the knowledge required to perform femoro-popliteal
interventions
▸ To demonstrate a step-by-step approach
▸ To learn how to avoid and manage complications
▸ Introduction and objectives - R. Dave
▸ What you need to know before you start - I. Moussa
▸ Superficial femoral artery interventions step-by-step - H. Krankenberg
▸ How to avoid and manage complications - C. Schonholz
▸ Take-home message - M. Schillinger
08:30-10:00 Room 251 Break-out
Plenary session
Acute stroke interventions
Chairpersons: I. Grunwald, H. Sievert
Objectives:
▸ To learn about state-of-the-art acute medical treatment of stroke
▸ To understand how catheter interventions might improve outcome
▸ To understand how to establish a stroke centre
▸ Introduction and objectives - H. Sievert
▸ Epidemiology, pathophysiology and clinical presentation of acute stroke
I. Grunwald
▸ Best medical therapy and how to deliver it - K. Fassbender
▸ Techniques and devices for catheter based acute stroke interventions
G. Schroth
▸ How not to harm - N. Hopkins
▸ How to implement acute stroke intervention and how can cardiologists
become involved - M. Abelson
▸ Discussion
▸ Take-home message - I. Grunwald
Wednesday 18th
192
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 193.
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page192
We
dn
esd
ay 1
8th
End
ova
scula
r
Endovascular
09:00-17:00 Near Theatre Bordeaux and TV studio
Innovation Incubator Space
On your way to or from a session, visit the Innovation Incubator Space and
learn about the latest technology from innovative companies. Grab a bite
from the buffet and talk with the representatives at each table. This space is
open to everyone, all day long.
▸ Cardiatis - Multilayer flow modulator for global aneurysm repair
▸ Avinger - Optical coherence tomography for peripheral intervention
▸ Avidal Vascular - Wombat drug reservoir technology
▸ Envision Scientific - Focusnp: sirolimus based nano carrier eluting-
coronary stent system
▸ Svelte Medical Systems - Novel DES: an amino acid based drug carrier
▸ Abbott Vascular - ABSORB bioresorbable vascular scaffold for peripheral
use
▸ ReCor Medical - Therapeutic ultrasound for the treatment of mitral
regurgitation
▸ Meril Life Sciences - Novel nanotechnology based Mitsu: merilimus
eluting coronary stent system
▸ Concept Medical - Magictouch: a sirolimus based nano carrier eluting
balloon catheter for treatment of coronary artery disease
▸ Valtech - Cardioband: transfemoral, surgical like, adjustable mitral
annuloplasty
09:00-10:30 Room 242A
How should I treat?
Critical decisions in critical limb ischemia
Under the auspices of the Belgian Society for Vascular Surgery (BSVS)
and the Vascular Surgery Society of Southern Africa (VASSA)
Chairpersons: P. Matley, P. Peeters
Objectives:
▸ To understand the interaction of disease at multiple levels on the
management and outcome of critical limb ischemia
▸ To teach a structured step-by-step approach to the management of critical
limb ischemia
▸ To introduce and review new endovascular techniques in below the knee
peripheral arterial disease
193
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page193
▸ Introduction and objectives - P. Peeters
▸ Critical limb ischemia: complex multilevel disease
- Case presentation - N. Naidoo
- How would I treat? - J. Pillai
- How would I treat? - M. Bosiers
- How did I treat? - N. Naidoo
- Discussion
- Consensus - P. Matley
▸ Critical limb ischemia: complex multilevel disease
- Case presentation - F. Vermassen
- How would I treat? - M. Bosiers
- How would I treat? - J. Pillai
- How did I treat? - F. Vermassen
- Discussion
- Consensus - P. Peeters
▸ Take-home message - P. Matley
10:00-11:30 Room 251 Evidence
All you need to know about carotid artery stenting
Chairpersons: M. Roffi, A. Cremonesi
Objective:
▸ At the end of this 90 minute ‘All you need to know about...’ session the
audience should have an up to date knowledge of the field, relevant for
their clinical practice. They should be familiar with the current evidence
base, existing guidelines and have an understanding of the open questions
that need addressing in the near future
▸ Introduction and objectives - M. Roffi
▸ Background - Risk of stroke in carotid stenosis - M. Mazighi
▸ Clinical data - Updates on randomised trials and registries - F. Ribichini
▸ Issues in clinical practice - Technique and patient selection are equally
important - E. Minar
▸ Guidelines on carotid revascularisation - B. Reimers
▸ Unresolved issues and outlook in carotid artery stenting - S. MacDonald
▸ Questions & answers
▸ Take-home message - A. Cremonesi
Wednesday 18th
194
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page194
We
dn
esd
ay 1
8th
End
ova
scula
r
Endovascular
10:30-12:00 Room 341 Clinic
Abstract session
Endovascular management of lower limb ischemia
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: D-D. Do, F. Castriota
▸ Introduction - D-D. Do
▸ The duplex sonography guided percutaneous peripheral intervention for
chronic total occlusion lesions in the superficial femoral arteries
K. Meguro
▸ EURO CANAL: study design of a prospective randomised trial investigating
Paclitaxel-coated balloons for infrapopliteal angioplasty in patients with
critical limb ischemia - N. Diehm
▸ Percutaneous management of lower limb ischemia following the use of
vascular closure devices - S. Rekik
▸ Bail-out stenting for treatment of below the knee arterial disease: acute
results and one-year clinical follow-up - A single centre experience
A. Cioppa
▸ Rheolytic thrombectomy for treatment of arterial limb ischemia: report of
a prospective multicentre registry - A. Amin
▸ Take-home message - F. Castriota
11:30-13:00 Room 251 Clinic
Forum
Occlusion after internal carotid stenting
Session comprising selected EuroPCR 2011 clinical case & complication
submissions
Chairpersons: N. Hopkins, S. MacDonald
▸ Introduction - N. Hopkins
▸ Simultaneous intracranial and internal carotid angioplasty - D. Grinfeld
▸ No flow after carotid stenting - J.C. Londono
▸ Think, don't panic! Vanishing carotid artery flow before actual intervention
J.K. Lee
▸ Delayed shortening of carotid Wallstent with resultant restenosis, and its
treatment with additional stent deployment - K. Muramatsu
▸ How do we handle mud pie? Endovascular re-canalisation in patient with
carotid occlusion and repeated transient ischemic attack - J.K. Lee
▸ Take-home message - S. Macdonald
195
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page195
12:00-13:30 Room 341 Innovation
Plenary session
Cardiovascular Innovation Pipeline - Peripheral vascular disease and
structural heart disease
Chairpersons: P. Bonhoeffer, M.C. Morice, H. Sievert
▸ Overview of companies - E. Lehto
▸ ReCor Medical - Therapeutic ultrasound for the treatment of mitral
regurgitation - W. Schillinger
▸ Questions & answers
▸ Pi-R-Squared - Impacting valve repai - E. Golan
▸ Questions & answers
▸ Cardiatis - Multilayer flow modulator for global aneurysm repair - P. Gruffaz
▸ Questions & answers
▸ Avinger - Optical coherence tomography for peripheral intervention - B. Ford
▸ Questions & answers
▸ Odierna - Software for automatic IV-optical coherence tomography stent
analysis, image registration and 3D reconstruction - G. Ughi
▸ Questions & answers
▸ Avidal Vascular - Wombat drug reservoir technology - T. Heilmann
▸ Questions & answers
12:00-13:30 Room 343 Clinic
Abstract session
Stenting for complex lesions above and below the inguinal ligament
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: A. Sauguet, F. Vermassen
▸ Introduction - A. Sauguet
▸ Mid-term outcome of endovascular treatment with primary self
expandable stent placement for chronic total occlusion of iliac artery
M. Araki
▸ Creation of a new aortic bifurcation with covered stent-grafts through a 9fr
access: a new technique to treat aorto-iliac occlusive disease - P. Goverde
▸ Role of endovascular therapy in the treatment of patients with Leriche
syndrome: initial and mid-term outcomes - O. Iida
▸ Mid-term results of iliac TASC C-D angioplasty in a single centre
experience - A. Liso
Wednesday 18th
196
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 193.
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page196
We
dn
esd
ay 1
8th
End
ova
scula
r
Endovascular
▸ Procedural success and clinical follow-up in endovascular treatment for
TASC II C and D lesions in femoropopliteal arterial disease - A. Furgieri
▸ Results through 2-year follow-up from the reform clinical study
(evaluation of safety and effectiveness of the formula balloon-expandable
stent for renal artery stenosis) - R. Bersin
▸ Take-home message - F. Vermassen
12:00-13:30 Room Maillot
Symposium
Titanium-nitride-oxide bioactive stent technology in acute coronary
syndrome patients: present and future
With an unrestricted educational grant from HEXACATH
Chairpersons: J. Fajadet, M. Sabate
Objectives:
▸ To review why acute coronary syndrome patients are a challenging
indication for PCI
▸ To understand the titanium-nitride-oxide coated stents potential interest
for acute coronary syndrome patients
▸ To describe the latest Titan2 bioactive stent clinical data and share the next
applications of this technology
▸ Introduction and objectives - M. Sabate
▸ How the thrombogenic and inflammation context of acute coronary
syndrome patients must lead to a rationale stent choice - M. Sabate
▸ Perspective of optical coherence tomography findings after Titan2 stent
implantation in acute coronary syndrome patients - P. Karjalainen
▸ Optimal revascularisation in patients with acute myocardial infarction: the
CATS-AMI large scale registry - M. Angioi
▸ Randomised comparison between the bioactive stent Titan2 and the
Everolimus-eluting stent XienceV: the BASE-ACS trial - P. Karjalainen
▸ Introducing the future of bioactive stents - J. Fajadet
▸ Discussion
▸ Take-home message - J. Fajadet
197
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page197
12:00-13:30 Room 353
How should I treat?
How should I treat challenging superficial femoral artery lesions?With an unrestricted educational grant from COOK MEDICALChairperson: M. Schillinger
Objectives:▸ To learn how to recanalise long superficial femoral artery occlusions
▸ To understand the impact of new treatment options to prevent recurrentstenoses
▸ Introduction and objectives - M. Schillinger
▸ Challenging superficial femoral artery lesions 1
- Case presentation - N. Diehm
- How would I treat? - D. Scheinert
- How would I treat? - T. Zeller
- How did I treat? - N. Diehm
- Discussion
- Consensus - M. Schillinger
▸ Challenging superficial femoral artery lesions 2
- Case presentation - F. Airoldi
- How would I treat? - D. Scheinert
- How would I treat? - T. Zeller
- How did I treat? - F. Airoldi
- Discussion
- Consensus - M. Schillinger
▸ Take-home message - M. Schillinger
13:30-16:30 Room Maillot How to...
Plenary session
How to do endovascular interventions: aorto-iliac interventionsChairpersons: I. Moussa, C. Schonholz
With continuous live demonstration from Universität Leipzig Herzzentrum,
Leipzig - Germany
Objectives:▸ To review the knowledge required to perform aorto-iliac interventions
▸ To demonstrate a step-by-step approach
▸ To learn how to avoid and manage complications
▸ Introduction and objectives - I. Moussa
▸ What you need to know before you start - P. Pattynama
▸ Aorto-iliac interventions step-by-step - M. Schillinger
▸ How to avoid and manage complications - R. Dave
▸ Take-home message - C. Schonholz
Wednesday 18th
198
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page198
We
dn
esd
ay 1
8th
End
ova
scula
r
Endovascular
13:30-15:00 Room 253 Break-out
Plenary session
Critical limb ischemiaChairpersons: D. Scheinert, P. Peeters
Objectives:▸ To learn how to create and manage a wound care programme
▸ To define which arterial level to treat
▸ To select the appropriate therapy in patients with critical limb ischemia
▸ To present new therapeutic options
▸ Introduction and objectives - D. Scheinert
▸ How to create and manage a wound care programme - P. Leger
▸ Critical limb ischemia: endovascular and surgical options - M. Bosiers
▸ Advanced techniques for optimal interventional recanalisation in complexbelow the knee disease - R. Ferraresi
▸ Special considerations in diabetic patients - D-D. Do
▸ Critical limb ischemia: does long-term patency matter? - D. Scheinert
▸ End stage critical limb ischemia: bone marrow cell transplantation andmore? - M.A. Sevestre-Pietri
▸ Take-home message - P. Peeters
15:00-16:30 Room 342AB Break-out
Plenary session
Renal denervation therapyChairpersons: M. Roffi, E. Blessing
Objectives:▸ To understand the mechanisms of renal denervation therapy
▸ To learn how to select the patients and perform the procedure
▸ To review current results and limitations of the available data
▸ Introduction - M. Roffi
▸ There is a huge need for improved antihypertensive treatment! - H. Schunkert
▸ Pathophysiology of nerve-mediated blood pressure regulation and pre-clinical data of renal denervation - P. Sobotka
▸ Patient selection and technique of application - T. Zeller
▸ Clinical data of renal denervation - H. Sievert
▸ Open questions, other potential indications and future perspectives - T. Lüscher
▸ Discussion
▸ Take-home message - E. Blessing
199
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page199
16:30-18:00 Room 343 Technique
Abstract session
Latest aspects on carotid artery stenting
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: F. Castriota, I. Moussa
▸ Introduction - F. Castriota
▸ Carotid endarterectomy versus carotid stenting in symptomatic and
asymptomatic patients with carotid artery stenosis: a meta-analysis - P. Meier
▸ Early and long-term outcomes following combined percutaneous
revascularisation in patients with carotid and coronary artery stenoses
F. Tomai
▸ Transradial / transbrachial carotid stenting safety and feasibility trial
A. Youssef
▸ Carotid artery angioplasty in complex aortic arch anatomy - Predictors of
major and minor adverse events, including non-cardiovascular adverse
events - F. Damas De Los Santos
▸ Simultaneous hybrid revascularisation of carotid and coronary disease in
patients with acute coronary syndrome: initial results of a new therapeutic
approach - M. Ponte
▸ Proposal of an anatomical-procedural classification for evaluating carotid
angioplasty and stenting - E. Carvalho De Campos Martins
▸ Take-home message - I. Moussa
16:30-18:00 Room Maillot
Symposium
Advancing the Paccocath technology and the future of drug-elutingballoon angioplastyWith an unrestricted educational grant from B. BRAUN and MEDRADINTERVENTIONAL/POSSISChairpersons: J.F. Granada, B. Scheller
Objectives:▸ To understand the concept and the basic principals of the Paccocath
balloon coating technology
▸ To get an overview/summary of the pre-clinical and clinical drug-elutingballoon evaluation for coronary and peripheral applications
▸ To learn about the possible coronary and peripheral indications of thePaccocath drug-eluting balloon technology
▸ To learn about procedural treatment recommendations and how the drug-eluting balloon should be used to achieve optimal long-term results
▸ To take home practical tips & tricks for the drug-eluting balloon usage
Wednesday 18th
200
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 193.
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page200
We
dn
esd
ay 1
8th
End
ova
scula
r
Endovascular
▸ Introduction to the Paccocath technology - J.F. Granada
▸ Comprehensive review of clinical data with the Paccocath technologyB. Scheller
▸ Treatment recommendations of the German Consensus Group - D. Mathey
▸ Paccocath technology advances: insights into pre-clinical studies of thelatest generation Cotavance drug-eluting balloon - J.F. Granada
▸ A new look into Paccocath clinical data: THUNDER trial and beyond - G. Tepe
▸ Current Cotavance clinical trial status and future study designs - N. Diehm
▸ Discussion
▸ Take-home message - B. Scheller
16:30-18:00 Room 353
How should I treat?
Optimal revascularisation in patients with peripheral artery diseasetreated with titanium-nitride-oxide bioactive coated stentsWith an unrestricted educational grant from HEXACATHChairpersons: A. Cremonesi, H. Sievert
Objectives:▸ To understand what are the unresolved issues regarding percutaneous
transluminal angioplasty stenting both for superficial femoral artery andrenal indications
▸ To learn how the combination of a new design and titanium-nitride-oxidecoating can be a solution
▸ To discuss and compare superficial femoral artery and renal stentingstrategies from different countries
▸ Introduction and objectives - H. Sievert
▸ Complex superfical femoral artery angioplasty
- Case presentation - A. Sauguet
- How would I treat? - M. Akesson
- How would I treat? - S. Saccà
- How did I treat? - A. Sauguet
- Discussion
- Consensus - A. Cremonesi
▸ Complex renal artery angioplasty
- Case presentation - P. Commeau
- How would I treat? - J.J. Munos
- How would I treat? - S. Sathe
- How did I treat? - P. Commeau
- Discussion
- Consensus - H. Sievert
▸ Take-home message - A. Cremonesi
201
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page201
08:30-12:00 Room Maillot How to...
Plenary session
How to do endovascular interventions: below the knee interventions
Chairpersons: M. Schillinger, H. Sievert
With continuous live demonstration from Villa Maria Cecilia Hospital,
Cotignola - Italy
Objectives:
▸ To review the knowledge required to perform below the knee interventions
▸ To demonstrate a step-by-step approach
▸ To learn how to avoid and manage complications
▸ Introduction and objectives - M. Schillinger
▸ What you need to know before you start - G. Tepe
▸ Below the knee interventions step-by-step - T. Zeller
▸ How to avoid and manage complications - I. Moussa
▸ Take-home message - H. Sievert
08:30-10:00 Room 351 Break-out
Plenary session
Multilevel vascular disease: filling the gap between interventions and
medicine
Chairpersons: A. Cremonesi, F. Ribichini
Panellists: N. Diehm, D-D. Do, M. van Sambeek
Objectives:
▸ To understand the importance of clinical judgement in the vascular work-up
▸ To facilitate the creation of a local multidisciplinary team for evaluation
and decision-making
▸ To learn about the complexity of patients and risks associated with
multilevel vascular disease
▸ Introduction and objectives - A. Cremonesi
▸ Clinical case presentation: a patient admitted for transient ischemic
attack/minor stroke, with concomitant stable angina and uncontrolled
systemic hypertension (two drugs) - D. Capodanno
▸ Proposal of a complete vascular work-up: what really matters for the long-
term improvement of quality of life and survival - D-D. Do
▸ How to integrate the clinical findings and the technical challenges into a
coordinate vascular team - N. Diehm
▸ Multidisciplinary roundtable - N. Diehm, D-D. Do, M. van Sambeek
▸ What does evidence say on multilevel disease treatment strategy - F. Tomai
▸ Discussion
▸ Take-home message: the difference between "individual professional
opinions" and the opinion of a "cardiovascular team" - F. Ribichini
Thursday 19th
202
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page202
Thu
rsday 1
9th
End
ova
scula
r
Endovascular
10:00-11:30 Room 242A
How should I treat?
Challenging peripheral vessels intervention
Under the auspices of the Iranian Society of Interventional Cardiology
and the Turkish Working Group of Interventional Cardiology
Chairpersons: B.S. Cebeci, M. Hashemian
Objective:
▸ To learn how to treat patients with catheter-based technique of abdominal
aortic total occlusion when surgery cannot be done
▸ Introduction and objectives - B.S. Cebeci
▸ Hybrid approach to a patient with multiple coronary and aortic aneurysms
- Case presentation - E. Kardesoglu
- How would I treat? - O. Goktekin
- How would I treat? - A.M. Haj Zeinali
- How did I treat? - E. Kardesoglu
- Discussion
- Consensus - B.S. Cebeci
▸ Intervention of total occlusion of abdominal aorta
- Case presentation - A. Ghofraniha
- How would I treat? - A.M. Haj Zeinali
- How would I treat? - O. Goktekin
- How did I treat? - A. Ghofraniha
- Discussion
- Consensus - M. Hashemian
- Take-home message - M. Hashemian
11:30-13:30 Room 242A Technique
Forum
Carotid intervention
Session comprising selected EuroPCR 2011 clinical case & complication
submissions
Chairpersons: M. Roffi, E. Stabile
▸ Introduction - M. Roffi
▸ Recanalisation and balloon angioplasty of a symptomatic intracranial
symptomatic carotid stenosis in an 11 year-old child - I. Petrov
▸ Carotid stenting with protection - S. Singh
▸ A case of late carotid Wallstent migration leading to restenosis treated by
stent-in-stenting method with precise Pro RX - T. Umemoto
▸ Simultaneous brachiocephalic trunk and internal carotid angioplasty - D. Grinfeld
▸ Successful management of acute occlusion of internal carotid artery
during stenting procedure - C. Fantoni
▸ Take-home message - E. Stabile203
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page203
12:00-13:30 Room 251
How should I treat?
"Go distal": different approaches to infrainguinal challenges
With an unrestricted educational grant from BOSTON SCIENTIFIC
Chairperson: D. Scheinert
Objectives:
▸ To stress to the audience the importance of treating further and farther
infrainguinal disease
▸ To expose participants to various endovascular approaches, techniques
and options to treat lower limb disease
▸ To highlight some of the newest technologies on the market
▸ Introduction and objectives - D. Scheinert
▸ Crossing a challenging occluded superficial femoral artery
- Case presentation - A. Bolia
- How would I treat? - R. Langhoff
- How would I treat? - D. Scheinert
- How did I treat? - A. Bolia
- Discussion
- Consensus - D. Scheinert
▸ Extreme distal stenosis: how to restore flow to the foot?
- Case presentation - J. Clerissi
- How would I treat? - R. Langhoff
- How would I treat? - D. Scheinert
- How did I treat? - J. Clerissi
- Discussion
- Consensus - D. Scheinert
▸ Take-home message - D. Scheinert
12:00-13:30 Room 252AB
How should I treat?
Optimising treatment strategies for complex femoral and infrapopliteal
diseases
With an unrestricted educational grant from BIOTRONIK
Chairperson: O. d'Archambeau
Objectives:
▸ To discuss the role of long stenting in complex femoral and infrapopliteal
lesions
▸ To understand the emerging role and benefits of drug-coated balloons in
peripheral interventions
Thursday 19th
204
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page204
Thu
rsday 1
9th
End
ova
scula
r
Endovascular
▸ Introduction and objectives - O. d'Archambeau
▸ Emerging drug-coated balloon treatment options in femoral and
infrapopliteal lesion
- Case presentation - A. Schmidt
- How would I treat? - E. Calabrese
- How would I treat? - J. Van Den Berg
- How did I treat? - A. Schmidt
- Discussion
- Consensus - O. d'Archambeau
▸ Long stenting in complex lower limb interventions
- Case presentation - G. Pratesi
- How would I treat? - E. Calabrese
- How would I treat? - J. Van Den Berg
- How did I treat? - G. Pratesi
- Discussion
- Consensus - O. d'Archambeau
▸ Take-home message - O. d'Archambeau
12:00-13:30 Room 343 Clinic
Abstract session
Beyond the borders: new devices and indications for endovascular
treatment
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: N. Hopkins, M.A. Ruffino
▸ Introduction - N. Hopkins
▸ Feasibility and safety of transradial arterial approach for simultaneous
right and left vertebral artery angiographic studies and stenting
A. Youssef
▸ Transluminal treatment of ischemic stroke with distal atherosclerotic
lesions of brain vessels - I. Maksimovich
▸ Transcatheter treatment of Alzheimer's disease - I. Maksimovich
▸ Catheter-based interventional therapy of acute ischemic stroke -
Experience from a single stroke centre, India - P. Veera Raghava Sarma
▸ Angiojet rheolytic thrombectomy in pulmonary embolism with cardiogenic
shock: a feasibility and safety pilot study - R. Bonvini
▸ Subclavian artery trauma: an endovascular approach - D. Benitti
▸ Take-home message - M.A. Ruffino
205
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page205
13:30-16:30 Room Maillot How to...
Plenary session
How to do endovascular interventions: renal and visceral interventions
Chairpersons: H. Sievert, P. Pattynama
With continuous live demonstration from Villa Maria Cecilia Hospital,
Cotignola - Italy
Objectives:
▸ To review the knowledge required to perform renal and visceral
interventions
▸ To demonstrate a step-by-step approach
▸ To learn how to avoid and manage complications
▸ Introduction and objectives - H. Sievert
▸ What you need to know before you start - C. Mialhe
▸ Renal interventions step-by-step - M. Schillinger
▸ Visceral interventions step-by-step - T. Zeller
▸ How to avoid and manage complications - B. Reimers
▸ Take-home message - P. Pattynama
13:30-15:00 Room 342AB Break-out
Plenary session
Catheter-based management of massive intravascular thrombosis
Chairpersons: M. Roffi, A. Sauguet
Objectives:
▸ To learn about therapeutic options in patients presenting acute lower limb
occlusion
▸ To know how to deal with a patient presenting lower limb graft occlusion
▸ To select the appropriate therapy in patients with massive deep vein
thrombosis and/or pulmonary embolism
▸ Introduction and objectives - A. Sauguet
▸ Acute native lower limb occlusion: the endovascular options - A. Schmidt
▸ Discussion
▸ Management of graft occlusion in the lower limb - C. Schonholz
▸ Discussion
▸ Massive deep vein thrombosis: thrombolysis and mechanical thrombus
removal - N. Kucher
▸ Discussion
▸ Catheter-based options in massive pulmonary embolism - R. Bonvini
▸ Discussion
▸ Take-home message - M. Roffi
Thursday 19th
206
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page206
Thu
rsday 1
9th
End
ova
scula
r
Endovascular
15:00-16:30 Room 342AB Break-out
Plenary session
Hybrid approach for the treatment of the thoracic aortic disease: casebased discussion Chairpersons: C. Setacci, M. van Sambeek
Objectives:▸ To learn about new therapeutic options and endovascular devices
▸ To learn about optimal pre-operative imaging
▸ To show the importance of multidisciplinary approach between surgicaland interventional team
▸ Introduction and objectives - C. Setacci
▸ Pathophysiology, definitions and medical treatment of complex thoracicaorta disease - C. Nienaber
▸ Indications, techniques and outcome of treatment of patients withcomplex thoracic aorta disease - R. Fattori
▸ Case presentation - F. Ribichini
▸ Expert opinion - G. Torsello
▸ How it was done - F. Ribichini
▸ Technical options for complex throracic aortic disease - M. van Sambeek
▸ Roundtable discussion
▸ Take-home message - M. van Sambeek
15:00-16:30 Room 353 Clinic
Abstract session
Cardiovascular impact of non coronary atherosclerosisSession comprising selected EuroPCR 2011 abstract submissionsChairpersons: M. Balghith, M. Haude
▸ Introduction - M. Balghith
▸ Three-year follow-up of patients with asymptomatic coronary arterydisease in the prevalence of asymptomatic coronary artery disease inischemic stroke patients (PRECORIS) trial - H. Aelion
▸ Renal artery stenosis increases overall mortality in patients with advancedchronic kidney disease - M. Hori
▸ Diseased arterial segment of lower extremity impact on adverse cardiacevents over combined coronary and peripheral artery disease patientsY. Sakamoto
▸ The necessity of myocardial revascularisation in patients with diabetesmellitus and critical limb ischemia - V. Kalashnikov
▸ Burden of coronary artery disease in severe limb ischemia patients is overhalf - C.W. Goh
▸ The 12-month prognosis of patients with critical limb ischemia andextensive gangrene after infrapopliteal endovascular therapy is extremelypoor - M. Nakano
▸ Take-home message - M. Haude207
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page207
16:30-18:00 Room Maillot
Symposium
Drug-eluting balloons: current status and new perspectives
With an unrestricted educational grant from MEDTRONIC
Chairpersons: G. Tepe, B. Scheller
Objectives:
▸ To provide a comprehensive overview of the span of potential clinical
indications for drug-eluting balloons in the coronary and peripheral areas
and understand where and why drug-eluting balloons should be
considered to address unmet needs
▸ To provide attendees with results of Medtronic drug-eluting balloons
(IN.PACT) within coronary and peripheral applications
▸ To share current limitations and future needs to further establish drug-
eluting balloon clinical evidence
▸ Introduction and objectives - G. Tepe
▸ Drug-eluting balloons in coronary in-stent restenosis: insights from
optical coherence tomography - P. Stella
▸ Discussion
▸ Drug-eluting balloons in very long and diffuse coronary lesions
G.M. Sangiorgi
▸ Discussion
▸ Drug-eluting balloons in peripheral haemodialysis fistulas - D. Patanè
▸ Discussion
▸ Drug-eluting balloons for lower limb arterial diseas - A. Schmidt
▸ Discussion
▸ Take-home message - G. Tepe
16:30-18:00 Room 352AB
Symposium
Catheter-based renal denervation treatment for hypertension
With an unrestricted educational grant from MEDTRONIC ARDIAN
Chairperson: K. Rocha-Singh
Objectives:
▸ To learn how affecting sympathetic nervous system activation may lower
blood pressure
▸ To consider recent data regarding renal denervation treatment in
hypertension
▸ To review information about the technology and procedure
▸ To understand how this physiology might affect other related areas (e.g.
insulin resistance, heart failure and other diseases)
Thursday 19th
208
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page208
Thu
rsday 1
9th
End
ova
scula
r
Endovascular
▸ Introduction and objectives - K. Rocha-Singh
▸ Background, physiology, and technique of catheter based renal
denervation - E. Blessing
▸ Results from the Symplicity HTN-1 and Symplicity HTN-2 trials - H. Sievert
▸ Impact of renal denervation on glucose metabolism, insulin resistance and
diabetes - F. Mahfoud
▸ Heart failure, sleep apnea and other areas of future research - A. Witkowski
▸ Discussion
▸ Take-home message - K. Rocha-Singh
17:00-18:00 Room 242B Clinic
Forum
Endovascular treatment for thoracic aorta aneurysm
Session comprising selected EuroPCR 2011 clinical case & complication
submissions
Chairpersons: M. van Sambeek, C. Mialhe
▸ Introduction - M. van Sambeek
▸ Percutaneous transfemoral stent graft treatment of thoracic aortic
aneurysm of surgically repaired coarctation of aorta - S. Khogali
▸ Successful transluminal endoprosthetic correction of type A aortic
dissection after coronary artery bypass surgery - G. Pires De Morais
▸ The modified chimney technique with a thoracic aortic stent graft to
preserve the blood flow of the left common carotid artery for treating
descending thoracic aortic aneurysm and dissection - S.G. An
▸ Endovascular thoracic aortic aneurysm repair: impacted and partially
opened aortic stent - A. Abou Issa
▸ Take-home message - C. Mialhe
209
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page209
09:00-12:30 Room Maillot Break-out
Plenary session
Carotid revascularisation: Live it! Great news: carotid stenting is Class Irecommendation Chairpersons: A. Cremonesi, M. Roffi
Panellist: J.P. Becquemin
With continuous live demonstration from Hôpital Henri Mondor, Créteil -
France
Objectives:▸ To review the role of carotid artery stenting in the latest European Society
of Vascular Surgery (ESVS) and American Heart Asssociation (AHA) -American Stroke Association (ASA) guidelines
▸ To know the relationship between operator experience and outcomes in
carotid revascularisation
▸ To learn about advantages and limitations of carotid endarterectomy andcarotid artery stenting
▸ Introduction and objectives - M. Roffi
▸ Impact of learning curve in carotid endarterectomy and stenting - W. Gray
▸ Debate : is carotid artery stenting a Class I recommendation in
symptomatic patients ?
- Pro - N. Hopkins
- Against - D. Raithel
▸ Multidisciplinary roundtable discussion
▸ Advantages and limitations of carotid endarterectomy - C. Mialhe
▸ Advantages and limitations of carotid artery stenting - C. Schonholz
▸ Patient selection and operator experience are key for success - S. MacDonald
▸ Take-home message - A. Cremonesi
Friday 20th
210
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page210
Friday 2
0th
End
ova
scula
r
Endovascular
09:30-11:00 Room 241 Clinic
Abstract session
Endovascular treatment of thoracic and abdominal aortaSession comprising selected EuroPCR 2011 abstract submissionsChairperson: P. Pattynama
▸ Introduction - P. Pattynama
▸ New conformable stent graft devices - Can they solve the apposition
problems in the thoracic aorta near the arch? - M. Gawenda
▸ Endovascular peripheral and visceral aneurysms repair with Cardiatismultilayer stent: Italian multicentre registry results at 6- and 12-monthfollow-up - M.A. Ruffino
▸ Endovasvascular treatment of complicated aortic dissection: the use of anew device - R. Aun
▸ Endovascular repair of ruptured abdominal aortic aneurysms: University ofSao Paulo experience - D. Benitti
▸ Endovascular treatment of thoracic aortic disease: eleven year follow-up
A. Bortone
▸ Treatment of thoracic aortic disease using endovascular stent graft:
clinical outcomes and favorable effects on aortic remodeling - M. Ponte
▸ Take-home message - P. Pattynama
09:30-12:30 Room 252AB How to...
Plenary session
How to do endovascular interventions: abdominal aortic aneurysm
treatment in the cathlab
Chairpersons: T. Zeller, H. Krankenberg
With continuous live demonstration from Catharina Ziekenhuis, Eindhoven -
The Netherlands
Objectives:
▸ To review the knowledge required to perform aortic endografting
▸ To demonstrate a step-by-step approach
▸ To learn how to avoid and manage complications
▸ Introduction and objectives - T. Zeller
▸ What you need to know before you start - H. Sievert
▸ Aortic aneurysm interventions step-by-step - R. Dave
▸ How to avoid and manage acute and long-term complications - G. Torsello
▸ Take-home message - H. Krankenberg
211
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page211
11:00-12:30 Room 241 Clinic
Abstract session
Latest on femoro-popliteal interventions
Session comprising selected EuroPCR 2011 abstract submissions
Chairpersons: S.M. Hiremath, S. Duda
▸ Introduction - S.M. Hiremath
▸ Mid-term clinical outcomes and predictor of restenosis in self-expanding
Nitinol stent implantation for chronic total occlusion in femoropopliteal
artery - Multicentre registry in Japan - Y. Sakamoto
▸ Endovascular treatment of common femoral artery disease: medium-term
outcomes of 360 consecutive procedures - R. Bonvini
▸ Zilver PTX randomised trial of paclitaxel-eluting stents for femoropopliteal
artery disease: 24-month update - D. Scheinert
▸ Superficial femoral artery stenting: results from a 1,000-patient registry
T. Tuebler
▸ Acute and mid-term results of a new paclitaxel-eluting ballon use for
femoropopliteal obtructions angioplasty - A. Micari
▸ Should a stent be used to treat dissection when a paclitaxel-coated balloon
is used to treat lesions? - G. Tepe
▸ Take-home message - S. Duda
11:00-12:30 Room 352AB Technique
Forum
Aorto-iliac interventions
Session comprising selected EuroPCR 2011 clinical case submissions
Chairpersons: P. Pattynama, A. Schmidt
▸ Introduction - A. Schmidt
▸ Percutaneous treatment of multifocal atherosclerosis: staged procedure?
How many stages? - A. Babunashvili
▸ Successful true-lumen stenting for the in-stent chronic total occlusion
occurred after pseudo-lumen stenting in the common iliac artery
T. Ishihara
▸ Endovascular treatment for high take-off Leriche syndrome - A. Nomura
▸ Dual route approach to right common illiac artery coronary chronic total
occlusion intervention using subintimal snare technique - S. Reddy
▸ Stenting of long total occlusion in the left iliac artery - W. Kadro
▸ Take-home message - P. Pattynama
Friday 20th
212
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page212
Friday 2
0th
End
ova
scula
r
Endovascular
13:00-14:00 Main arena
Main session
Presentation of 2011 EuroPCR/EAPCI awards
and closing ceremony
Chairperson: W. Wijns
Panellists: J. Marco, P.W. Serruys, J. Fajadet, M.C. Morice, B. De Bruyne,
A. Vahanian, M. van Sambeek, E. Eeckhout, A. Cremonesi, H. Sievert,
D. Scheinert, C. Ruiz, P. Bonhoeffer, T.H. Koh, M. Thomas
▸ Introduction - W. Wijns
▸ 2011 EuroPCR innovation award - S. Windecker
▸ Best abstract - J. Fajadet
▸ Abstract presentation by the awardee
▸ Best clinical case - A. Baumbach
▸ Case presentation by the awardee
▸ Most educational complication case - E. Eeckhout
▸ Case presentation by the awardee
▸ EAPCI training awards - C. Di Mario
▸ Closing remarks - P.W. Serruys
213
11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page213
scientific programme
Nurse and technician
programme
PART III
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page215
10:00-11:00 Main arena Innovation
Main session
Welcome and live demonstration from Frankfurt
Chairperson: W. Wijns
Panellists: A. Cremonesi, T. Lüscher, C. Rihal, C. Ruiz, P.W. Serruys,
R. Whitbourn
With continuous live demonstration from CardioVascular Center Frankfurt -
Germany
▸ Introduction - W. Wijns
▸ Renal denervation: a new treatment option in hypertension and beyond?
T. Lüscher
11:00-12:30 Main arena
Main session
PCR Family: Innovation in education at work
Chairperson: W. Wijns
Panellists: E. Eeckhout, J.B. Ge, T.H. Koh, J. Marco, M.C. Morice, R. Ng,
P.W. Serruys, M. Thomas, A. Vahanian
▸ Introduction - W. Wijns
European Society of Cardiology: a word from the President - M. Komajda
PCR courses
▸ EuroPCR - W. Wijns
▸ AsiaPCR/SingLive - T.H. Koh
▸ PCR London Valves - M. Thomas
PCR communications
▸ PCRonline - A. Vahanian
▸ PCR Publishing: impact factors in the digital era - P.W. Serruys
▸ Percutaneous interventional cardiovascular medicine. The PCR-EAPCI
textbook - E. Eeckhout
PCR educative solutions - J. Marco
PCR trials - P.W. Serruys
EAPCI: vision of the future - J. Fajadet, EAPCI President-Elect 2011-2013
and the EAPCI President-Elect 2013-2015
Tuesday 17th
216
Don’t forget to check the Training programme, page 224.
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page216
Tue
sday 1
7th
Nu
rses a
nd
tech
nicia
ns
Nurses and technicians
13:30-15:30 Room 241
Nurse and technician session
Nurse research from daily cathlab practice
Chairpersons: L. Kløvgaard, R. Vermeulen
Objectives:
▸ To be able to identify different types of studies we meet in our daily
practice
▸ To learn about specific nurse-driven clinical studies
▸ To understand the impact of research in the cathlab on patient care
▸ Introduction and objectives - L. Kløvgaard
▸ Different study designs - An overview - N. Aerts
▸ Transradial hemostasis with the Dorchester protocol - J. Wheelband
▸ Quality of life before and after PCI - D. Zughaft
▸ Anxiety as a risk factor in patients undergoing PCI - T. Wagenaar-Streefkerk
▸ TAVI treated patients: What kind of specialised nursing do they need?
K.H. Lisby
▸ Take-home message - L. Kløvgaard
217
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page217
09:30-11:30 Room 241
Nurse and technician session
Structural heart disease interventionsChairpersons: M. Leahy, S. Buendia
Objectives:▸ To present the benefits of inter-institutional nurse collaborations
▸ To know how to deal with complications during structural heart diseaseinterventions
▸ To better understand the practical steps involved in preparing valves for TAVI
▸ Introduction and objectives - M. Leahy
▸ Percutaneous mitral valve repair using MitraClip - The benefit of inter-institutional nurse collaboration - B. Wulff
▸ The Geneva experience on melody valve implementation - X. Jacottin
▸ Nursing management: TAVI acute complications and comorbid conditionsin the cathlab - M. Ghorbati
▸ The Edwards experience - A practical step-by-step approach to devicepreparation - V. Rodriguez Garcia-Abad
▸ The CoreValve experience - A practical step-by-step approach to devicepreparation - M. De Ronde
▸ Take-home message - M. Leahy
11:30-13:00 Room 241
Nurse and technician session
Coronary clinical cases from a nursing perspectiveChaipersons: R. Vermeulen, S. Buendia
Objectives:▸ To recognise some of the complications that happen during standardprocedures and how to treat them
▸ To better understand the underlying principles of cardiac catheterisationrelated complications
▸ To present the nursing perspective in anticipating, observing and treatingcardiac catheterisation related complications
▸ Introduction and objectives - R. Vermeulen
▸ Dissection of the aorta after failed PCI: case - R. Vermeulen
▸ Coronary artery perforation: a nursing perspective - M. Van Der Heijden
▸ Microcirculation evaluation in the cathlab - R. Esteves
▸ How to retrieve a lost stent - B. Finn
▸ Take-home message - R. Vermeulen
Wednesday 18th
218
Wednesday is the innovation dayVisit the Innovation Incubator Space
Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page218
We
dn
esd
ay 1
8th
Nu
rses a
nd
tech
nicia
ns
Nurses and technicians
14:30-16:30 Room 241 Technique
LTT - Scrubbing-in for bifurcation PCI
Facilitators: S. Buendia, M. Leahy, M. Oberhoff
Panellist: M. Simon
Media driver: A.A. Fassa
Live in-a-box® from Institut Cardiovasculaire Paris Sud, Massy - France
219
We hope to see you in other sessionsboth coronary/structural heart disease and endovascular
the Course is open to everybody!
The LTT sessions are highly educative and interactive.
Don’t miss them!!
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page219
09:30-11:00 Room 241
Nurse and technician session
New developments in the modern cathlab
Chairpersons: R. Vermeulen, M. Leahy
Objectives:
▸ To learn about some of the new developments in the modern cathlab, in
medicine, equipment and staffing
▸ To better understand the impact of new developments on daily practice
▸ To present the most recent innovative ideas for potential future
applications
▸ Introduction and objectives - R. Vermeulen
▸ New antithrombotic medicines in the cathlab - M. Pascual
▸ Percutaneous repair of mitral regurgitation - M. Van Der Heijden
▸ Post-nursing careers in the cathlab - Working with nurse practitioners and
physician assistants - H. Deuling
▸ Experiences with 3D roadmapping in cardiovascular imaging - S. Van Weenen
▸ Take-home message - R. Vermeulen
11:00-12:30 Room 241
Nurse and technician session
The miscellaneous abstract session
Chairpersons: L. Kløvgaard, M. Leahy
Objectives:
▸ To learn about the safety and feasibility using manual aspiration during
primary PCI for STEMI
▸ To understand the value of information pathways between units attending
to the care of patients
▸ To learn about a simple no-instruction compression to be used after radial
access
▸ Introduction and objectives - L. Kløvgaard
▸ Proximal aspiration in acute myocardial infarction - J.A. Fernandez Rodriguez
▸ Minimising complications by improving communication - M. Holton
▸ New innovations, new ways to work: multi-skilling in the cardiac cathlab
C. Loder
▸ Radial access compression devices: complication can develop - What our
team developed to prevent this - L. Hinterbuchner
▸ Take-home message - L. Kløvgaard
Thursday 19th
220
Don’t forget to check the Training programme, page 224.
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page220
Thu
rsday 1
9th
Nu
rses a
nd
tech
nicia
ns
Nurses and technicians
14:00-16:00 Room 241
Nurse and technician session
The treatment of STEMI from a cathlab management perspective
Chairpersons: M. Leahy, R. Vermeulen
Objectives:
▸ To present how primary PCI services are delivered across differing
geographies
▸ To better understand how optimal management practices can improve the
patient pathway
▸ To identify and overcome common barriers in implementing optimal
patient care in STEMI
▸ Introduction and objectives - M. Leahy
▸ The treatment of STEMI from a cathlab management perspective
- The Polish experience - M. Wizimirski
- The Spanish experience - E. Sanchez Hernandez
- The German experience - M. Jacobs
- The English experience - V. Oriolo
- The Danish experience - M. Christensen
▸ Panel discussion/Open forum
▸ Take-home message - M. Leahy
STENT
FOR LIFE
221
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page221
13:00-14:00 Main arena
Main session
Presentation of 2011 EuroPCR/EAPCI awards
and closing ceremony
Chairperson: W. Wijns
Panellists: J. Marco, P.W. Serruys, J. Fajadet, M.C. Morice,
B. De Bruyne, A. Vahanian, M. van Sambeek, E. Eeckhout, A. Cremonesi,
H. Sievert, D. Scheinert, C. Ruiz, P. Bonhoeffer, T.H. Koh, M. Thomas
▸ Introduction - W. Wijns
▸ 2011 EuroPCR innovation award - S. Windecker
▸ Best abstract - J. Fajadet
▸ Abstract presentation by the awardee
▸ Best clinical case - A. Baumbach
▸ Case presentation by the awardee
▸ Most educational complication case - E. Eeckhout
▸ Case presentation by the awardee
▸ EAPCI training awards - C. Di Mario
▸ Closing remarks - P.W. Serruys
Friday 20th
222
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page222
Training
villag
e - Level 3
Corona
ry and
stru
ctural hea
rt disease
Nurses & te
chnician
s
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
8h30
Vascular
closu
rep. 173
Bifu
rcat
ion
lesion
sp. 173
Tues
day 17
th
CORD
IS CA
RDIA
C &
VASC
ULAR
INST
ITUTE
CROS
SROA
DS, T
he A
bbot
t Va
scular
Educ
ation
Netw
ork
EDWA
RDS L
IFESC
IENCE
S
MEDT
RONI
C ACA
DEMI
A
ST. J
UDE M
EDICA
L
Radial app
roac
hp. 173
AMI f
or n
urse
sp. 227
Bifu
rcat
ion
lesion
sp. 174
Tran
scat
hete
r hea
rt valve
sp. 174
Tran
scat
hete
r hea
rt valve
sp. 174
MVD
p. 174
Hem
osta
sis
man
agem
ent
p. 175
Hem
osta
sis
man
agem
ent f
ornu
rses
p. 227
Hem
osta
sis
man
agem
ent
for n
urse
sp. 227
Hem
osta
sis
man
agem
ent f
ornu
rses
p. 227
Training
villag
e - Level 3
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page224
Nu
rses a
nd
tech
nicia
ns
Corona
ry and
stru
ctural hea
rt disease
Nurses & te
chnician
sTraining
villag
e - Level 3
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
8h30
Vascular
closu
rep. 175
Radial app
roac
hp. 175
Wed
nesd
ay 18th
CORD
IS CA
RDIA
C &
VASC
ULAR
INST
ITUTE
CROS
SROA
DS, T
he A
bbot
t Va
scular
Educ
ation
Netw
ork
EDWA
RDS L
IFESC
IENCE
S
MEDT
RONI
C ACA
DEMI
A
ST. J
UDE M
EDICA
L
Bifu
rcat
ion
lesion
sp. 176
Intra
card
iac ec
hoca
rdiogr
aphy
in TAV
Ip. 176
Vascular
closu
rep. 175
AMI f
or n
urse
sp. 228
CTO
p. 177
Tran
scat
hete
r hea
rt valve
sp. 177
Tran
scat
hete
r hea
rt valve
sp. 177
MVD
p. 178
FFR
for p
hysician
sp. 178
STEM
Ip. 176
Tran
scat
hete
r hea
rt valve
sp. 177
Tran
scat
hete
r hea
rt valve
sp. 177
Tran
scat
hete
r hea
rt valve
sp. 177
Bifu
rcat
ion
lesion
sp. 177
MVD
p. 178
MVD
for n
urse
sp. 228
AMI f
or n
urse
sp. 228
FFR
for n
urse
sp. 229
FFR
for n
urse
sp. 229
FFR
for n
urse
sp. 229
FFR
for n
urse
sp. 229
FFR
for n
urse
sp. 229
FFR
for n
urse
sp. 229
FFR
for p
hysician
sp. 178
FFR
for p
hysician
sp. 178
FFR
for p
hysician
sp. 178
FFR
for p
hysician
sp. 178
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page225
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
8h30
TAVI
p. 183
Friday
20th
MEDT
RONI
C ACA
DEMI
A
9h
10h
11h
12h
13h
14h
15h
16h
17h
18h
19h
8h30
Radial app
roac
hp. 179
FFR
for n
urse
sp. 229
AMI
p. 180
CORD
IS CA
RDIA
C &
VASC
ULAR
INST
ITUTE
CROS
SROA
DS, T
he A
bbot
t Va
scular
Educ
ation
Netw
ork
EDWA
RDS L
IFESC
IENCE
S
MEDT
RONI
C ACA
DEMI
A
ST. J
UDE M
EDICA
L
Vascular
closu
rep. 179
Intra
card
iac ec
hoca
rdiogr
aphy
in TAV
Ip. 179
Radial app
roac
hp. 180
CTO
p. 180
Bifu
rcat
ion
lesion
sp. 181
AMI
p. 180
Tran
scat
hete
r hea
rt valve
sp. 181
Tran
scat
hete
r hea
rt valve
sp. 181
Tran
scat
hete
r hea
rt valve
sp. 181
Tran
scat
hete
r hea
rt valve
sp. 181
TAVI
p. 182
TAVI
p. 182
TAVI
p. 182
TAVI
p. 182
FFR
for n
urse
sp. 229
FFR
for n
urse
sp. 229
FFR
for n
urse
sp. 229
FFR
for n
urse
sp. 229
FFR
for n
urse
sp. 229
OCT fo
r phy
sician
sp. 182
OCT fo
r phy
sician
sp. 182
OCT fo
r phy
sician
sp. 182
OCT fo
r phy
sician
sp. 182
OCT fo
r phy
sician
sp. 182
Training
villag
e - Level 3
Thur
sday
19th
Corona
ry and
stru
ctural hea
rt disease
Nurses & te
chnician
s
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page226
Nu
rses a
nd
tech
nicia
ns
227
Tuesday 17th May
Room CROSSROADS, the Abbott Vascular Education Network
14:00-15:30 Training Village
Acute myocardial infarction patient management from
a cathlab nurse perspective
With an unrestricted educational grant from
CROSSROADS, the Abbott Vascular Education Network
Trainers: J. Hunter, J. Spratt
Objectives:
▸ To give an update on acute myocardial infarction management from a
cathlab nurse perspective (pre-, per- and post-procedure management
aspects, patient preparation and monitoring, patient preparation for
emergency strategies)
▸ To provide hands-on exercise on virtual reality monitor
Room ST JUDE MEDICAL
14:00-15:00 Training Village
15:15-16:15
16:30-17:30
Hemostasis management for nurses - Practical hands-on session on
usage of passive and active closure devices
With an unrestricted educational grant from ST. JUDE MEDICAL
Trainers: H. Curling Gustafsson, P. Vanloock
Objectives:
▸ To discuss active and passive closure devices
▸ To understand how to reduce complication risk following vessel closure
▸ To practice deployment techniques and application of active and passive
closure devices
STENT
FOR LIFE
Train
ing
village
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page227
Wednesday 18th May
Room CROSSROADS, the Abbott Vascular Education Network
14:00-15:30 Training Village
Acute myocardial infarction patient management from
a cathlab nurse perspective
With an unrestricted educational grant from
CROSSROADS, the Abbott Vascular Education Network
Trainers: D. Hildick-Smith, J. Hunter
Objectives:
▸ To give an update on acute myocardial infarction management from a
cathlab nurse perspective (pre-, per- and post-procedure management
aspects, patient preparation and monitoring, patient preparation for
emergency strategies)
▸ To provide hands-on exercise on virtual reality simulator
Room MEDTRONIC ACADEMIA
14:00-16:00 Training Village
Multivessel disease
With an unrestricted educational grant from MEDTRONIC ACADEMIA
Trainers: N. Aerts, A. Alonso, L. Jones, B. O'Meara
Objectives:
▸ To review simulated case scenarios integrating Syntax
score/Euroscore/Fractional flow reserve
▸ To discuss and plan treatment strategy with peers and experts
▸ To implement the chosen strategy during the simulation session
16:30-18:30 Training Village
Acute myocardial infarction
With an unrestricted educational grant from
MEDTRONIC ACADEMIA
Trainers: A. Alonso, S. Buendia, L. Jones, L. Lamerichs
Objective:
▸ To achieve better angiographic outcomes due to the
hands-on training using the thrombo-aspiration (Export) and a focused
simulation session for cathlab teams
STENT
FOR LIFE
STENT
FOR LIFE
228
Training village
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page228
Train
ing
village
Nu
rses a
nd
tech
nicia
ns
Nurses and technicians
229
Room ST JUDE MEDICAL
09:00-10:00 Training Village
10:00-11:00
11:00-12:00
14:00-15:00
15:00-16:00
16:00-17:00
Functional coronary lesion assessment - Cathlab efficiency for nurses
and technicians - Practical hands-on session: fractional flow reserve set
up from A-Z
With an unrestricted educational grant from ST. JUDE MEDICAL
Trainers: H. Curling Gustafsson, P. Vanloock
Objectives:
▸ To practice accurate fractional flow reserve set up
▸ To understand the different steps during coronary flow measurement
▸ To improve daily clinical practice through an accurate fractional flow
reserve approach
Thursday 19th May
Training VillageRoom ST JUDE MEDICAL
09:00-10:00 Training Village
10:00-11:00
11:00-12:00
14:00-15:00
15:00-16:00
16:00-17:00
Functional coronary lesion assessment - Cathlab efficiency for nurses
and technicians - Practical hands-on session: fractional flow reserve set
up from A-Z
With an unrestricted educational grant from ST. JUDE MEDICAL
Trainers: H. Curling Gustafsson, P. Vanloock
Objectives:
▸ To practice accurate fractional flow reserve set up
▸ To understand the different steps during coronary flow measurement
▸ To improve daily clinical practice through an accurate fractional flow
reserve approach
11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page229
PCR Family
230
EuroPCREuroPCR, our flagship, is the leading
interventional cardiovascular Course, and the
official annual meeting of the European
Association for Percutaneous Cardiovascular
Interventions.
Next edition: 15th-18th May, 2012.
www.europcr.com
AsiaPCR/SingLiveBased on a strong and respectful collaboration
with prominent PCR family members, this
Course is built by and for the Asia-Pacific
cardiovascular community.
It reaches out to a wider international
audience, to share and learn from the expertise
in Asia-Pacific, and stimulate regional projects.
Join us from 12th - 14th January, 2012.
www.asiapcr.com
PCR London ValvesA meeting centered on the “Heart-team”
approach, fully dedicated to the new
modalities of valves treatment.
Next edition: 16th-18th October, 2011.
www.pcrlondonvalves.com
Booth M20 - Level 2!
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page230
231
PCR Family - Innovation in education at workPatient-centred, innovative session formats, open-mindedness,
interactivity, continuous evaluation and improvement are the
fundamental building-blocks of the PCR Courses. In 2010, more than
15,000 participants from all over the world attended the PCR courses.
PCRonlineAn online reference platform to inform and
impulse the new formats of education to
the whole cardiovascular interventional
community.
www.pcronline.com
PCR PublishingEdits scientific publications.
EuroIntervention Journal, the monthly official
journal of the EAPCI, now PubMed / Medline
referenced. The first 2 textbooks are available,
another is in progress.
www.pcrpublishing.com
www.eurointervention.com
Educative solutionsThe mission is to implement the Participatory
learning group development concept.
Acting as an R&D cell, this branch has created
the LTT sessions and PCR Seminars.
TrialsThe mission is to federate and stimulate new
clinical trials within our interventional
cardiovascular field and to inform the
community. The trials with the PCR label will
benefit from the PCR communication arsenal.
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page231
Your A-Z for EuroPCR
233
Airport shuttleFree shuttles will take you from Charles de Gaulle airport to thePalais des Congrès and back.
From CDG airport to Palais des Congrès
c Tuesday 17th: Every 30 min from 8:00 am to 11:00 am
cWednesday 18th: Every 30 min from 8:30 to 11:00 am
c Departure points- Terminal 1: departure level, gate 8- Terminal 2A: gate 8- Terminal 2D: gate 8- Terminal 2F: gallery 6
From Palais des Congrès to CDG airport
c Thursday 19th: Every 30 min from 17:00 to 18:30
c Friday 20th: Every 30 min from 12:30 to 14:30
c Departure point: Parking Pershing - Boulevard Pershing
AndroïdThe application dedicated to EuroPCR is available and includes:breaking news, the scientific programme, all exhibitors, maps andmore. Download it now at europcr.com!
Bag pick-upLocated on Level 1.
BlackBerryThe application dedicated to EuroPCR is available and includes:breaking news, the scientific programme, all exhibitors, maps andmore. Download it now at europcr.com!
BusBus lines for the Palais des Congrès: 82, 73, 43, 244, PC 1, PC 2 or PC 3.Ask at the Concierge "counter" on Level 0 for more information.
Case cornerLocated on Level 3 it gives you the opportunity to review the com-plication and clinical cases submitted for EuroPCR. See page 8 formore information.
CateringSee "Lunch".
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page233
234
Your A-Z for EuroPCR
234
ConciergeOpen 8:00 to 18:00 Monday to Friday. Located on Level 0. This servicecan help you with daily needs: courier services, dry-cleaning, restaurantreservations, flower delivery, train tickets, taxis…
CloakroomLocated in the main arena foyer (Level 0,5). It's free of charge and openthe same hours as the registration.
Convention centreThe Palais des Congrès de Paris is located at 2, place de la Porte Maillot,75017 Paris. See "Airport shuttle", "Bus", "Metro", or "Train station shuttle".
Cyber spaceThe Cyber space provides free access to computers connected to the Internet.Located on Level 1. See also "WiFi".
Daily newsHot off the press, distributed every morning at Level 0 escalators and atself-serve points throughout the Palais des Congrès.
E-badgeTo pick up your E-badge, go to the E-badge desk with the barcode youprinted when you pre-registered online.
EuroIntervention JournalOfficial journal of the EAPCI. Pick-up your copies at the distributionpoints situated throughout the Palais des Congrès. The May issue plus3 supplements are available free!
ExhibitorsSee page 244 for the exhibition map.Consult the Exhibit Guide to find more information about the companies.Information also available in the smartphone applications (iPhone, Androïd and Blackberry). Download them now from europcr.com!See also “Opening hours” for Exhibit hall information.
Exhibitor support centre For exhibitors only - office located on Level 1.
FoodSee "Lunch".
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page234
235235
FreeYour badge* includes access to all scientific sessions, the exhibition area,the Materials Catalogue, the Randomised Trials Book, EuroPCR &AsiaPCR/SingLIVE Abstracts Book, the EuroIntervention supplement andMay Issues.
A one-year subscription to EuroIntervention Journal from 17th May, 2011to 15th May, 2012 is also included, except for exhibitor and press badges.
Guest loungeAccess to the Guest Lounge is reserved for Guest Faculty only.
Badges will be checked at the entrance. Located on Level 2.
HotelsSee page 240 to find the complete list.Information also available in the smartphone applications (iPhone, Androïd and Blackberry). Download them now from europcr.com!
HoursFor onsite registration, scientific sessions, and exhibition area: see "Opening hours".
Interactive case cornerRendez-vous at the interactive case corner to discuss the cases submittedfor EuroPCR 2011. Participants will exchange on their experience in afriendly environment, without time constraints.
Innovation incubatorGrab a bite to eat at the buffet and chat with representatives from companies who bring you the latest innovations.Wednesday only, open to all, Level 3.
InternetFree WiFi is available in selected areas. If you need a computer, visit the Cyber space, located on Level 1.
IPhoneThe application dedicated to EuroPCR is available and includes: breakingnews, the scientific programme, all exhibitors, maps and more.
Download it now at europcr.com!
LanguageEnglish is the official language of EuroPCR.
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page235
Your A-Z for EuroPCR
236
LinkedInLinkedIn account holders can join the LinkedIn PCRonline group to conti-nue to share their EuroPCR visit online and stay up-to-date with all thelatest news.
Live messagesWrite and send instant messages published on PCRonline during theCourse! Tell us about your EuroPCR experience and post your text at thePCR Family stand M20, Level 2.
Lost and FoundLost property can be found at the Exhibitor support centre. Located on Level 1.
LunchLunch buffets open at 12:00 at the cafés situated Level 1 and Level 2: Bistrot Montmartre, London Pub, Singapore Food Court, Café de Paris. Lunch bags distributed at 13:00. As a reminder, eating is not allowed insession rooms.
Meeting roomsLocated on the mezzanines, Levels 1, 2, 3.Access via the stairs on the leftand right of the building. See maps page 2.
MetroLine 1 direction Porte Maillot - Palais des Congrès stop.
NewsStay updated with all EuroPCR events. Read the Daily, consult the brea-king news on the EuroPCR smartphone applications, or consult PCRon-line.com at the Cyber space.
Opening hours
Scientific sessions
Tuesday 17th May 10:00 - 19:00
Wednesday 18th May 08:00 - 18:30
Thursday 19th May 08:00 - 19:00
Friday 20th May 09:00 - 14:00
Exhibition area
Tuesday 17th May 09:00 - 18:30
Wednesday 18th May 07:30 - 18:30
Thursday 19th May 07:30 - 18:30
Friday 20th May 08:30 - 13:00
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page236
Onsite registration
Sunday 15th May 14:00 - 18:00
Monday 16th May 08:00 - 18:00
Tuesday 17th May 07:00 - 18:30
Wednesday 18th May 07:00 - 18:30
Thursday 19th May 07:00 - 18:30
Friday 20th May 08:00 - 13:00
Preview room:
Monday 16th May 09:00 - 18:00
Tuesday 17th May 07:00 - 18:30
Wednesday 18th May 07:00 - 19:00
Thursday 19th May 07:00 - 19:00
Friday 20th May 08:00 - 13:00
PharmacyThe nearest pharmacy is on Level 0 of the Palais des Congrès shoppingcentre.
PhotographyPhotography and filming are strictly prohibited.
Poster areaVisit the poster area on Level 1.Poster presentations with authors: Wednesday 18th: 12:00 - 13:30 Thursday 19th: 12:00 - 13:30
PCR family boothVisit us at booth M20 – Level 2 and find out more about the PCR family:EuroPCR, AsiaPCR/SingLIVE, PCR London Valves, EuroIntervention,PCRonline, PCR publishing, PCR seminars and PCR trials.
PCRonlineA trusted online reference source for the entire cardiovascular community,offering you free access all year round to the scientific content from EuroPCR, reviews, comments and much more. A place for the wholecommunity to stay in touch, to share and exchange.Visit us at the PCR family booth M20, Level 2.
PressThe Press office and the Press conference room are located on Level 3 -rooms 301/302/303.
237
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page237
Your A-Z for EuroPCR
238
Preview roomFor speakers only. All speakers must upload their slides at least 3hours before the start of the session. Located on Level 2, open from9:00 am Monday 16th.
ShuttlesSee “Airport shuttle” or “Train station shuttle”.
SmokingThe Palais des Congrès is a non-smoking building.
TourismFor tours of Paris or other tourist information, go to the Conciergedesk. Located on Level 0.
Train station shuttleFree shuttles will take you from the Gare du Nord train station tothe Palais des Congrès and back.
From Gare du Nord train station to Palais des Congrès
Tuesday 17th 9:30, 10:30, 11:30, 12:30, 13:30
Wednesday 18th 9:30, 10:30, 11:30, 12:30, 13:30
Departure points: Bus station Level 1 - Gare routière
From Palais des Congrès to Gare du Nord train station
Thursday 19th 16:30, 17:30, 18:30
Friday 20th 11:00, 12;00, 13:00
Departure points: Parking Pershing - Boulevard Pershing
VisitsSee "Tourism".
WaterSelf-service fountains are provided on Level 1,2 & 3.
WiFiFree WiFi connection is available in selected areas.
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page238
Paris hotels
240
ALL SEASONS LAFAYETTE** 25 rue Vernet, 75008 PARISTel: +33 1 48 01 09 82 [email protected] www.accorhotels.com
APARTHOTEL ADAGIO HASSMAN*** 129 - 131 boulevard Haussmann 75008 PARISTel: +33 1 56 88 61 00 [email protected] www.accorhotels.com
APARTHOTEL ADAGIO TOUR EIFFEL*** 14 rue du Théatre 75015 PARISTel: +33 1 45 71 88 88 [email protected] www.accorhotels.com
APARTHOTEL ADAGIO OPÉRA*** 43 rue Caumartin 75009 PARISTel: +33 1 58 18 08 20 [email protected] www.accorhotels.com
APARTHOTEL ADAGIO PARC COURBEVOIE*** 1 rue des Lilas d’Espagne 92400 COURBEVOIETel: +33 1 55 70 79 79 [email protected] www.accorhotels.com
HOTEL ASTRID*** 27 avenue Carnot 75017 PARISTel: +33 1 44 09 26 00 [email protected] www.hotelastridparis.fr
HOTEL BASSANO**** 15 rue Bassano 75016 PARISTel: +33 1 47 23 78 23 [email protected] www.hotel-bassano.com
HOTEL BEST WESTERN DUCS DE BOURGOGNE 19 rue du Pont Neuf, 75001 PARISTel: +33 1 42 33 95 64 [email protected] paris-hotel-bourgogne.com
HOTEL BEST WESTERN MATHIS ELYSÉES MATIGNON 3 rue de Ponthieu, 75008 PARISTel: +33 1 42 25 73 01 [email protected] paris-hotel-mathis.com
HOTEL BEST WESTERN REGENTS GARDEN**** 6 rue Pierre Demours 75017 PARISTel: +33 1 45 74 07 30 [email protected] www.hotel-regents-paris.com
HOTEL BEST WESTERN STAR CHAMPS ELYSÉES*** 18 rue de l'Arc de Triomphe 75017 PARISTel: +33 1 43 80 27 69 [email protected] www.paris-hotel-staretoile.com
HOTEL BEST LOUVRE WESTERN ST HONORE**** 141 rue Saint Honoré 75001 PARISTel: +33 1 42 96 23 23 [email protected] www.bestwestern.fr
HOTEL CECILIA*** 11 avenue Mac Mahon 75017 PARISTel: +33 1 43 80 32 10 [email protected] www.hotelceciliaparis.mobi
HOTEL CHÂTEAU FRONTENAC**** 54 rue Pierre Charbon 75008 PARISTel: +33 1 53 23 13 13 [email protected] www.hfrontenac.com
HOTEL CONCORDE LAFAYETTE**** 3 place du Général Koenig 75017 PARISTel: +33 1 40 68 50 68 [email protected] www.concorde-lafayette.com
HOTEL CONCORDE MONTPARNASSE**** 40 rue du Commandant Mouchotte 75014 PARISTel: +33 1 56 54 84 00 [email protected] www.montparnasse.concorde-hotels.fr
HOTEL CONCORDE OPERA**** 108 rue Saint-Lazare 75008 PARISTel: +33 1 40 08 44 44 [email protected] www.operaparis.concorde-hotels.fr
HOTEL COURCELLES ETOILE*** 184 rue de Courcelles 75017 PARISTel: +33 1 47 63 65 30 [email protected] www.hotel-ce.com
HOTEL COURTYARD NEUILLY**** 58 boulevard Victor-Hugo 92200 NEUILLY-SUR-SEINETel: +33 1 55 63 64 65 [email protected] www.marriott.fr
HOTEL DU BOIS*** 11 rue du Dôme 75116 PARISTel: +33 1 45 00 31 96 [email protected] www.hoteldubois.com
HOTEL ELYSEES REGENCIA**** 41 avenue Marceau 75016 PARISTel: +33 1 47 20 42 65 [email protected] www.regencia.com
HOTEL ETOILE PARK*** 10 avenue Mac Mahon 75017 PARISTel: +33 1 42 67 69 63 [email protected] www.etoileparkhotel.com
HOTEL EVERGREEN**** 8 place Georges Pompidou 92300 LEVALLOIS-PERRETTel: + 33 1 47 58 88 99 [email protected] www.evergreenhotel-paris.com
HOTEL FRANCOIS ITel: +33 1 47 23 44 04
HOTEL FRANKLIN ROOSEVELT****Tel: +33 1 53 57 49 50
FRASER SUITES HARMONIE LA DEFENSE****Tel: +33 1 55 23 26 26
FRASER SUITES CHAMPS ÉLYSÉES****Tel: +33 1 44 13 33 33
HOLIDAY INN PORTE DE CLICHY***Tel: +33 1 76 68 77 00
HOTEL HILTON ARC DE TRIOMPHE****Tel: +33 1 58 36 67 00
HOTEL HILTON DEFENSE****Tel: +33 1 46 92 10 10
HOTEL HIDDEN HOTEL****Tel: +33 1 40 55 03 57
HOTEL IBIS DEFENSE**Tel: +33 1 41 97 40 40
HOTEL JARDIN DE NEUILLY****Tel: +33 1 46 24 22 77
HOTEL KEPPLER****Tel: +33 1 47 20 65 05
HOTEL LE LUMEN****Tel: +33 1 44 50 77 00
HOTEL LE LUTETIA****Tel: +33 1 49 54 46 46
HOTEL LOUVRE CONCORDE****Tel: +33 1 44 58 38 38
HOTEL MAGELLAN***Tel: +33 1 45 72 44 51
HOTEL MERCURE DEFENSE 5***Tel: +33 1 49 04 75 00
HOTEL MERCURE LAFAYETTE***Tel: +33 1 47 70 26 75
HOTEL MERCURE MONTMARTRE****Tel: +33 1 44 69 70 70
HOTEL MERCURE MONTY OPÉRA***Tel: +33 1 47 70 26 10
HOTEL MERCURE OPERA CUSSET***Tel: +33 1 42 97 48 90
HOTEL PARIS NEUILLY***Tel: +33 1 47 47 14 67
HOTEL MERCURE ROYAL MADELEINE***Tel: +33 1 42 66 13 81
HOTEL MERCURE TOUR EIFFEL SUFFREN****Tel: +33 1 45 78 50 00
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page240
241
HOTEL FRANCOIS Ier**** 7 rue Magellan 75008 PARIS Tel: +33 1 47 23 44 04 [email protected] www.the-paris-hotel.com
HOTEL FRANKLIN ROOSEVELT**** 18 rue Clément Marot 75008 PARISTel: +33 1 53 57 49 50 [email protected] www.hroosevelt.com
FRASER SUITES HARMONIE LA DEFENSE**** 6 boulevard de Neuilly 92400 COURBEVOIETel: +33 1 55 23 26 26 [email protected] paris.frasershospitality.com
FRASER SUITES CHAMPS ÉLYSÉES**** 74 avenue des Champs-Elysées 75008 PARISTel: +33 1 44 13 33 33 [email protected] paris.frasershospitality.com
HOLIDAY INN PORTE DE CLICHY*** 2 rue du 8 Mai 1945 92110 CLICHYTel: +33 1 76 68 77 00 [email protected] www.holidayinn.com
HOTEL HILTON ARC DE TRIOMPHE**** 57 rue de Courcelles 75008 PARISTel: +33 1 58 36 67 00 [email protected] www1.hilton.com
HOTEL HILTON DEFENSE**** 2 place de la Défense CNIT 92053 PARISTel: +33 1 46 92 10 10 [email protected] www1.hilton.com
HOTEL HIDDEN HOTEL**** 28 rue de l'Arc de Triomphe 75017 PARISTel: +33 1 40 55 03 57 [email protected] hidden-hotel.com
HOTEL IBIS DEFENSE** 4 boulevard de Neuilly La Défense 1 Pont de Neuilly 92081 LA DEFENSETel: +33 1 41 97 40 40 [email protected] www.ibishotel.com
HOTEL JARDIN DE NEUILLY**** 5 rue Paul Déroulède 92200 NEUILLY-SUR-SEINETel: +33 1 46 24 22 77 [email protected] www.hoteljardindeneuilly.com
HOTEL KEPPLER**** 10 rue Keppler 75016 PARISTel: +33 1 47 20 65 05 [email protected] www.keppler.fr
HOTEL LE LUMEN**** 15 rue des Pyramides 75001 PARISTel: +33 1 44 50 77 00 [email protected] www.hotel-lumenparis.com
HOTEL LE LUTETIA**** 45 boulevard Raspail 75006 PARISTel: +33 1 49 54 46 46 [email protected] www.lutetia-paris.com
HOTEL LOUVRE CONCORDE**** Place André Malraux 75001 PARISTel: +33 1 44 58 38 38 [email protected] www.louvre.concorde-hotels.fr
HOTEL MAGELLAN*** 17-19 rue Jean-Baptiste Dumas 75017 PARISTel: +33 1 45 72 44 51 [email protected] www.hotelmagellan.com
HOTEL MERCURE DEFENSE 5*** 18-30 rue Baudin Place Charras 92400 COURBEVOIETel: +33 1 49 04 75 00 [email protected] www.mercure.com
HOTEL MERCURE LAFAYETTE*** 7 rue de Trevise 75009 PARISTel: +33 1 47 70 26 75 [email protected] www.mercure.com
HOTEL MERCURE MONTMARTRE**** 3 rue Caulaincourt 75018 PARISTel: +33 1 44 69 70 70 [email protected] www.mercure.com
HOTEL MERCURE MONTY OPÉRA*** 5 rue de Montyon 75009 PARISTel: +33 1 47 70 26 10 [email protected] www.mercure.com
HOTEL MERCURE OPERA CUSSET*** 95 rue de Richelieu 75002 PARISTel: +33 1 42 97 48 90 [email protected] www.accorhotels.com
HOTEL PARIS NEUILLY*** 199 avenue Charles de Gaulle 92200 NEUILLY-SUR-SEINE Tel: +33 1 47 47 14 67 [email protected] www.accorhotels.com
HOTEL MERCURE ROYAL MADELEINE*** 29 rue de l'arcade 75008 PARISTel: +33 1 42 66 13 81 [email protected] www.accorhotels.com
HOTEL MERCURE TOUR EIFFEL SUFFREN**** 20 rue Jean-Rey 75015 PARISTel: +33 1 45 78 50 00 [email protected] www.mercure.com
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page241
Paris hotels
242
HOTEL MERIDIEN ETOILE**** 81 boulevard Gouvion St-Cyr 75017 PARISTel: +33 1 40 68 34 34 [email protected] www.lemeridienetoile.com
HOTEL MERIDIEN MONTPARNASSE**** 19 rue du Commandant Mouchotte 75014 PARISTel: +33 1 44 36 44 36 [email protected] www.lemeridien-montparnasse.com
HOTEL MON HOTEL**** 1 rue d'Argentine 75116 PARISTel: +33 1 45 02 76 76 monhotel.fr
HOTEL MONTFLEURI**** 21 avenue de la Grande Armée 75116 PARISTel: +33 1 45 00 33 65 [email protected] www.paris-hotel-montfleuri.com
HOTEL NAPOLEON**** 40 avenue de Frieldalnd 75008 PARISTel: +33 1 56 68 43 21 [email protected] www.hotelnapoleonparis.com
HOTEL NOVOTEL MONTPARNASSE**** 17 rue du Cotentin 75015 PARISTel: +33 1 53 91 23 75 [email protected] www.novotel.com
HOTEL NOVOTEL PARIS LA DEFENSE*** 2 boulevard de Neuilly 92081 LA DEFENSETel: +33 1 41 45 23 23 [email protected] www.novotel.com
HOTEL NOVOTEL PARIS LES HALLES**** 8 place Marguerite de Navarre 75001 PARISTel: +33 1 42 21 31 31 [email protected] www.accorhotels.com
HOTEL NOVOTEL PORTE D ASNIERES*** 34 avenue Porte d'Asnières 75017 PARISTel: +33 1 44 40 52 52 [email protected] www.accorhotels.com
HOTEL NOVOTEL TOUR EIFFEL**** 61 quai de Grenelle 75015 PARISTel: +33 1 40 58 20 00 [email protected] www.novotel.com
HOTEL NOVOTEL VAUGIRARD*** 257 rue de Vaugirard 75015 PARISTel: +33 1 40 45 10 00 [email protected] www.novotel.com
HOTEL PULLMAN LA DEFENSE**** 11 avenue de l'Arche 92081 PARIS LA DEFENSETel: +33 1 47 17 50 00 [email protected] www.accorhotels.com
HOTEL PULLMAN RIVE GAUCHE**** 8-12 rue Louis Armand 75015 PARISTel: +33 1 40 60 30 30 [email protected] www.accorhotels.com
HOTEL PULLMAN TOUR EIFFEL**** 18 avenue de Suffren 75015 PARISTel: +33 1 44 38 56 00 [email protected] www.accorhotels.com
HOTEL RADISSON BLU BOULOGNE**** 33 Avenue Edouard Vaillant - 92100 ParisTel: +33 1 46 08 85 00 [email protected] www.radissonblu.com
HOTEL RADISSON BLU LE DOKHAN'S**** 117 rue Lauriston 75016 PARISTel: +33 1 53 65 66 99 [email protected] www.radissonblu.fr
HOTEL RADISSON BLU METROPOLITAN**** 10 place de Mexico 75116 PARISTel: +33 1 56 90 40 04 [email protected] www.radissonblu.com
HOTEL RADISSON CHAMPS ELYSEES**** 78 bis avenue Marceau 75008 PARISTel: +33 1 53 234343 [email protected] www.radissonblu.com
HOTEL REGINA**** 2 places des Pyramides 75001 PARISTel: +33 1 42 60 31 10 [email protected] www.regina-hotel.com
HOTEL RENAISSANCE ARC DE TRIOMPHE**** 39 avenue de Wagram 75017 PARISTel: +33 1 55 37 55 37 [email protected] www.marriott.com
HOTEL RENAISSANCE LA DEFENSE**** 60 jardin de Valmy, boulevard Circulaire 92918 PARIS LA DEFENSETel: +33 1 41 97 50 50 [email protected] www.marriott.fr
HOTEL ROCHESTER CHAMPS ELYSEES**** 92 rue de la Boétie 75008 PARISTel: +33 1 56 69 69 00 [email protected] www.hrochester.com
HOTEL ST JAMES & ALBANY**** 202 rue de Rivoli 75001 PARISTel: + +33 1 44 58 43 21 [email protected] www.hotels-francepatrimoine.com
HOTEL SCRIBE BY SOFITEL*****Tel: +33 1 44 71 24 24
HOTEL SEZZ****Tel: +33 1 56 75 26 26
HOTEL SPLENDID ETOILE****Tel: +33 1 45 72 72 00
HOTEL SOFITEL ARC DE TRIOMPHE****Tel: +33 1 53 89 50 50
HOTEL SOFITEL LE BALTIMORE****Tel: +33 1 44 34 54 54
HOTEL SOFITEL DEFENSE CENTRE*****Tel: +33 1 47 76 44 43
HOTEL SOFITEL LE FAUBOURG*****Tel: +33 1 44 94 14 14
HOTEL VILLA DES TERNES***Tel: +33 1 53 81 94 94
HOTEL VERNET****Tel: +33 1 44 31 98 00
HOTEL WALDORF ARC DE TRIOMPHE****Tel: +33 1 47 64 67 67
HOTEL WALDORF TROCADERO****Tel: + 33 1 45 53 83 30
HOTEL WARWICK****Tel: +33 1 45 63 14 11
HOTEL WESTIN****Tel: +33 1 44 77 11 11
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page242
243
HOTEL SCRIBE BY SOFITEL***** 1 rue Scribe 75009 PARISTel: +33 1 44 71 24 24 [email protected] www.sofitel.com
HOTEL SEZZ**** 6 avenue Fremiet, 75016 PARISTel: +33 1 56 75 26 26 hotelsezz-paris.com
HOTEL SPLENDID ETOILE**** 1 avenue Carnot 75017 PARISTel: +33 1 45 72 72 00 [email protected] www.hsplendid.com
HOTEL SOFITEL ARC DE TRIOMPHE**** 14 rue Beaujon 75008 PARISTel: +33 1 53 89 50 50 [email protected] www.accorhotels.com
HOTEL SOFITEL LE BALTIMORE**** 88 bis avenue Kléber 75016 PARISTel: +33 1 44 34 54 54 [email protected] www.accorhotels.com
HOTEL SOFITEL DEFENSE CENTRE***** 33 voie des Sculpteurs 92800 PUTEAUXTel: +33 1 47 76 44 43 [email protected] www.sofitel.com
HOTEL SOFITEL LE FAUBOURG***** 15 rue Boissy d'Anglas 75008 PARISTel: +33 1 44 94 14 14 [email protected] www.sofitel.com
HOTEL VILLA DES TERNES*** 97 avenue des Ternes 75017 PARISTel: +33 1 53 81 94 94 [email protected] www.paris-hotel-ternes.com
HOTEL VERNET**** 25 rue Vernet, 75008 PARISTel: +33 1 44 31 98 00 [email protected] hotelvernet.com
HOTEL WALDORF ARC DE TRIOMPHE**** 36 rue Pierre Demours 75017 PARISTel: +33 1 47 64 67 67 [email protected] www.hotelswaldorfparis.com
HOTEL WALDORF TROCADERO**** 97 rue Lauriston 75016 PARISTel: + 33 1 45 53 83 30 [email protected] www.hotelswaldorfparis.com
HOTEL WARWICK**** 5 rue de Berri 75008 PARISTel: +33 1 45 63 14 11 [email protected] www.warwickparis.com
HOTEL WESTIN**** 3 rue de Castiglione 75001 PARISTel: +33 1 44 77 11 11 [email protected] www.starwoodhotels.com
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page243
Exhibition halls
244
Asahi Intecc Co., Ltd. P12
AstraZeneca M74
Atrium Europe BV F05
B. Braun Melsungen AG P01
BALTON M69
Biosensors International F30 + F31
Bioteque Corporation M85
BIOTRONIK F16
Boston Scientific F17 + F18
Cambus Medical M23
Cappella Medical Devices M01
COMPANY STAND Nr
Aachen Resonance GmbH N13-1
Abbott Vascular International
BVBA F11 + F12 + F13
Abiomed Europe GmbH M72
Accumetrics N13
Acist Medical Systems N19
ACROSTAK M02
Alvimedica Medical Technologies P10
amg International GmbH M41
Andramed GmbH N09
Angioplasty Summit-TCTAP T11
COMPANY STAND Nr
N19
N17
N14N16
N13
N13-1
N11
N09
N07
N05
N18
N15
N12
N08
N06
N04
N02
N03
N01
P16
P14
P12
P10
P07
P05
P04
P02P01
P03
P06
P08
P09
P11
P13
P15
F19F14
F10
F29
F20
F17 F15
F16
F12F11
F09
F08
F06F07
F04
F05F28
F30
F31
F27 F21
F22
F18
F26 F25 F24 F23
LONDON PUB
ABSTRACT
POSTERS
MAIN ARENA
SINGAPOREFOOD COURT
BAG PICK-UP
CYBER SPACE
T24 T23T22 T21 T20
T01 T02 T03-04-05
T18 T17T16 T15 T14
T07 T08 T09 T10 T11 T12T13
BOOTHS P01 TO P16
BOOTHSN01 TO
N19
BOOTHS FO4 TO F31
BOOTHS TO1 TO T24
F13
MONTMARTRE
Level 1
M18
M20
M12
M15
M07M09
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page244
245
F04
F05
FOOD COURT
BOOTHS P01 TO P16
M11
M14
M17
M64
M01
M65
M66
M67
M68
M73M74
M69M69-1
M70
M71M72
M02 M03 M04 M05
M06
M19M18
M85
M84
M83
M23M22
M56
M57
M54M55
M78M82
M77
M76
M81
M79M80
M75
M31M32
M34M35
M33
M36M37
M38
M39
M43M44
M42
M41
M45M46
M47
M49M50
M48M51M52
M53
M40
M20
M12 M13
M16M15
M07M09
M08M10
BOOTHS M01 TO M85
BISTROT MONTMARTRE
ROOMMAILLOT
PREVIEWROOM
GUEST LOUNGE
Level 2
GE HEALTHCARE M68
HEXACATH F09 + F10
HRA RESEARCH P09
IHT - Cordynamic N03 + N04
InspireMD P14
INVENT BIO-MED PVT.LTD. M49 + M50
IROKO CARDIO N12
ITGI Medical F24
Japan Stent Technology M11
JenaValve Technology M17
JIM 2012 T07
JOLIFE AB M47
KIMAL PLC M36 + M37
Lake Region Medical M31 + M32
Lancer Medical Technology
Pvt Ltd M78 + M82
Lepu Medical Technology
(Beijing) Co., Ltd M45 + M46
Liaoning Biomedical Center M83
Lifetech Scientific Co.,Ltd M42
Lumenous Device Technologies, Inc M18
CARDIOREPORT M13
Celonova Biosciences N07
Charing Cross / BIBA Medical T09
CID Srl N01 + N02
CIT T01
Comed BV N15
Cook Medical P16
Cordis, Johnson & Johnson F15
Creganna-Tactx Medical P08
CRF & ACC T03 + T04 + T05
CRTonline.org T08
Daiichi Sankyo Europe GmbH/Eli Lilly
International F04
Demax Medical Technology M76
DISA Vascular M04
EBIT AET (a business unit of ESAOTESpA) M03
Edwards Lifesciences F27
ESC / EAPCI M07 + M09
eucatech AG P15
Eurocor F28
EUROPEAN CARDIOVASCULAR
RESEARCH CENTER - CERC M06
COMPANY STAND Nr COMPANY STAND Nr
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page245
Exhibition halls
246
MINVASYS P04
Multiplate M22
NATEC MEDICAL LTD. P13
Occlutech M71
Onset Medical Corporation M39
OptiMed Medizinische Instrumente
GmbH F25
OrbusNeich N06
Ostial Corp. M38
Paieon Inc. M77
PAN MEDICAL LTD. M08 + M10
COMPANY STAND Nr
MAQUET Cardiovascular P05
Medis Medical Imaging Systems BV P11
MEDRAD Interventional / Bayer
Healthcare Pharmaceuticals N18
Medtronic International
Trading Sarl F19 + F20 + F21
Mentice AB N08
MERIL LIFE SCIENCES PVT. LTD. F22 + F23
Merit Medical M64
MicroPort Medical (Shanghai) Co., Ltd. M66
MINITUBES / QUALIMED / MEKO N17
COMPANY STAND Nr
Level 1
M18
M20
M12
M15
M07M09
N19
N17
N14N16
N13
N13-1
N11
N09
N07
N05
N18
N15
N12
N08
N06
N04
N02
N03
N01
P16
P14
P12
P10
P07
P05
P04
P02P01
P03
P06
P08
P09
P11
P13
P15
F19F14
F10
F29
F20
F17 F15
F16
F12F11
F09
F08
F06F07
F04
F05F28
F30
F31
F27 F21
F22
F18
F26 F25 F24 F23
LONDON PUB
ABSTRACT
POSTERS
MAIN ARENA
SINGAPOREFOOD COURT
BAG PICK-UP
CYBER SPACE
T24 T23T22 T21 T20
T01 T02 T03-04-05
T18 T17T16 T15 T14
T07 T08 T09 T10 T11 T12T13
BOOTHS P01 TO P16
BOOTHSN01 TO
N19
BOOTHS FO4 TO F31
BOOTHS TO1 TO T24
F13
MONTMARTRE
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page246
247
Level 2
STENTYS N05
Svelte Medical Systems, Inc. M57
Symetis SA M53
Synexmed (Shenzhen) Company Limited M81
Teleflex F26
Terumo Europe F14
The Medicines Company M70
theheart.org M19
TOBI & EVACS T02
TORAY M40
Toshiba Medical Systems M84
translumina GmbH M51 + M52
TriReme Medical M16
Tryton Medical, Inc. P03
Vascular Concepts Ltd M65
Vascular Solutions, Inc. P06
Vasmed Technologies Ltd. N14 + N16
VOLCANO F29
Wisepress T12 + T13
Ziehm Imaging M54 + M55
ZOLL Medical Corporations M15
PCR Family M20
PendraCare P07
PEROUSE MEDICAL M05
pfm medical ag M14
PHILIPS HEALTHCARE M73
Pie Medical Imaging M48
PLC Medical Systems, Inc. M12
PRECISION WIRE COMPONENTS M75
Promed Medical Tech. (Suzhou) Co., Ltd M33
QuikClot® M69-1
Rontis AG P02
Sahajanand Medical
Technologies Private Limited M34 + M35
Scientific Village T14 to T23
SCITECH MED M43 + M44
Siemens AG Healthcare Sector M67
Silicon Valley Medical Instruments, Inc M56
Simbionix USA Corp. N11
SIS MEDICAL AG M79 + M80
SOLACI T10
St Jude Medical F06 + F07 + F08
COMPANY STAND Nr COMPANY STAND Nr
M11
M14
M17
M64
M01
M65
M66
M67
M68
M73M74
M69M69-1
M70
M71M72
M02 M03 M04 M05
M06
M19M18
M85
M84
M83
M23M22
M56
M57
M54M55
M78M82
M77
M76
M81
M79M80
M75
M31M32
M34M35
M33
M36M37
M38
M39
M43M44
M42
M41
M45M46
M47
M49M50
M48M51M52
M53
M40
M20
M12 M13
M16M15
M07M09
M08M10
BOOTHS M01 TO M85
BISTROT MONTMARTRE
ROOMMAILLOT
PREVIEWROOM
GUEST LOUNGE
F04
F05
FOOD COURT
BOOTHS P01 TO P16
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page247
Palais des Congrès plan
248
133M 132M 131M
138M
137M
136M
135M
134M
128M
127M
126M
125M
124M
121M 122M 123M
EXHIBITION HALL
LONDON PUB
CYBER SPACE ABSTRACTPOSTERS
SINGAPOREFOOD COURT
BAG PICK-UP
MAIN ARENA
EX
HI
BI
TI
ON
EX
HI
BI
TI
ON
103102101
104
111112113
EXHIBITOR SUPPORT CENTRE
MEET WITHTHE TRIALISTS
WC
WC WC
WCWC
WC WC
WC
MEZZANINE MEZZANINE
ENTRANCE
REGISTRATION AREA
TO LEVEL 1 TO LEVEL 1
CONCIERGE,HOTEL
FACULTYDESKS
TO LEVEL 0,5:
COMPANIES DESK, CLOAKROOM
Level 0
Level 1
11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page248
MEZZANINE MEZZANINEPRESS
342AB
341351
353
THEATREBORDEAUX
THEATREHAVANE
TRAININGVILLAGE
INNOVATION INCUBATORWEDNESDAY
303
304
305
302313 301
329M
328M
327M
326M
325M
227M320M
227M321M
227M322M
324M
323M
339M
338M
337M
336M
335M
CASE CORNER
WC
WC WC
WCWC
WC WC
WC
PCRTV
352AB
343
334M
333M 332M
331M
330M
312
314 311
INTERACTIVECASE CORNER
233M 232M 231M
237M
236M
235M
234M
227M
226M
225M
224M
221M 222M 223M
EXHIBITION HALL
243
241251
253
BISTROT MONTMARTRE
PCR FAMILY STAND
PREVIEW
THEATREBLEU
ROOMMAILLOT
MAIN ARENA
204
211213 203202201212
WC
WC WC
WCWC
WC WC
WC
MEZZANINE MEZZANINE
242A
242B
GUESTLOUNGE
252AB
Level 2
Level 3
11T0768_PCRpocket_00_Couv 18/04/11 11:29 Page3